TW202128973A - Cleaning agent, and cleaning method and cleaning device using cleaning agent - Google Patents
Cleaning agent, and cleaning method and cleaning device using cleaning agent Download PDFInfo
- Publication number
- TW202128973A TW202128973A TW109142718A TW109142718A TW202128973A TW 202128973 A TW202128973 A TW 202128973A TW 109142718 A TW109142718 A TW 109142718A TW 109142718 A TW109142718 A TW 109142718A TW 202128973 A TW202128973 A TW 202128973A
- Authority
- TW
- Taiwan
- Prior art keywords
- cleaning
- mass
- cleaning agent
- fluorine
- based alcohol
- Prior art date
Links
- 238000004140 cleaning Methods 0.000 title claims abstract description 328
- 239000012459 cleaning agent Substances 0.000 title claims abstract description 303
- 238000000034 method Methods 0.000 title claims abstract description 153
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 266
- 241000700605 Viruses Species 0.000 claims abstract description 137
- 229910052731 fluorine Inorganic materials 0.000 claims abstract description 130
- 239000011737 fluorine Substances 0.000 claims abstract description 130
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims abstract description 129
- 241000894006 Bacteria Species 0.000 claims abstract description 51
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 125000005010 perfluoroalkyl group Chemical group 0.000 claims abstract description 14
- 239000002689 soil Substances 0.000 claims description 108
- 239000002904 solvent Substances 0.000 claims description 46
- 239000000645 desinfectant Substances 0.000 claims description 36
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims description 34
- 125000004432 carbon atom Chemical group C* 0.000 claims description 23
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 20
- 241000701161 unidentified adenovirus Species 0.000 claims description 14
- 241000709661 Enterovirus Species 0.000 claims description 13
- AQYSYJUIMQTRMV-UHFFFAOYSA-N hypofluorous acid Chemical compound FO AQYSYJUIMQTRMV-UHFFFAOYSA-N 0.000 claims description 10
- 241001263478 Norovirus Species 0.000 claims description 9
- PSQZJKGXDGNDFP-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropan-1-ol Chemical compound OCC(F)(F)C(F)(F)F PSQZJKGXDGNDFP-UHFFFAOYSA-N 0.000 claims description 8
- 241000711549 Hepacivirus C Species 0.000 claims description 8
- 241000712461 unidentified influenza virus Species 0.000 claims description 8
- 241000702670 Rotavirus Species 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 138
- -1 pH adjusters Substances 0.000 description 72
- 239000000523 sample Substances 0.000 description 61
- 238000011156 evaluation Methods 0.000 description 53
- 210000004027 cell Anatomy 0.000 description 52
- 238000005406 washing Methods 0.000 description 50
- 235000002639 sodium chloride Nutrition 0.000 description 48
- 102000004190 Enzymes Human genes 0.000 description 47
- 108090000790 Enzymes Proteins 0.000 description 47
- 229940088598 enzyme Drugs 0.000 description 47
- 230000000694 effects Effects 0.000 description 43
- 238000003860 storage Methods 0.000 description 36
- 238000004659 sterilization and disinfection Methods 0.000 description 32
- 239000004365 Protease Substances 0.000 description 31
- 239000003795 chemical substances by application Substances 0.000 description 30
- 150000003839 salts Chemical class 0.000 description 30
- 102000035195 Peptidases Human genes 0.000 description 29
- 108091005804 Peptidases Proteins 0.000 description 29
- 230000000052 comparative effect Effects 0.000 description 28
- 239000000243 solution Substances 0.000 description 28
- 238000012360 testing method Methods 0.000 description 28
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 27
- 238000005260 corrosion Methods 0.000 description 27
- 230000007797 corrosion Effects 0.000 description 27
- 235000019419 proteases Nutrition 0.000 description 27
- 230000001954 sterilising effect Effects 0.000 description 26
- 239000000654 additive Substances 0.000 description 25
- 230000000844 anti-bacterial effect Effects 0.000 description 25
- 229910052751 metal Inorganic materials 0.000 description 24
- 239000002184 metal Substances 0.000 description 24
- 230000009849 deactivation Effects 0.000 description 23
- 239000007788 liquid Substances 0.000 description 23
- 239000011550 stock solution Substances 0.000 description 23
- 229920005862 polyol Polymers 0.000 description 22
- 150000003077 polyols Chemical class 0.000 description 22
- 239000004094 surface-active agent Substances 0.000 description 22
- 239000012153 distilled water Substances 0.000 description 21
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 20
- 230000002779 inactivation Effects 0.000 description 20
- 235000018102 proteins Nutrition 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 108090000623 proteins and genes Proteins 0.000 description 20
- 239000004367 Lipase Substances 0.000 description 19
- 102000004882 Lipase Human genes 0.000 description 19
- 108090001060 Lipase Proteins 0.000 description 19
- 235000019421 lipase Nutrition 0.000 description 19
- 241000714201 Feline calicivirus Species 0.000 description 18
- 239000002253 acid Substances 0.000 description 18
- PPBOKXIGFIBOGK-BDTUAEFFSA-N bvdv Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)CC)C1=CN=CN1 PPBOKXIGFIBOGK-BDTUAEFFSA-N 0.000 description 18
- 239000003381 stabilizer Substances 0.000 description 18
- 239000003599 detergent Substances 0.000 description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 15
- 229910052799 carbon Inorganic materials 0.000 description 15
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 14
- 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 239000002518 antifoaming agent Substances 0.000 description 14
- 239000002738 chelating agent Substances 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 14
- 239000003002 pH adjusting agent Substances 0.000 description 14
- 238000009835 boiling Methods 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 13
- 239000002609 medium Substances 0.000 description 13
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 12
- 108091000054 Prion Proteins 0.000 description 12
- 102000029797 Prion Human genes 0.000 description 12
- 150000001298 alcohols Chemical class 0.000 description 12
- 125000002947 alkylene group Chemical group 0.000 description 12
- 238000010586 diagram Methods 0.000 description 12
- 239000002736 nonionic surfactant Substances 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 230000002378 acidificating effect Effects 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 239000005416 organic matter Substances 0.000 description 9
- 239000011734 sodium Substances 0.000 description 9
- 229910052708 sodium Inorganic materials 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000003146 anticoagulant agent Substances 0.000 description 8
- 229940127219 anticoagulant drug Drugs 0.000 description 8
- 239000007844 bleaching agent Substances 0.000 description 8
- 238000004113 cell culture Methods 0.000 description 8
- 210000004748 cultured cell Anatomy 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 8
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 102000005158 Subtilisins Human genes 0.000 description 7
- 108010056079 Subtilisins Proteins 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 230000009385 viral infection Effects 0.000 description 7
- 102000013142 Amylases Human genes 0.000 description 6
- 108010065511 Amylases Proteins 0.000 description 6
- 108010059892 Cellulase Proteins 0.000 description 6
- 108010006035 Metalloproteases Proteins 0.000 description 6
- 102000005741 Metalloproteases Human genes 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Natural products OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 102000012479 Serine Proteases Human genes 0.000 description 6
- 108010022999 Serine Proteases Proteins 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 235000019418 amylase Nutrition 0.000 description 6
- 230000003013 cytotoxicity Effects 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 238000007865 diluting Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 230000002458 infectious effect Effects 0.000 description 6
- 150000004715 keto acids Chemical class 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- 239000012488 sample solution Substances 0.000 description 6
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 5
- 239000004382 Amylase Substances 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 239000004115 Sodium Silicate Substances 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 239000002280 amphoteric surfactant Substances 0.000 description 5
- 239000003945 anionic surfactant Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 229940106157 cellulase Drugs 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- 239000012091 fetal bovine serum Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 150000002772 monosaccharides Chemical class 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 229910052911 sodium silicate Inorganic materials 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- GILIYJDBJZWGBG-UHFFFAOYSA-N 1,1,1-trifluoropropan-2-ol Chemical compound CC(O)C(F)(F)F GILIYJDBJZWGBG-UHFFFAOYSA-N 0.000 description 4
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 4
- 102000004580 Aspartic Acid Proteases Human genes 0.000 description 4
- 108010017640 Aspartic Acid Proteases Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108090000787 Subtilisin Proteins 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 230000002421 anti-septic effect Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000019864 coconut oil Nutrition 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 241001493065 dsRNA viruses Species 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 229910052913 potassium silicate Inorganic materials 0.000 description 4
- 235000019353 potassium silicate Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000006283 soil fumigant Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 125000003396 thiol group Chemical group [H]S* 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 210000003501 vero cell Anatomy 0.000 description 4
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 241000589291 Acinetobacter Species 0.000 description 3
- 108010005843 Cysteine Proteases Proteins 0.000 description 3
- 102000005927 Cysteine Proteases Human genes 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 3
- 241001480714 Humicola insolens Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004111 Potassium silicate Substances 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010041925 Staphylococcal infections Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 108010059993 Vancomycin Proteins 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 229910052910 alkali metal silicate Inorganic materials 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 150000001639 boron compounds Chemical class 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 3
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 3
- 150000002169 ethanolamines Chemical class 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 235000011007 phosphoric acid Nutrition 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- NNHHDJVEYQHLHG-UHFFFAOYSA-N potassium silicate Chemical compound [K+].[K+].[O-][Si]([O-])=O NNHHDJVEYQHLHG-UHFFFAOYSA-N 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 235000003441 saturated fatty acids Nutrition 0.000 description 3
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 238000004506 ultrasonic cleaning Methods 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 3
- 229960003165 vancomycin Drugs 0.000 description 3
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
- ZMJBYMUCKBYSCP-UHFFFAOYSA-N (+)-Erythro-hydroxycitric acid Natural products OC(=O)C(O)C(O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- YAXKTBLXMTYWDQ-UHFFFAOYSA-N 1,2,3-butanetriol Chemical compound CC(O)C(O)CO YAXKTBLXMTYWDQ-UHFFFAOYSA-N 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 2
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 2
- NPHULPIAPWNOOH-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(2,3-dihydroindol-1-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCC2=CC=CC=C12 NPHULPIAPWNOOH-UHFFFAOYSA-N 0.000 description 2
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 2
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 241000194103 Bacillus pumilus Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- 229940123150 Chelating agent Drugs 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 208000001528 Coronaviridae Infections Diseases 0.000 description 2
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VZWGRQBCURJOMT-UHFFFAOYSA-N Dodecyl acetate Chemical compound CCCCCCCCCCCCOC(C)=O VZWGRQBCURJOMT-UHFFFAOYSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000007976 Ketosis Diseases 0.000 description 2
- 101710172072 Kexin Proteins 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 2
- 241001661345 Moesziomyces antarcticus Species 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- 108090000284 Pepsin A Proteins 0.000 description 2
- 102000057297 Pepsin A Human genes 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000000474 Poliomyelitis Diseases 0.000 description 2
- 229920000388 Polyphosphate Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 description 2
- 241000589614 Pseudomonas stutzeri Species 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- IHTFTOGFXXXQBO-UHFFFAOYSA-B [C+4].[C+4].[C+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O Chemical compound [C+4].[C+4].[C+4].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O IHTFTOGFXXXQBO-UHFFFAOYSA-B 0.000 description 2
- OAUXSBFJNWOKFV-UHFFFAOYSA-N [C].OS(O)(=O)=O Chemical compound [C].OS(O)(=O)=O OAUXSBFJNWOKFV-UHFFFAOYSA-N 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-N acetoacetic acid Chemical compound CC(=O)CC(O)=O WDJHALXBUFZDSR-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 108010007093 dispase Proteins 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003337 fertilizer Substances 0.000 description 2
- 239000003063 flame retardant Substances 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 150000002584 ketoses Chemical class 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 108010020132 microbial serine proteinases Proteins 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 229940111202 pepsin Drugs 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229920005646 polycarboxylate Polymers 0.000 description 2
- 239000001205 polyphosphate Substances 0.000 description 2
- 235000011176 polyphosphates Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 229940043230 sarcosine Drugs 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 2
- 229940082004 sodium laurate Drugs 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000003900 soil pollution Methods 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 125000000542 sulfonic acid group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000005727 virus proliferation Effects 0.000 description 2
- 239000004034 viscosity adjusting agent Substances 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- CIOXZGOUEYHNBF-UHFFFAOYSA-N (carboxymethoxy)succinic acid Chemical compound OC(=O)COC(C(O)=O)CC(O)=O CIOXZGOUEYHNBF-UHFFFAOYSA-N 0.000 description 1
- DQPISTPJWDOSBF-UHFFFAOYSA-N (diacetyloxyamino) acetate Chemical compound CC(=O)ON(OC(C)=O)OC(C)=O DQPISTPJWDOSBF-UHFFFAOYSA-N 0.000 description 1
- ORTVZLZNOYNASJ-UPHRSURJSA-N (z)-but-2-ene-1,4-diol Chemical compound OC\C=C/CO ORTVZLZNOYNASJ-UPHRSURJSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 150000000180 1,2-diols Chemical class 0.000 description 1
- QNGBRPMOFJSFMF-UHFFFAOYSA-N 1-(4-sulfanylphenyl)ethanone Chemical compound CC(=O)C1=CC=C(S)C=C1 QNGBRPMOFJSFMF-UHFFFAOYSA-N 0.000 description 1
- XKQMKMVTDKYWOX-UHFFFAOYSA-N 1-[2-hydroxypropyl(methyl)amino]propan-2-ol Chemical compound CC(O)CN(C)CC(C)O XKQMKMVTDKYWOX-UHFFFAOYSA-N 0.000 description 1
- HKGKYUVCADNOOC-UHFFFAOYSA-N 1-aminotetradecan-2-ol Chemical compound CCCCCCCCCCCCC(O)CN HKGKYUVCADNOOC-UHFFFAOYSA-N 0.000 description 1
- LOCUWELCCSIXGV-UHFFFAOYSA-N 1-cyclohexylpropane-1,2,3-triol Chemical compound OCC(O)C(O)C1CCCCC1 LOCUWELCCSIXGV-UHFFFAOYSA-N 0.000 description 1
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- LZXATDXVQWFSFA-UHFFFAOYSA-N 2,3-dimethylhex-1-ene-1,1-diol Chemical compound CCCC(C)C(C)=C(O)O LZXATDXVQWFSFA-UHFFFAOYSA-N 0.000 description 1
- LXOFYPKXCSULTL-UHFFFAOYSA-N 2,4,7,9-tetramethyldec-5-yne-4,7-diol Chemical compound CC(C)CC(C)(O)C#CC(C)(O)CC(C)C LXOFYPKXCSULTL-UHFFFAOYSA-N 0.000 description 1
- IHJUECRFYCQBMW-UHFFFAOYSA-N 2,5-dimethylhex-3-yne-2,5-diol Chemical compound CC(C)(O)C#CC(C)(C)O IHJUECRFYCQBMW-UHFFFAOYSA-N 0.000 description 1
- ZWNMRZQYWRLGMM-UHFFFAOYSA-N 2,5-dimethylhexane-2,5-diol Chemical group CC(C)(O)CCC(C)(C)O ZWNMRZQYWRLGMM-UHFFFAOYSA-N 0.000 description 1
- CFPOJWPDQWJEMO-UHFFFAOYSA-N 2-(1,2-dicarboxyethoxy)butanedioic acid Chemical compound OC(=O)CC(C(O)=O)OC(C(O)=O)CC(O)=O CFPOJWPDQWJEMO-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- LCZVSXRMYJUNFX-UHFFFAOYSA-N 2-[2-(2-hydroxypropoxy)propoxy]propan-1-ol Chemical compound CC(O)COC(C)COC(C)CO LCZVSXRMYJUNFX-UHFFFAOYSA-N 0.000 description 1
- BYACHAOCSIPLCM-UHFFFAOYSA-N 2-[2-[bis(2-hydroxyethyl)amino]ethyl-(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)CCN(CCO)CCO BYACHAOCSIPLCM-UHFFFAOYSA-N 0.000 description 1
- RAEOEMDZDMCHJA-UHFFFAOYSA-N 2-[2-[bis(carboxymethyl)amino]ethyl-[2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]ethyl]amino]acetic acid Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CCN(CC(O)=O)CC(O)=O)CC(O)=O RAEOEMDZDMCHJA-UHFFFAOYSA-N 0.000 description 1
- QCHFGCDNLNBQLJ-UHFFFAOYSA-N 2-[2-ethylhexyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCC(CC)CN(CCO)CCO QCHFGCDNLNBQLJ-UHFFFAOYSA-N 0.000 description 1
- HHRGNKUNRVABBN-UHFFFAOYSA-N 2-[2-hydroxyethyl(propan-2-yl)amino]ethanol Chemical compound OCCN(C(C)C)CCO HHRGNKUNRVABBN-UHFFFAOYSA-N 0.000 description 1
- OZICRFXCUVKDRG-UHFFFAOYSA-N 2-[2-hydroxyethyl(propyl)amino]ethanol Chemical compound CCCN(CCO)CCO OZICRFXCUVKDRG-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- GVNHOISKXMSMPX-UHFFFAOYSA-N 2-[butyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCN(CCO)CCO GVNHOISKXMSMPX-UHFFFAOYSA-N 0.000 description 1
- HHPDFYDITNAMAM-UHFFFAOYSA-N 2-[cyclohexyl(2-hydroxyethyl)amino]ethanol Chemical compound OCCN(CCO)C1CCCCC1 HHPDFYDITNAMAM-UHFFFAOYSA-N 0.000 description 1
- NKFNBVMJTSYZDV-UHFFFAOYSA-N 2-[dodecyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCCCCCCCCCN(CCO)CCO NKFNBVMJTSYZDV-UHFFFAOYSA-N 0.000 description 1
- BTSLIUXABUIMPK-UHFFFAOYSA-N 2-amino-3-methylbutane-2,3-diol Chemical compound CC(C)(O)C(C)(N)O BTSLIUXABUIMPK-UHFFFAOYSA-N 0.000 description 1
- VHGFAEBHLBZCIX-UHFFFAOYSA-N 2-dodecylbenzenesulfonate;2-hydroxyethylazanium Chemical compound NCCO.CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O VHGFAEBHLBZCIX-UHFFFAOYSA-N 0.000 description 1
- GYGSAQSEAVBTIR-UHFFFAOYSA-N 2-ethylbutane-1,1,1-triol Chemical compound CCC(CC)C(O)(O)O GYGSAQSEAVBTIR-UHFFFAOYSA-N 0.000 description 1
- OPILSEWGCLFHQW-UHFFFAOYSA-N 2-methylbutane-1,1,1-triol Chemical compound CCC(C)C(O)(O)O OPILSEWGCLFHQW-UHFFFAOYSA-N 0.000 description 1
- IDEOPBXRUBNYBN-UHFFFAOYSA-N 2-methylbutane-2,3-diol Chemical compound CC(O)C(C)(C)O IDEOPBXRUBNYBN-UHFFFAOYSA-N 0.000 description 1
- BWYPWTJPMDVZCK-UHFFFAOYSA-N 2-methylpent-1-ene-1,1-diol Chemical compound CCCC(C)=C(O)O BWYPWTJPMDVZCK-UHFFFAOYSA-N 0.000 description 1
- SRJDGBOAWTZVBX-UHFFFAOYSA-N 3,3-dimethylbut-1-ene-1,1-diol Chemical compound CC(C)(C)C=C(O)O SRJDGBOAWTZVBX-UHFFFAOYSA-N 0.000 description 1
- VYZKQGGPNIFCLD-UHFFFAOYSA-N 3,3-dimethylhexane-2,2-diol Chemical group CCCC(C)(C)C(C)(O)O VYZKQGGPNIFCLD-UHFFFAOYSA-N 0.000 description 1
- DKAPFPUUXKLAJO-UHFFFAOYSA-N 3,4-dimethylpentane-2,3-diol Chemical compound CC(C)C(C)(O)C(C)O DKAPFPUUXKLAJO-UHFFFAOYSA-N 0.000 description 1
- NUYADIDKTLPDGG-UHFFFAOYSA-N 3,6-dimethyloct-4-yne-3,6-diol Chemical compound CCC(C)(O)C#CC(C)(O)CC NUYADIDKTLPDGG-UHFFFAOYSA-N 0.000 description 1
- FRPAVHFNOFSNDR-UHFFFAOYSA-N 3-(2,4-dioxo-1,3-thiazolidin-3-yl)propanoic acid Chemical compound OC(=O)CCN1C(=O)CSC1=O FRPAVHFNOFSNDR-UHFFFAOYSA-N 0.000 description 1
- AGNTUZCMJBTHOG-UHFFFAOYSA-N 3-[3-(2,3-dihydroxypropoxy)-2-hydroxypropoxy]propane-1,2-diol Chemical compound OCC(O)COCC(O)COCC(O)CO AGNTUZCMJBTHOG-UHFFFAOYSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- XXCGEBQDLDEDDE-UHFFFAOYSA-N 3-[dodecyl(methyl)amino]propanoic acid;sodium Chemical compound [Na].CCCCCCCCCCCCN(C)CCC(O)=O XXCGEBQDLDEDDE-UHFFFAOYSA-N 0.000 description 1
- BYUYKEYECBRPCH-UHFFFAOYSA-N 3-amino-4-methylhexane-3,4-diol Chemical compound C(C)C(C(O)(N)CC)(C)O BYUYKEYECBRPCH-UHFFFAOYSA-N 0.000 description 1
- CVNPKVXQUCOSOI-UHFFFAOYSA-N 3-ethylheptane-2,3-diol Chemical group CCCCC(O)(CC)C(C)O CVNPKVXQUCOSOI-UHFFFAOYSA-N 0.000 description 1
- ZHDGRSNJOTYDNG-UHFFFAOYSA-N 3-ethylnonane-2,2-diol Chemical group CCCCCCC(CC)C(C)(O)O ZHDGRSNJOTYDNG-UHFFFAOYSA-N 0.000 description 1
- PJCFOSBWMFNMHT-UHFFFAOYSA-N 3-methylhexane-2,3-diol Chemical compound CCCC(C)(O)C(C)O PJCFOSBWMFNMHT-UHFFFAOYSA-N 0.000 description 1
- MWMODOXJCVGXML-UHFFFAOYSA-N 3-methylnonane-2,2-diol Chemical group CCCCCCC(C)C(C)(O)O MWMODOXJCVGXML-UHFFFAOYSA-N 0.000 description 1
- RLWWHEFTJSHFRN-UHFFFAOYSA-N 3-methylpentane-2,3-diol Chemical compound CCC(C)(O)C(C)O RLWWHEFTJSHFRN-UHFFFAOYSA-N 0.000 description 1
- FNQIYTUXOKTMDM-UHFFFAOYSA-N 3-phenoxypropane-1,2-diol Chemical compound OCC(O)COC1=CC=CC=C1 FNQIYTUXOKTMDM-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- QJRVOJKLQNSNDB-UHFFFAOYSA-N 4-dodecan-3-ylbenzenesulfonic acid Chemical compound CCCCCCCCCC(CC)C1=CC=C(S(O)(=O)=O)C=C1 QJRVOJKLQNSNDB-UHFFFAOYSA-N 0.000 description 1
- DYXPFYWJHRUFPW-UHFFFAOYSA-N 4-ethyldecane-3,3-diol Chemical group CCCCCCC(CC)C(O)(O)CC DYXPFYWJHRUFPW-UHFFFAOYSA-N 0.000 description 1
- BUUSNVSJZVGMFY-UHFFFAOYSA-N 4-ethylheptane-3,3-diol Chemical group CCCC(CC)C(O)(O)CC BUUSNVSJZVGMFY-UHFFFAOYSA-N 0.000 description 1
- HAIVWDGLCRYQMC-UHFFFAOYSA-N 4-methylpentane-1,4-diol Chemical compound CC(C)(O)CCCO HAIVWDGLCRYQMC-UHFFFAOYSA-N 0.000 description 1
- NSFDNGNAGGOHRU-UHFFFAOYSA-N 5,5,6-trimethylnon-3-yne-2,2-diol Chemical compound CCCC(C)C(C)(C)C#CC(C)(O)O NSFDNGNAGGOHRU-UHFFFAOYSA-N 0.000 description 1
- SBJGYMAFEJLGIL-UHFFFAOYSA-N 5,5,6-trimethyltridec-3-yne-2,2-diol Chemical compound CCCCCCCC(C)C(C)(C)C#CC(C)(O)O SBJGYMAFEJLGIL-UHFFFAOYSA-N 0.000 description 1
- LEGVTAFKUDAZRE-UHFFFAOYSA-N 5-ethylnonane-1,2,3-triol Chemical compound CCCCC(CC)CC(O)C(O)CO LEGVTAFKUDAZRE-UHFFFAOYSA-N 0.000 description 1
- KOGXLWSTWNMCHZ-UHFFFAOYSA-N 5-methylhexane-1,2,3-triol Chemical compound CC(C)CC(O)C(O)CO KOGXLWSTWNMCHZ-UHFFFAOYSA-N 0.000 description 1
- CKPKHTKLLYPGFM-UHFFFAOYSA-N 6,6-dimethylheptane-1,1-diol Chemical group CC(CCCCC(O)O)(C)C CKPKHTKLLYPGFM-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- FVBLOXPYVJBORO-UHFFFAOYSA-N 6-ethylhexadec-4-yne-3,3-diol Chemical compound C(C)C(C#CC(O)(O)CC)CCCCCCCCCC FVBLOXPYVJBORO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 208000009746 Adult T-Cell Leukemia-Lymphoma Diseases 0.000 description 1
- 208000016683 Adult T-cell leukemia/lymphoma Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000006382 Bacillus halodurans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000589513 Burkholderia cepacia Species 0.000 description 1
- JJNFWPJRCUZZHF-UHFFFAOYSA-N C(C)(C)C(C(O)(N)C(C)C)(C)O Chemical compound C(C)(C)C(C(O)(N)C(C)C)(C)O JJNFWPJRCUZZHF-UHFFFAOYSA-N 0.000 description 1
- AQQKXPXYQYOYMB-UHFFFAOYSA-N CC(C)(C)CCCCCCCC(O)O Chemical group CC(C)(C)CCCCCCCC(O)O AQQKXPXYQYOYMB-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108090000087 Carboxypeptidase B Proteins 0.000 description 1
- 102000003670 Carboxypeptidase B Human genes 0.000 description 1
- 102000000496 Carboxypeptidases A Human genes 0.000 description 1
- 108010080937 Carboxypeptidases A Proteins 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 102000003908 Cathepsin D Human genes 0.000 description 1
- 108090000258 Cathepsin D Proteins 0.000 description 1
- 102000004178 Cathepsin E Human genes 0.000 description 1
- 108090000611 Cathepsin E Proteins 0.000 description 1
- 108090000619 Cathepsin H Proteins 0.000 description 1
- 102000004175 Cathepsin H Human genes 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 102000004172 Cathepsin L Human genes 0.000 description 1
- 241000282552 Chlorocebus aethiops Species 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 206010010755 Conjunctivitis viral Diseases 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-CBPJZXOFSA-N D-Gulose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-CBPJZXOFSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- FVGJPCFYGPKBKJ-UHFFFAOYSA-N Dodecyl propionate Chemical compound CCCCCCCCCCCCOC(=O)CC FVGJPCFYGPKBKJ-UHFFFAOYSA-N 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 208000030820 Ebola disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 1
- 241001529459 Enterovirus A71 Species 0.000 description 1
- 206010014909 Enterovirus infection Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical compound CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 1
- 108090000270 Ficain Proteins 0.000 description 1
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010017918 Gastroenteritis viral Diseases 0.000 description 1
- 241000193385 Geobacillus stearothermophilus Species 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
- 241000193096 Human adenovirus B3 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 201000005807 Japanese encephalitis Diseases 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- YEJSPQZHMWGIGP-YFKPBYRVSA-N L-glutamic acid, dimethyl ester Chemical compound COC(=O)CC[C@H](N)C(=O)OC YEJSPQZHMWGIGP-YFKPBYRVSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241000023320 Luma <angiosperm> Species 0.000 description 1
- 241000213879 Lyssa Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000000932 Marburg Virus Disease Diseases 0.000 description 1
- 201000011013 Marburg hemorrhagic fever Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027260 Meningitis viral Diseases 0.000 description 1
- 102100034256 Mucin-1 Human genes 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 description 1
- AKNUHUCEWALCOI-UHFFFAOYSA-N N-ethyldiethanolamine Chemical compound OCCN(CC)CCO AKNUHUCEWALCOI-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- UAJFTICTIXLVSD-UHFFFAOYSA-N P(=O)(O)(O)O.OCCC[Na] Chemical compound P(=O)(O)(O)O.OCCC[Na] UAJFTICTIXLVSD-UHFFFAOYSA-N 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 102100039277 Pleiotrophin Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 241000168225 Pseudomonas alcaligenes Species 0.000 description 1
- 241000589630 Pseudomonas pseudoalcaligenes Species 0.000 description 1
- 101000968491 Pseudomonas sp. (strain 109) Triacylglycerol lipase Proteins 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 229910004298 SiO 2 Inorganic materials 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HIWPGCMGAMJNRG-ACCAVRKYSA-N Sophorose Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-ACCAVRKYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N Tetraethylene glycol, Natural products OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 108090001109 Thermolysin Proteins 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- GTTSNKDQDACYLV-UHFFFAOYSA-N Trihydroxybutane Chemical compound CCCC(O)(O)O GTTSNKDQDACYLV-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 208000005914 Viral Conjunctivitis Diseases 0.000 description 1
- 201000006449 West Nile encephalitis Diseases 0.000 description 1
- 206010057293 West Nile viral infection Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- NARKTLKJPPMFJF-LEJQEAHTSA-N [(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl n-[(2s)-2,6-diaminohexanoyl]sulfamate Chemical compound O[C@@H]1[C@H](O)[C@@H](COS(=O)(=O)NC(=O)[C@@H](N)CCCCN)O[C@H]1N1C2=NC=NC(N)=C2N=C1 NARKTLKJPPMFJF-LEJQEAHTSA-N 0.000 description 1
- YDONNITUKPKTIG-UHFFFAOYSA-N [Nitrilotris(methylene)]trisphosphonic acid Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CP(O)(O)=O YDONNITUKPKTIG-UHFFFAOYSA-N 0.000 description 1
- DJLSRKXNWJVNTA-UHFFFAOYSA-N [Si]([O-])([O-])(O)O.[Si](O)(O)(O)O.[Si](O)(O)(O)O.[K+].[K+] Chemical compound [Si]([O-])([O-])(O)O.[Si](O)(O)(O)O.[Si](O)(O)(O)O.[K+].[K+] DJLSRKXNWJVNTA-UHFFFAOYSA-N 0.000 description 1
- 108010076089 accutase Proteins 0.000 description 1
- FLURBNVEVKVLLJ-UHFFFAOYSA-N acetic acid ethoxyethane Chemical compound C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)(=O)O.C(C)OCC FLURBNVEVKVLLJ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 201000006966 adult T-cell leukemia Diseases 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- SYWDWCWQXBUCOP-UHFFFAOYSA-N benzene;ethene Chemical group C=C.C1=CC=CC=C1 SYWDWCWQXBUCOP-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- HIWPGCMGAMJNRG-UHFFFAOYSA-N beta-sophorose Natural products OC1C(O)C(CO)OC(O)C1OC1C(O)C(O)C(O)C(CO)O1 HIWPGCMGAMJNRG-UHFFFAOYSA-N 0.000 description 1
- 229940064804 betadine Drugs 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 239000003876 biosurfactant Substances 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- DKSMCEUSSQTGBK-UHFFFAOYSA-N bromous acid Chemical compound OBr=O DKSMCEUSSQTGBK-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- FWGNBHVCSBZRDK-UHFFFAOYSA-N cyclodecane-1,1-diol Chemical compound OC1(O)CCCCCCCCC1 FWGNBHVCSBZRDK-UHFFFAOYSA-N 0.000 description 1
- MGBBJDOYTDFYHH-UHFFFAOYSA-N cyclododecane-1,1-diol Chemical compound OC1(O)CCCCCCCCCCC1 MGBBJDOYTDFYHH-UHFFFAOYSA-N 0.000 description 1
- CYZQPSLPZSTBHD-UHFFFAOYSA-N cycloheptane-1,1-diol Chemical compound OC1(O)CCCCCC1 CYZQPSLPZSTBHD-UHFFFAOYSA-N 0.000 description 1
- PDXRQENMIVHKPI-UHFFFAOYSA-N cyclohexane-1,1-diol Chemical compound OC1(O)CCCCC1 PDXRQENMIVHKPI-UHFFFAOYSA-N 0.000 description 1
- FUBGBEHQUHRTBB-UHFFFAOYSA-N cyclooct-2-ene-1,1-diol Chemical compound OC1(O)CCCCCC=C1 FUBGBEHQUHRTBB-UHFFFAOYSA-N 0.000 description 1
- SUGGJLOBTAREMB-UHFFFAOYSA-N cyclooctane-1,1-diol Chemical compound OC1(O)CCCCCCC1 SUGGJLOBTAREMB-UHFFFAOYSA-N 0.000 description 1
- UYDJAHJCGZTTHB-UHFFFAOYSA-N cyclopentane-1,1-diol Chemical compound OC1(O)CCCC1 UYDJAHJCGZTTHB-UHFFFAOYSA-N 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical group CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- NRQTTYGIVFAJLQ-UHFFFAOYSA-N decane-1,2,3-triol Chemical compound CCCCCCCC(O)C(O)CO NRQTTYGIVFAJLQ-UHFFFAOYSA-N 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- KDJOAYSYCXTQGG-UHFFFAOYSA-N disilicic acid Chemical compound O[Si](O)(O)O[Si](O)(O)O KDJOAYSYCXTQGG-UHFFFAOYSA-N 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- VFNGKCDDZUSWLR-UHFFFAOYSA-N disulfuric acid Chemical compound OS(=O)(=O)OS(O)(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-N 0.000 description 1
- YEJSPQZHMWGIGP-UHFFFAOYSA-N dl-glutamic acid dimethyl ester Natural products COC(=O)CCC(N)C(=O)OC YEJSPQZHMWGIGP-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- GTZOYNFRVVHLDZ-UHFFFAOYSA-N dodecane-1,1-diol Chemical group CCCCCCCCCCCC(O)O GTZOYNFRVVHLDZ-UHFFFAOYSA-N 0.000 description 1
- XZJFFBYDNVNJCE-UHFFFAOYSA-N dodecane-1,2,3-triol Chemical compound CCCCCCCCCC(O)C(O)CO XZJFFBYDNVNJCE-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- JRBPAEWTRLWTQC-UHFFFAOYSA-N dodecylamine Chemical compound CCCCCCCCCCCCN JRBPAEWTRLWTQC-UHFFFAOYSA-N 0.000 description 1
- 238000001312 dry etching Methods 0.000 description 1
- DUYCTCQXNHFCSJ-UHFFFAOYSA-N dtpmp Chemical compound OP(=O)(O)CN(CP(O)(O)=O)CCN(CP(O)(=O)O)CCN(CP(O)(O)=O)CP(O)(O)=O DUYCTCQXNHFCSJ-UHFFFAOYSA-N 0.000 description 1
- NFDRPXJGHKJRLJ-UHFFFAOYSA-N edtmp Chemical compound OP(O)(=O)CN(CP(O)(O)=O)CCN(CP(O)(O)=O)CP(O)(O)=O NFDRPXJGHKJRLJ-UHFFFAOYSA-N 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- ZOZZQPFBMNNPPO-UHFFFAOYSA-N ethyl-dimethyl-propylazanium Chemical compound CCC[N+](C)(C)CC ZOZZQPFBMNNPPO-UHFFFAOYSA-N 0.000 description 1
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 1
- 235000019836 ficin Nutrition 0.000 description 1
- 229960005051 fluostigmine Drugs 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-HXUWFJFHSA-N glycerol monolinoleate Natural products CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-HXUWFJFHSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- QFWPJPIVLCBXFJ-UHFFFAOYSA-N glymidine Chemical compound N1=CC(OCCOC)=CN=C1NS(=O)(=O)C1=CC=CC=C1 QFWPJPIVLCBXFJ-UHFFFAOYSA-N 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- BGOACMQIAZPHMP-UHFFFAOYSA-N henicos-4-ene-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCC=CC(O)C(O)CO BGOACMQIAZPHMP-UHFFFAOYSA-N 0.000 description 1
- FLYFLESWJKLOMD-UHFFFAOYSA-N henicosane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)C(O)CO FLYFLESWJKLOMD-UHFFFAOYSA-N 0.000 description 1
- GMCRPSQBZNVGNM-UHFFFAOYSA-N hept-2-yne-1,1-diol Chemical compound CCCCC#CC(O)O GMCRPSQBZNVGNM-UHFFFAOYSA-N 0.000 description 1
- HOZOFMIVACKJMX-UHFFFAOYSA-N heptadecane-1,1-diol Chemical group CCCCCCCCCCCCCCCCC(O)O HOZOFMIVACKJMX-UHFFFAOYSA-N 0.000 description 1
- SGTOOTINVZNELQ-UHFFFAOYSA-N heptadecane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCC(O)C(O)CO SGTOOTINVZNELQ-UHFFFAOYSA-N 0.000 description 1
- MHIBEGOZTWERHF-UHFFFAOYSA-N heptane-1,1-diol Chemical compound CCCCCCC(O)O MHIBEGOZTWERHF-UHFFFAOYSA-N 0.000 description 1
- HXYCHJFUBNTKQR-UHFFFAOYSA-N heptane-1,2,3-triol Chemical compound CCCCC(O)C(O)CO HXYCHJFUBNTKQR-UHFFFAOYSA-N 0.000 description 1
- VUVZASHBYYMLRC-UHFFFAOYSA-N heptane-2,3-diol Chemical group CCCCC(O)C(C)O VUVZASHBYYMLRC-UHFFFAOYSA-N 0.000 description 1
- XRVUFNZZLJWIBD-UHFFFAOYSA-N hex-1-ene-1,1-diol Chemical compound CCCCC=C(O)O XRVUFNZZLJWIBD-UHFFFAOYSA-N 0.000 description 1
- KXUSQYGLNZFMTE-UHFFFAOYSA-N hex-2-yne-1,1-diol Chemical compound CCCC#CC(O)O KXUSQYGLNZFMTE-UHFFFAOYSA-N 0.000 description 1
- JUXQIAGPGICHCX-UHFFFAOYSA-N hex-3-yne-2,2-diol Chemical compound CCC#CC(C)(O)O JUXQIAGPGICHCX-UHFFFAOYSA-N 0.000 description 1
- WJJFZQJZLVWTAM-UHFFFAOYSA-N hexa-1,3-diene-1,1-diol Chemical compound CCC=CC=C(O)O WJJFZQJZLVWTAM-UHFFFAOYSA-N 0.000 description 1
- SRYDOKOCKWANAE-UHFFFAOYSA-N hexadecane-1,1-diol Chemical group CCCCCCCCCCCCCCCC(O)O SRYDOKOCKWANAE-UHFFFAOYSA-N 0.000 description 1
- FGMSPVCCAOQDQZ-UHFFFAOYSA-N hexadecane-1,2,3-triol Chemical compound CCCCCCCCCCCCCC(O)C(O)CO FGMSPVCCAOQDQZ-UHFFFAOYSA-N 0.000 description 1
- TZMQHOJDDMFGQX-UHFFFAOYSA-N hexane-1,1,1-triol Chemical compound CCCCCC(O)(O)O TZMQHOJDDMFGQX-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PEYVWSJAZONVQK-UHFFFAOYSA-N hydroperoxy(oxo)borane Chemical compound OOB=O PEYVWSJAZONVQK-UHFFFAOYSA-N 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- JNNNAJIAXISWGB-UHFFFAOYSA-N icosane-1,1-diol Chemical compound CCCCCCCCCCCCCCCCCCCC(O)O JNNNAJIAXISWGB-UHFFFAOYSA-N 0.000 description 1
- 150000002453 idose derivatives Chemical class 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 201000006747 infectious mononucleosis Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- SRPSOCQMBCNWFR-UHFFFAOYSA-N iodous acid Chemical compound OI=O SRPSOCQMBCNWFR-UHFFFAOYSA-N 0.000 description 1
- 238000005468 ion implantation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108010003855 mesentericopeptidase Proteins 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N methyl pentane Natural products CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- MJCJUDJQDGGKOX-UHFFFAOYSA-N n-dodecyldodecan-1-amine Chemical compound CCCCCCCCCCCCNCCCCCCCCCCCC MJCJUDJQDGGKOX-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QTNLALDFXILRQO-UHFFFAOYSA-N nonadecane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCC(O)C(O)CO QTNLALDFXILRQO-UHFFFAOYSA-N 0.000 description 1
- FVXBCDWMKCEPCL-UHFFFAOYSA-N nonane-1,1-diol Chemical group CCCCCCCCC(O)O FVXBCDWMKCEPCL-UHFFFAOYSA-N 0.000 description 1
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 description 1
- KRISBJIGEQYHDD-UHFFFAOYSA-N nonane-2,2-diol Chemical group CCCCCCCC(C)(O)O KRISBJIGEQYHDD-UHFFFAOYSA-N 0.000 description 1
- RVSCBJNWEMQNJZ-UHFFFAOYSA-N octadec-1-ene-1,1-diol Chemical compound CCCCCCCCCCCCCCCCC=C(O)O RVSCBJNWEMQNJZ-UHFFFAOYSA-N 0.000 description 1
- VJQGGZWPOMJLTP-UHFFFAOYSA-N octadecane-1,1-diol Chemical compound CCCCCCCCCCCCCCCCCC(O)O VJQGGZWPOMJLTP-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- AZJXQVRPBZSNFN-UHFFFAOYSA-N octane-3,3-diol Chemical compound CCCCCC(O)(O)CC AZJXQVRPBZSNFN-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- VSXGXPNADZQTGQ-UHFFFAOYSA-N oxirane;phenol Chemical compound C1CO1.OC1=CC=CC=C1 VSXGXPNADZQTGQ-UHFFFAOYSA-N 0.000 description 1
- VGTPKLINSHNZRD-UHFFFAOYSA-N oxoborinic acid Chemical compound OB=O VGTPKLINSHNZRD-UHFFFAOYSA-N 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- VPYCETDHMHXUAO-UHFFFAOYSA-N pent-2-yne-1,1-diol Chemical compound CCC#CC(O)O VPYCETDHMHXUAO-UHFFFAOYSA-N 0.000 description 1
- FDUBTTQMOFEVRB-UHFFFAOYSA-N pentadecane-1,1-diol Chemical group CCCCCCCCCCCCCCC(O)O FDUBTTQMOFEVRB-UHFFFAOYSA-N 0.000 description 1
- HISQRFFCSVGSGI-UHFFFAOYSA-N pentadecane-1,2,3-triol Chemical compound CCCCCCCCCCCCC(O)C(O)CO HISQRFFCSVGSGI-UHFFFAOYSA-N 0.000 description 1
- FVGBHSIHHXTYTH-UHFFFAOYSA-N pentane-1,1,1-triol Chemical compound CCCCC(O)(O)O FVGBHSIHHXTYTH-UHFFFAOYSA-N 0.000 description 1
- AALKGALVYCZETF-UHFFFAOYSA-N pentane-1,2,3-triol Chemical compound CCC(O)C(O)CO AALKGALVYCZETF-UHFFFAOYSA-N 0.000 description 1
- XLMFDCKSFJWJTP-UHFFFAOYSA-N pentane-2,3-diol Chemical compound CCC(O)C(C)O XLMFDCKSFJWJTP-UHFFFAOYSA-N 0.000 description 1
- OWFWBVMKGRQNQT-UHFFFAOYSA-N pentane;propane-1,2,3-triol Chemical compound CCCCC.OCC(O)CO OWFWBVMKGRQNQT-UHFFFAOYSA-N 0.000 description 1
- 229960003330 pentetic acid Drugs 0.000 description 1
- LLYCMZGLHLKPPU-UHFFFAOYSA-N perbromic acid Chemical compound OBr(=O)(=O)=O LLYCMZGLHLKPPU-UHFFFAOYSA-N 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NIXKBAZVOQAHGC-UHFFFAOYSA-N phenylmethanesulfonic acid Chemical compound OS(=O)(=O)CC1=CC=CC=C1 NIXKBAZVOQAHGC-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-M phosphinate Chemical compound [O-][PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-M 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229920002120 photoresistant polymer Polymers 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001444 polymaleic acid Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108010043393 protease N Proteins 0.000 description 1
- 238000002331 protein detection Methods 0.000 description 1
- 229940048084 pyrophosphate Drugs 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000019795 sodium metasilicate Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- KKDONKAYVYTWGY-UHFFFAOYSA-M sodium;2-(methylamino)ethanesulfonate Chemical compound [Na+].CNCCS([O-])(=O)=O KKDONKAYVYTWGY-UHFFFAOYSA-M 0.000 description 1
- HIWPGCMGAMJNRG-RTPHMHGBSA-N sophorose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HIWPGCMGAMJNRG-RTPHMHGBSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000013020 steam cleaning Methods 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 150000003470 sulfuric acid monoesters Chemical class 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- PMBKSTOGTODXJZ-UHFFFAOYSA-N tetracosane-1,1-diol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(O)O PMBKSTOGTODXJZ-UHFFFAOYSA-N 0.000 description 1
- FUDOTWBYKLBWCY-UHFFFAOYSA-N tetradec-1-ene-1,1-diol Chemical compound CCCCCCCCCCCCC=C(O)O FUDOTWBYKLBWCY-UHFFFAOYSA-N 0.000 description 1
- CQTBQILMJBCTRS-UHFFFAOYSA-N tetradecane-1,1-diol Chemical group CCCCCCCCCCCCCC(O)O CQTBQILMJBCTRS-UHFFFAOYSA-N 0.000 description 1
- QSECJVHNIUDXDA-UHFFFAOYSA-N tetradecane-1,2,3-triol Chemical compound CCCCCCCCCCCC(O)C(O)CO QSECJVHNIUDXDA-UHFFFAOYSA-N 0.000 description 1
- RLQWHDODQVOVKU-UHFFFAOYSA-N tetrapotassium;silicate Chemical compound [K+].[K+].[K+].[K+].[O-][Si]([O-])([O-])[O-] RLQWHDODQVOVKU-UHFFFAOYSA-N 0.000 description 1
- POWFTOSLLWLEBN-UHFFFAOYSA-N tetrasodium;silicate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-][Si]([O-])([O-])[O-] POWFTOSLLWLEBN-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
- 229940103494 thiosalicylic acid Drugs 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- BBIUWPMGWINSFC-UHFFFAOYSA-N tridecane-1,2,3-triol Chemical compound CCCCCCCCCCC(O)C(O)CO BBIUWPMGWINSFC-UHFFFAOYSA-N 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 239000006150 trypticase soy agar Substances 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- GRXOWOKLKIZFNP-UHFFFAOYSA-N undecane-1,1-diol Chemical group CCCCCCCCCCC(O)O GRXOWOKLKIZFNP-UHFFFAOYSA-N 0.000 description 1
- LONLGEZTBVAKJF-UHFFFAOYSA-N undecane-1,2,3-triol Chemical compound CCCCCCCCC(O)C(O)CO LONLGEZTBVAKJF-UHFFFAOYSA-N 0.000 description 1
- 238000010407 vacuum cleaning Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 201000010044 viral meningitis Diseases 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/02—Cleaning by the force of jets or sprays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/04—Cleaning involving contact with liquid
- B08B3/08—Cleaning involving contact with liquid the liquid having chemical or dissolving effect
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/04—Cleaning involving contact with liquid
- B08B3/10—Cleaning involving contact with liquid with additional treatment of the liquid or of the object being cleaned, e.g. by heat, by electricity or by vibration
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/26—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/22—Organic compounds
- C11D7/28—Organic compounds containing halogen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D7/00—Compositions of detergents based essentially on non-surface-active compounds
- C11D7/50—Solvents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Detergent Compositions (AREA)
Abstract
Description
本揭露係關於清洗劑、使用清洗劑的清洗方法及清洗裝置。This disclosure relates to a cleaning agent, a cleaning method and a cleaning device using the cleaning agent.
社會對於以流行性感冒病毒或諾羅病毒等病毒為病原體之感染症高度關切,要求舒適、清潔的生活環境,抗病毒產品的需求在各式各樣的領域中日益擴大。尤其在要求清潔的醫療領域中,感染對策非常重要,透過確實實施,對於守護患者及醫護人員的安全有所助益。舉例而言,對患者使用之醫療用器具會因應此器具的使用目的來施以清洗、消毒、滅菌處理。此等處理的方法係以使用醫療用器具時之感染的風險為基準來選擇。無論何種方法,進行充分之清洗最為重要。至於為何,係因清洗不完善會成為之後消毒、滅菌不完善的原因。The society is highly concerned about infections that use viruses such as influenza virus or norovirus as pathogens, requiring a comfortable and clean living environment, and the demand for antiviral products is expanding in various fields. Especially in the medical field where cleanliness is required, infection countermeasures are very important, and it is helpful to protect the safety of patients and medical staff through reliable implementation. For example, medical equipment used by patients will be cleaned, disinfected, and sterilized according to the purpose of use of the equipment. These treatment methods are selected based on the risk of infection when using medical devices. Regardless of the method, adequate cleaning is the most important. As for why, imperfect cleaning will become the cause of imperfect disinfection and sterilization in the future.
醫療用器具的清洗大致分為手工清洗(包含浸漬清洗)、超音波清洗、清洗器―消毒器3種。清洗方法係考慮設施環境或醫療用器具的特性來選擇。醫療用器具的清洗劑大致上主要分為鹼性清洗劑、酸性清洗劑、酵素清洗劑3種。鹼性清洗劑雖然清洗力優異,但對於材質或皮膚的影響強。酸性清洗劑雖然適於無機物(鏽蝕、水垢、水鏽、氧化物膜等)的清洗,但對於金屬的腐蝕性強。酵素系清洗劑雖然對材質的影響少,但清洗力低劣。是故,有必要依醫療用器具的特性或清洗方法(機械清洗、手工清洗、浸漬清洗)來選擇適切的清洗劑。The cleaning of medical equipment is roughly divided into three types: manual cleaning (including immersion cleaning), ultrasonic cleaning, and washer-sterilizer. The cleaning method is selected in consideration of the facility environment or the characteristics of medical equipment. The cleaning agents for medical equipment are roughly divided into three types: alkaline cleaning agents, acidic cleaning agents, and enzyme cleaning agents. Although the alkaline cleaning agent has excellent cleaning power, it has a strong effect on the material and the skin. Although acidic cleaning agents are suitable for cleaning inorganic substances (rust, scale, scale, oxide film, etc.), they are highly corrosive to metals. Although the enzyme-based cleaning agent has little effect on the material, its cleaning power is inferior. Therefore, it is necessary to choose an appropriate cleaning agent according to the characteristics of medical equipment or cleaning methods (mechanical cleaning, manual cleaning, immersion cleaning).
在各式各樣的領域中,清洗實屬重要,有必要依要清洗的目標物與要自目標物去除者來選擇適切的清洗劑。舉例而言,在半導體製造工序中,已知有使用包含1,1,1,3,3,3-六氟-2-丙醇的清洗劑。專利文獻1已揭露利用1,1,1,3,3,3-六氟-2-丙醇的聚合物溶解性,為了殘存於STI、金屬閘、接觸孔、通孔、電容器、金屬佈線等之側壁的聚合物剝離,並且為了離子植入後的光阻殘渣去除或者在單鑲嵌或雙鑲嵌製程中之乾式蝕刻後之附著聚合物的剝離又或者在單鑲嵌或雙鑲嵌製程中之CMP後的清洗,而使用包含1,1,1,3,3,3-六氟-2-丙醇的清洗用組成物。專利文獻2已揭露利用1,1,1,3,3,3-六氟-2-丙醇會與水以任意比例混合的性質,於各微影工序之半導體晶圓的清洗乾燥中使用1,1,1,3,3,3-六氟-2-丙醇的蒸氣。In various fields, cleaning is really important, and it is necessary to select the appropriate cleaning agent according to the target to be cleaned and the person to be removed from the target. For example, in the semiconductor manufacturing process, it is known to use a cleaning agent containing 1,1,1,3,3,3-hexafluoro-2-propanol.
『專利文獻』
《專利文獻1》:日本專利公開第2015-108041號公報
《專利文獻2》:日本專利公開第H3-106024號公報『Patent Literature』
"
本揭露之目的在於提供具有充分之清洗力的清洗劑、使用清洗劑的清洗方法及清洗裝置。The purpose of this disclosure is to provide a cleaning agent with sufficient cleaning power, a cleaning method and a cleaning device using the cleaning agent.
本發明人等潛心研究,結果發現係為氟系醇的1,1,1,3,3,3-六氟-2-丙醇(HFIP)、2,2,2-三氟乙醇(TFE)及2,2,3,3,3-五氟-1-丙醇有病毒去活化作用及殺菌效果。The inventors of the present invention have studied intensively and found that 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) and 2,2,2-trifluoroethanol (TFE) are fluorine-based alcohols. And 2,2,3,3,3-pentafluoro-1-propanol has virus deactivation and bactericidal effects.
本揭露係包含以下態樣者。This disclosure includes the following aspects.
[1]一種清洗劑,其含有氟系醇作為將病毒去活化之化合物。[1] A cleaning agent containing a fluorine-based alcohol as a compound for deactivating viruses.
[2]一種清洗劑,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[2] A cleaning agent in which the fluorine alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent perfluoroalkyl groups with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[3]一種清洗劑,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[3] A cleaning agent, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[4]一種清洗劑,其中作用於病毒時之氟系醇的濃度為0.1質量%以上。[4] A cleaning agent in which the concentration of the fluoroalcohol when acting on the virus is 0.1% by mass or more.
[5]一種清洗劑,其更包含溶媒。[5] A cleaning agent, which further contains a solvent.
[6]一種清洗劑,其中病毒係選自由流行性感冒病毒、C型肝炎病毒、輪狀病毒、諾羅病毒、腺病毒及腸病毒而成之群組之至少一種。[6] A cleaning agent, wherein the virus is selected from at least one of the group consisting of influenza virus, hepatitis C virus, rotavirus, norovirus, adenovirus and enterovirus.
[7]一種清洗劑,其使用於醫療用器具的清洗。[7] A cleaning agent used for cleaning medical appliances.
[8]一種清洗劑,其使用於土壤的清洗。[8] A cleaning agent used for soil cleaning.
[9]一種清洗方法,其包含使氟系醇作用於病毒。[9] A cleaning method comprising allowing a fluorine-based alcohol to act on a virus.
[10]一種清洗方法,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[10] A cleaning method in which the fluorine alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent perfluoroalkyl groups with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[11]一種清洗方法,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[11] A cleaning method, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[12]一種清洗方法,其中作用於病毒時之氟系醇的濃度為0.1質量%以上。[12] A cleaning method in which the concentration of the fluoroalcohol when acting on the virus is 0.1% by mass or more.
[13]一種清洗方法,其中氟系醇係以溶媒來稀釋。[13] A cleaning method in which the fluorine-based alcohol is diluted with a solvent.
[14]一種清洗方法,其中病毒係選自由流行性感冒病毒、C型肝炎病毒、輪狀病毒、諾羅病毒、腺病毒及腸病毒而成之群組之至少一種。[14] A cleaning method, wherein the virus is selected from at least one of the group consisting of influenza virus, hepatitis C virus, rotavirus, norovirus, adenovirus and enterovirus.
[15]一種清洗方法,其使用於醫療用器具的清洗。[15] A cleaning method used in the cleaning of medical appliances.
[16]一種清洗方法,其使用於土壤的清洗。[16] A cleaning method used in soil cleaning.
[17]一種清洗裝置,其包含:供應含有氟系醇作為將病毒去活化之化合物之清洗劑的清洗劑供應裝置。[17] A cleaning device comprising: a cleaning agent supply device that supplies a cleaning agent containing a fluorine-based alcohol as a compound that deactivates viruses.
[18]一種清洗裝置,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[18] A cleaning device in which the fluorine-based alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent a perfluoroalkyl group with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[19]一種清洗裝置,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[19] A cleaning device, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[20]一種清洗裝置,其中作用於病毒時之氟系醇的濃度為0.1質量%以上。[20] A cleaning device in which the concentration of the fluoroalcohol when acting on the virus is 0.1% by mass or more.
[21]一種清洗裝置,其中氟系醇係以溶媒來稀釋。[21] A cleaning device in which the fluorine-based alcohol is diluted with a solvent.
[22]一種清洗裝置,其中病毒係選自由流行性感冒病毒、C型肝炎病毒、輪狀病毒、諾羅病毒、腺病毒及腸病毒而成之群組之至少一種。[22] A cleaning device, wherein the virus is selected from at least one of the group consisting of influenza virus, hepatitis C virus, rotavirus, norovirus, adenovirus and enterovirus.
[23]一種清洗裝置,其使用於醫療用器具的清洗。[23] A cleaning device used for cleaning medical appliances.
[24]一種清洗裝置,其使用於土壤的清洗。[24] A cleaning device used for soil cleaning.
[25]一種清洗劑,其含有氟系醇作為將細菌殺滅之化合物。[25] A cleaning agent containing a fluorine-based alcohol as a compound that kills bacteria.
[26]一種清洗劑,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[26] A cleaning agent in which the fluorine-based alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent perfluoroalkyl groups with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[27]一種清洗劑,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[27] A cleaning agent, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[28]一種清洗劑,其中作用於細菌時之氟系醇的濃度為0.1質量%以上。[28] A cleaning agent in which the concentration of the fluorine-based alcohol when acting on bacteria is 0.1% by mass or more.
[29]一種清洗劑,其更包含溶媒。[29] A cleaning agent, which further contains a solvent.
[30]一種清洗劑,其使用於醫療用器具的清洗。[30] A cleaning agent used for cleaning medical appliances.
[31]一種清洗劑,其使用於殺菌。[31] A cleaning agent used for sterilization.
[32]一種清洗劑,其使用於土壤的清洗。[32] A cleaning agent used to clean the soil.
[33]一種清洗方法,其包含使氟系醇作用於細菌。[33] A cleaning method comprising causing a fluorine-based alcohol to act on bacteria.
[34]一種清洗方法,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[34] A cleaning method in which the fluorine alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent perfluoroalkyl groups with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[35]一種清洗方法,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[35] A cleaning method, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[36]一種清洗方法,其中作用於細菌時之氟系醇的濃度為0.1質量%以上。[36] A cleaning method in which the concentration of the fluoroalcohol when acting on bacteria is 0.1% by mass or more.
[37]一種清洗方法,其中氟系醇係以溶媒來稀釋。[37] A cleaning method in which the fluorine-based alcohol is diluted with a solvent.
[38]一種清洗方法,其使用於醫療用器具的清洗。[38] A cleaning method used in the cleaning of medical appliances.
[39]一種清洗方法,其使用於土壤的清洗。[39] A cleaning method, which is used to clean the soil.
[40]一種清洗裝置,其包含:供應含有氟系醇作為將細菌殺滅之化合物之清洗劑的清洗劑供應裝置。[40] A cleaning device comprising: a cleaning agent supply device that supplies a cleaning agent containing a fluorine-based alcohol as a compound that kills bacteria.
[41]一種清洗裝置,其中氟系醇係由通式RfCH2 OH或RfRf′CHOH所示,Rf及Rf′表示碳數1~10的全氟烷基,Rf與Rf′彼此相異或相同。[41] A cleaning device in which the fluorine alcohol is represented by the general formula RfCH 2 OH or RfRf'CHOH, Rf and Rf' represent perfluoroalkyl groups with 1 to 10 carbon atoms, and Rf and Rf' are different or the same as each other .
[42]一種清洗裝置,其中氟系醇係選自由1,1,1,3,3,3-六氟-2-丙醇、2,2,2-三氟乙醇及2,2,3,3,3-五氟-1-丙醇而成之群組之至少一種。[42] A cleaning device, wherein the fluorine-based alcohol is selected from 1,1,1,3,3,3-hexafluoro-2-propanol, 2,2,2-trifluoroethanol and 2,2,3, At least one of the group consisting of 3,3-pentafluoro-1-propanol.
[43]一種清洗裝置,其中作用於細菌時之氟系醇的濃度為0.1質量%以上。[43] A cleaning device in which the concentration of the fluorine-based alcohol when acting on bacteria is 0.1% by mass or more.
[44]一種清洗裝置,其中氟系醇係以溶媒來稀釋。[44] A cleaning device in which the fluorine-based alcohol is diluted with a solvent.
[45]一種清洗裝置,其使用於醫療用器具的清洗。[45] A cleaning device used for cleaning medical appliances.
[46]一種清洗裝置,其使用於土壤的清洗。[46] A cleaning device used for soil cleaning.
根據本揭露之一實施型態,其目的在於提供具有充分之清洗力的清洗劑、使用清洗劑的清洗方法及清洗裝置。According to one embodiment of the present disclosure, its purpose is to provide a cleaning agent with sufficient cleaning power, a cleaning method and a cleaning device using the cleaning agent.
[清洗劑][detergent]
本揭露之清洗劑所包含之化合物係氟系醇。氟系醇適宜作為將病毒去活化之化合物。The compound contained in the cleaning agent of the present disclosure is a fluorine-based alcohol. Fluorine-based alcohols are suitable as compounds for deactivating viruses.
在一實施型態中,清洗劑含有氟系醇作為有效成分。在本說明書中,所謂「清洗」,係謂將附著於目標物的汙染物自目標物去除。並且,所謂「汙染物」,係謂例如源自生物體的血液或體液、脂肪、普里昂蛋白(Prion Protein,PrP)及感染性類澱粉蛋白等蛋白質或細胞組織等有機物、微生物、病毒、細菌等。在一實施型態中,清洗劑含有選自氟系醇之二種以上。In one embodiment, the cleaning agent contains a fluorine-based alcohol as an effective ingredient. In this specification, "cleaning" refers to removing contaminants attached to the target from the target. In addition, the so-called "pollutants" refer to, for example, blood or body fluids, fats, Prion Protein (PrP) and infectious amyloid-like proteins or organic matter such as cell tissues, microorganisms, viruses, and bacteria derived from living organisms. Wait. In one embodiment, the cleaning agent contains two or more kinds selected from fluorine-based alcohols.
在一實施型態中,本揭露之氟系醇係由下述通式(1)或(2)所示。 RfCH2 OH・・・(1) RfRf′CHOH・・・(2) 在通式中,Rf、Rf′表示碳數1~10的全氟烷基。In one embodiment, the fluorine-based alcohol disclosed in the present disclosure is represented by the following general formula (1) or (2). RfCH 2 OH···(1) RfRf′CHOH···(2) In the general formula, Rf and Rf′ represent a perfluoroalkyl group having 1 to 10 carbon atoms.
由通式(1)或(2)所示之化合物之中,尤其可示例1,1,1,3,3,3-六氟-2-丙醇(以下有時標示為HFIP)、2,2,2-三氟乙醇(以下有時標示為TFE)、2,2,3,3,3-五氟-1-丙醇。並且,在一實施型態中,本揭露之氟系醇包含1,1,1-三氟-2-丙醇(以下有時標示為TFIPL)。於此,TFIPL可為外消旋體(以下有時標示為TFIPL(外消旋體))、S體(以下有時標示為S-TFIPL)、R體(以下有時標示為R-TFIPL)之任一態樣。尤其,HFIP及TFIPL適宜作為將病毒去活化之化合物。Among the compounds represented by the general formula (1) or (2), particularly 1,1,1,3,3,3-hexafluoro-2-propanol (hereinafter sometimes referred to as HFIP), 2, 2,2-Trifluoroethanol (hereinafter sometimes referred to as TFE), 2,2,3,3,3-pentafluoro-1-propanol. Moreover, in one embodiment, the fluorine-based alcohol of the present disclosure includes 1,1,1-trifluoro-2-propanol (hereinafter sometimes referred to as TFIPL). Here, TFIPL can be racemate (hereinafter sometimes referred to as TFIPL (racemate)), S body (hereinafter sometimes referred to as S-TFIPL), R body (hereinafter sometimes referred to as R-TFIPL) Any aspect of it. In particular, HFIP and TFIPL are suitable as compounds for deactivating viruses.
在本說明書中,所謂病毒,擁有套膜的病毒(套膜病毒)與不擁有套膜的病毒(無套膜病毒)皆為所指對象,並且,擁有DNA作為基因體的病毒(DNA病毒)與擁有RNA作為基因體的病毒(RNA病毒)皆為所指目標。在本說明書中,所謂病毒,可示例流行性感冒病毒、C型肝炎病毒、輪狀病毒、諾羅病毒、腺病毒、腸病毒等,但並非受限於此等者。可示例例如:係為病毒性肝炎、病毒性腦膜炎、病毒性腸胃炎、病毒性結膜炎、後天免疫不全症候群(AIDS)、成人T細胞白血病、伊波拉出血熱、黃熱病、感冒症候群、巨細胞病毒感染症、嚴重急性呼吸道症候群(SARS)、中東呼吸道症候群(MERS)、進行性多部腦白質病、水痘/帶狀疱疹、單純疱疹、手足口症、登革熱、日本腦炎、傳染性紅斑、傳染性單核白血球增多症、天花、風疹、急性脊髓灰質炎(小兒麻痺症)、麻疹、咽結膜熱(泳池熱)、馬堡出血熱、腎症候性出血熱、賴薩熱、流行性腮腺炎、西尼羅河熱、疱疹性咽峽炎、屈公熱等病毒感染症之病原體的病毒。除此之外,可示例於上所述之病毒的替代病毒。再者,作為感染人以外之動物的病毒,有狂犬病病毒、豬霍亂病毒等。In this specification, the so-called viruses, viruses that have a mantle (mantle virus) and viruses that do not have a mantle (no-mantle virus) are all referred to, and viruses that have DNA as their genome (DNA virus) And viruses that have RNA as their genome (RNA viruses) are all targets. In this specification, the term "virus" includes influenza virus, hepatitis C virus, rotavirus, norovirus, adenovirus, enterovirus, etc., but is not limited to these. Examples can be: viral hepatitis, viral meningitis, viral gastroenteritis, viral conjunctivitis, acquired immune insufficiency syndrome (AIDS), adult T-cell leukemia, Ebola hemorrhagic fever, yellow fever, cold syndrome, giant cell Viral infection, Severe Acute Respiratory Syndrome (SARS), Middle East Respiratory Syndrome (MERS), Progressive Multiple Leukemia, Varicella/Zoster, Herpes Simplex, Hand, Foot and Mouth Disease, Dengue Fever, Japanese Encephalitis, Infectious Erythema, Infectious mononucleosis, smallpox, rubella, acute polio (poliomyelitis), measles, pharyngeal conjunctival fever (pool fever), Marburg hemorrhagic fever, nephrotic hemorrhagic fever, Lyssa fever, epidemic parotid glands Viruses that are the pathogens of viral infections such as inflammatory disease, West Nile fever, herpes angina, and Qu Gong fever. In addition, it can be exemplified as an alternative virus to the virus mentioned above. Furthermore, as viruses that infect animals other than humans, there are rabies virus, hog cholera virus, and the like.
在一實施型態中,清洗劑亦可包含本揭露之氟系醇與溶媒。在一實施型態中,清洗劑亦可包含由通式(1)或(2)所示之化合物與溶媒。作為能夠稀釋由通式(1)或(2)所示之化合物的溶媒,可列舉:水、生理食鹽水、硼酸緩衝液、磷酸緩衝液(例如磷酸緩衝生理食鹽水(亦稱作PBS))、乙酸緩衝液、Tris緩衝液、HEPES緩衝液、甲醇、乙醇、異丙醇、丙酮、甲苯、二甲亞碸、乙二醇、二乙二醇及丙二醇等。此等可為一種或多種,但並非受限於此等者。在一實施型態中,清洗劑包含由通式(1)或(2)所示之化合物與上述溶媒。HFIP係熔點為-3.3℃、沸點為58.6℃之無色透明的液體。TFE係熔點為-45.0℃、沸點為78.0℃之無色透明的液體。TFIPL係熔點為-78℃、沸點為22℃之無色透明的液體。HFIP、TFE及TFIPL由於對大部分的溶媒可溶,故可藉由以溶媒來稀釋而調整成任意濃度。在一實施型態中,本揭露之清洗劑中所包含之溶媒的含量(質量%),就清洗性之觀點而言,亦可為相對於清洗劑之質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上且71質量%以下為更佳。In one embodiment, the cleaning agent may also include the fluorine-based alcohol and solvent disclosed in the present disclosure. In one embodiment, the cleaning agent may also include a compound represented by the general formula (1) or (2) and a solvent. As the solvent capable of diluting the compound represented by the general formula (1) or (2), water, physiological saline, boric acid buffer, phosphate buffer (for example, phosphate buffered physiological saline (also called PBS)) , Acetic acid buffer, Tris buffer, HEPES buffer, methanol, ethanol, isopropanol, acetone, toluene, dimethyl sulfoxide, ethylene glycol, diethylene glycol and propylene glycol, etc. These may be one or more, but are not limited to these. In one embodiment, the cleaning agent includes a compound represented by the general formula (1) or (2) and the aforementioned solvent. HFIP is a colorless and transparent liquid with a melting point of -3.3°C and a boiling point of 58.6°C. TFE is a colorless and transparent liquid with a melting point of -45.0°C and a boiling point of 78.0°C. TFIPL is a colorless and transparent liquid with a melting point of -78°C and a boiling point of 22°C. HFIP, TFE and TFIPL are soluble in most solvents, so they can be adjusted to any concentration by diluting with solvent. In one embodiment, the content (mass%) of the solvent contained in the cleaning agent of the present disclosure may be 0 mass% or more and 99.9% by mass relative to the mass of the cleaning agent from the viewpoint of cleaning performance Below, 0 mass% or more and 99 mass% or less are preferable, 0 mass% or more and 92 mass% or less are particularly preferable, and 0 mass% or more and 71 mass% or less are more preferable.
在一實施型態中,清洗劑除了本揭露之氟系醇與溶媒以外還可包含添加劑。在一實施型態中,清洗劑除了由通式(1)或(2)所示之化合物與溶媒以外還可包含添加劑。作為能夠添加於清洗劑的添加劑,可列舉:界面活性劑、酵素、螯合劑、酵素穩定劑、抗凝血劑、抗金屬腐蝕劑、低分子多元醇、清洗助劑(增滌劑)、消泡劑、pH調整劑、香料、著色劑、抗氧化劑、防腐劑、漂白劑、漂白活化劑、腐蝕抑制劑、分散劑、增稠劑、黏度調整劑等,但並非受限於此等者。清洗劑亦可包含一種或二種以上之添加劑。在一實施型態中,清洗劑藉由包含由通式(1)或(2)所示之化合物、溶媒與上述添加劑,可進一步提升清洗力。In one embodiment, the cleaning agent may include additives in addition to the fluorine-based alcohol and solvent disclosed in the present disclosure. In one embodiment, the cleaning agent may include additives in addition to the compound represented by the general formula (1) or (2) and the solvent. Examples of additives that can be added to cleaning agents include: surfactants, enzymes, chelating agents, enzyme stabilizers, anticoagulants, anti-metal corrosion agents, low-molecular polyols, cleaning aids (detergents), and defoaming Agents, pH adjusters, fragrances, colorants, antioxidants, preservatives, bleaching agents, bleach activators, corrosion inhibitors, dispersants, thickeners, viscosity adjusters, etc., but are not limited to these. The cleaning agent may also contain one or more than two additives. In one embodiment, the cleaning agent can further improve the cleaning power by including the compound represented by the general formula (1) or (2), the solvent, and the above-mentioned additives.
界面活性劑(A)包含非離子性界面活性劑(A-1)、陰離子性界面活性劑(A-2)、陽離子性界面活性劑(A-3)、兩性界面活性劑(A-4)及生物界面活性劑(A-5)。Surfactants (A) include nonionic surfactants (A-1), anionic surfactants (A-2), cationic surfactants (A-3), and amphoteric surfactants (A-4) And biological surfactant (A-5).
作為非離子性界面活性劑(A-1),可列舉:環氧烷加成型非離子性界面活性劑(A-1-1)及多元醇型非離子性界面活性劑(A-1-2)等。Examples of nonionic surfactants (A-1) include: alkylene oxide addition type nonionic surfactants (A-1-1) and polyol type nonionic surfactants (A-1-2 )Wait.
作為環氧烷加成型非離子性界面活性劑(A-1-1),可列舉:高級醇(碳數8~18)環氧烷(碳數2~4,良佳為2)加成物(每1個活性氫的加成莫耳數為1~30)、烷基(碳數1~12)酚環氧乙烷(以下有時將環氧乙烷記載為EO)加成物(加成莫耳數1~30)、高級胺(碳數8~22)環氧烷(碳數2~4,良佳為2)加成物(每1個活性氫的加成莫耳數為1~40)、脂肪酸(碳數8~18)EO加成物(每1個活性氫的加成莫耳數為1~60)、聚丙二醇(分子量200~4000)EO加成物(每1個活性氫的加成莫耳數為1~50)、聚環氧乙烷(重複單元數3~30)烷基(碳數6~20)芳基醚,以及一月桂酸山梨醇酐酯EO加成物(每1個活性氫的加成莫耳數為1~30)及一油酸山梨醇酐酯EO加成物(每1個活性氫的加成莫耳數為1~30)等多元(2~8元或其以上)醇(碳數2~30)的脂肪酸(碳數8~24)酯EO加成物(每1個活性氫的加成莫耳數為1~30)等。Examples of alkylene oxide addition type nonionic surfactants (A-1-1) include: higher alcohols (8 to 18 carbons) alkylene oxides (2 to 4 carbons, preferably 2) adducts ( The number of added moles per active hydrogen is 1-30), alkyl (carbon number 1-12) phenol ethylene oxide (hereinafter sometimes referred to as EO) adduct (addition Mole number 1-30), higher amine (carbon number 8-22) alkylene oxide (carbon number 2-4, preferably 2) adducts (addition mole number per 1 active hydrogen is 1-40 ), fatty acid (carbon number 8-18) EO adduct (the number of moles added per 1 active hydrogen is 1-60), polypropylene glycol (molecular weight 200-4000) EO adduct (per 1 active hydrogen The number of addition moles is 1-50), polyethylene oxide (repeating unit number 3-30) alkyl (carbon number 6-20) aryl ether, and sorbitan monolaurate ester EO adduct (The number of added moles per active hydrogen is 1-30) and the EO adduct of sorbitan monooleate (the number of added moles per active hydrogen is 1-30), etc. (2 -8 valence or more) alcohol (carbon number 2-30) fatty acid (carbon number 8-24) ester EO adduct (addition mole per active hydrogen is 1-30), etc.
作為多元醇型非離子性界面活性劑(A-1-2),可列舉:一硬脂酸丙三醇酯、一油酸丙三醇酯、一月桂酸山梨醇酐酯及一油酸山梨醇酐酯等多元(2~8元或其以上)醇(碳數2~30)的脂肪酸(碳數8~24)酯,以及月桂醯一乙醇胺及月桂醯二乙醇胺等脂肪醯烷醇胺等。Examples of polyol type nonionic surfactants (A-1-2) include: glycerol monostearate, glycerol monooleate, sorbitan monolaurate and sorbitan monooleate Fatty acid (carbon number 8-24) esters of polyvalent (2-8 valent or more) alcohols (carbon number 2-30) such as alcohol anhydride esters, and fatty alkanolamines such as lauryl monoethanolamine and lauryl diethanolamine, etc. .
作為陰離子性界面活性劑(A-2),可列舉:羧酸碳數8~24的烷基醚酯或其鹽及羧酸碳數8~24的烷基(聚)環氧乙烷醚酯或其鹽(乙酸月桂基(聚)環氧乙烷(聚合度=1~100)醚酯鈉及磺基琥珀酸月桂基(聚)環氧乙烷(聚合度=1~100)酯二鈉等)、硫酸碳數8~24的烷酯鹽及硫酸碳數8~24的烷基(聚)環氧乙烷酯鹽(硫酸月桂酯鈉、硫酸月桂基(聚)環氧乙烷(聚合度=1~100)酯鈉及硫酸月桂基(聚)環氧乙烷(聚合度=1~100)酯三乙醇胺鹽等)、硫酸椰子油脂醯胺一乙醇酯鈉、碳數8~24的烷基苯磺酸鹽(十二基苯磺酸鈉等)、磷酸碳數8~24的烷酯鹽及磷酸碳數8~24的烷基(聚)環氧乙烷酯鹽(磷酸月桂酯鈉及磷酸月桂基(聚)環氧乙烷(聚合度=1~100)酯醚鈉等)、脂肪酸鹽(月桂酸鈉及月桂酸三乙醇胺等)、醯化胺基酸鹽(椰子油脂醯基甲基牛磺酸鈉、椰子油脂醯基肌胺酸鈉、椰子油脂醯基肌胺酸三乙醇胺、N-椰子油脂醯基-L-麩醯胺酸三乙醇胺、N-椰子油脂醯基-L-麩醯胺酸鈉及月桂醯基甲基-β-丙胺酸鈉等)。Examples of the anionic surfactant (A-2) include alkyl ether esters of carboxylic acid with 8 to 24 carbon atoms or their salts, and alkyl (poly)ethylene oxide ether esters of carboxylic acid with 8 to 24 carbon atoms. Or its salt (lauryl acetate (poly) ethylene oxide (polymerization degree = 1-100) ether ester sodium and sulfosuccinate lauryl (poly) ethylene oxide (polymerization degree = 1-100) ester disodium Etc.), sulfuric acid carbon number 8-24 alkyl ester salt and sulfuric acid carbon number 8-24 alkyl (poly) ethylene oxide ester salt Degree = 1~100) Sodium ester and lauryl sulfate (poly) ethylene oxide (polymerization degree = 1~100) ester triethanolamine salt, etc.), coconut oil sulphate amide monoethanol ester sodium, carbon number 8~24 Alkylbenzene sulfonate (sodium dodecylbenzene sulfonate, etc.), phosphate carbon number 8-24 alkyl ester salt, and phosphate carbon number 8-24 alkyl (poly)oxirane ester salt (lauryl phosphate) Sodium and phosphate lauryl (poly) ethylene oxide (polymerization degree = 1-100) ester ether sodium, etc.), fatty acid salt (sodium laurate and triethanolamine laurate, etc.), acylated amino acid salt (coconut oil syrup) Sodium methyl taurate, sodium coconut oil sarcosine sodium, coconut oil sarcosine triethanolamine, N-coconut oil glycine-L-glutamine triethanolamine, N-coco sarcosine- Sodium L-glutamate and sodium lauryl methyl-β-alanine, etc.).
作為陽離子性界面活性劑(A-3),可列舉:四級銨鹽型(氯化硬脂基三甲基銨、氯化二十二基三甲基銨、氯化二硬脂基二甲基銨及硫酸乙酯羊毛脂脂肪醯胺丙基乙基二甲基銨等)及胺鹽型(乳酸二乙基胺乙基硬脂醯胺鹽、鹽酸二月桂基胺鹽及乳酸油基胺鹽等)等。Examples of cationic surfactants (A-3) include: quaternary ammonium salt type (stearyl trimethyl ammonium chloride, behenyl trimethyl ammonium chloride, distearyl dimethyl ammonium chloride) Base ammonium and ethyl sulfate lanolin fatty amine propyl ethyl dimethyl ammonium, etc.) and amine salt type (lactate diethyl amine ethyl stearyl amine salt, dilauryl amine hydrochloride salt and oleyl amine lactate Salt etc.) etc.
作為兩性界面活性劑(A-4),可列舉:甜菜鹼型兩性界面活性劑(椰子油脂醯胺丙基二甲基胺基乙酸甜菜鹼、月桂基二甲基胺基乙酸甜菜鹼、2-烷基-N-羧甲基-N-羥乙基正咪唑甜菜鹼、月桂基羥基磺基甜菜鹼及月桂醯胺乙基羥乙基羧甲基甜菜鹼羥丙基磷酸鈉等)、胺基酸型兩性界面活性劑(β-月桂基胺基丙酸鈉等)。As amphoteric surfactants (A-4), betaine type amphoteric surfactants (coconut fat amine propyl dimethyl amino acetate betaine, lauryl dimethyl amino acetate betaine, 2- Alkyl-N-carboxymethyl-N-hydroxyethyl n-imidazole betaine, lauryl hydroxysultaine and lauryl amine ethyl hydroxyethyl carboxymethyl betaine hydroxypropyl sodium phosphate, etc.), amino group Acid type amphoteric surfactants (β-sodium lauryl propionate, etc.).
作為生物界面活性劑(A-5),可列舉:表面素(surfactin)、鼠李糖脂及此等的鹽等。作為鹽,可列舉:鹼金屬鹽、鹼土金屬鹽及鎓鹽等。Examples of biosurfactants (A-5) include surfactins, rhamnolipids, and salts thereof. Examples of the salt include alkali metal salts, alkaline earth metal salts, and onium salts.
作為界面活性劑(A),可使用1種或2種以上。在使用2種以上的情況下,作為其組合,可列舉例如:非離子性界面活性劑(A-1)與陰離子性界面活性劑(A-2)、非離子性界面活性劑(A-1)與陽離子性界面活性劑(A-3)以及非離子性界面活性劑(A-1)與兩性界面活性劑(A-4)的組合等。As the surfactant (A), one type or two or more types can be used. When two or more types are used, as the combination thereof, for example, nonionic surfactant (A-1), anionic surfactant (A-2), nonionic surfactant (A-1) ) Combinations with cationic surfactants (A-3), nonionic surfactants (A-1) and amphoteric surfactants (A-4), etc.
就清洗性之觀點而言,以單獨使用非離子性界面活性劑(A-1)及使用非離子性界面活性劑(A-1)與陰離子性界面活性劑(A-2)的組合作為界面活性劑(A)為佳。From the standpoint of cleaning properties, use a nonionic surfactant (A-1) alone or a combination of a nonionic surfactant (A-1) and an anionic surfactant (A-2) as the interface Active agent (A) is better.
作為非離子性界面活性劑(A-1),就清洗性之觀點而言,以脂族醇(碳數8~24)環氧乙烷加成物(聚合度=1~100)為佳,以脂族醇(碳數12~18)環氧乙烷加成物(聚合度4~20)為更佳,又以脂族醇(碳數12~15)環氧乙烷加成物(聚合度=8~12)為更佳,以月桂基醇環氧乙烷11莫耳加成物為尤佳。As the nonionic surfactant (A-1), from the viewpoint of cleaning properties, an aliphatic alcohol (carbon number 8-24) ethylene oxide adduct (polymerization degree = 1-100) is preferred, It is better to use aliphatic alcohol (carbon number 12-18) ethylene oxide adduct (polymerization degree 4-20), and aliphatic alcohol (carbon number 12-15) ethylene oxide adduct (polymerization Degree=8-12) is more preferred, and 11 mol adduct of lauryl alcohol ethylene oxide is particularly preferred.
作為陰離子性界面活性劑(A-2),就清洗性之觀點而言,以碳數8~24的烷基苯磺酸鹽、脂肪酸鹽、硫酸碳數8~24的烷酯鹽及硫酸碳數8~24的烷基(聚)環氧乙烷酯鹽為佳,以碳數12~16的烷基苯磺酸鹽及碳數8~16的脂肪酸鹽為更佳,又以十二基苯磺酸一乙醇胺鹽及月桂酸鈉為更佳。As an anionic surfactant (A-2), from the viewpoint of cleaning properties, alkylbenzene sulfonates with 8 to 24 carbon atoms, fatty acid salts, alkyl ester salts with 8 to 24 sulfuric acid carbons, and carbon sulfate Alkyl (poly)ethylene oxide ester salts with 8-24 are preferred, alkylbenzene sulfonates with 12-16 carbons and fatty acid salts with 8-16 carbons are more preferred, and dodecyl Benzenesulfonic acid monoethanolamine salt and sodium laurate are more preferred.
本揭露之清洗劑中所包含之界面活性劑(A)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且10質量%以下為佳,以0.1質量%以上且5質量%以下為更佳。The content (mass %) of the surfactant (A) contained in the cleaning agent of the present disclosure is preferably 0 mass% or more and 10 mass% or less relative to the mass of the cleaning agent from the viewpoint of cleaning properties, It is more preferably 0.1% by mass or more and 5% by mass or less.
酵素(B)包含蛋白酶(B-1)、澱粉酶(B-2)、脂酶(B-3)及纖維素酶(B-4)、胺肽酶等。Enzyme (B) includes protease (B-1), amylase (B-2), lipase (B-3), cellulase (B-4), aminopeptidase, etc.
在本揭露中,所謂蛋白酶(B-1),係將肽或蛋白質作為基質而催化加水分解的酵素。作為蛋白酶(B-1),包含起源於動物、植物或微生物者,就取得容易性之觀點而言,以起源於微生物者為佳。亦包含經化學上或基因上修飾的變異體。蛋白酶(B-1)亦可為在中性至鹼性側中存在最合適pH的蛋白酶(鹼性蛋白酶),並且可組合使用滿足此條件的多種蛋白酶。作為蛋白酶(B-1),包含絲胺酸蛋白酶(B-1-1)、天門冬胺酸蛋白酶(B-1-2)、半胱胺酸蛋白酶(B-1-3)及金屬蛋白酶(B-1-4)。In this disclosure, the so-called protease (B-1) is an enzyme that catalyzes hydrolysis by using peptides or proteins as a substrate. As the protease (B-1), those derived from animals, plants or microorganisms are included. From the viewpoint of ease of acquisition, those derived from microorganisms are preferred. It also includes chemically or genetically modified variants. The protease (B-1) may also be a protease (alkaline protease) having the most suitable pH on the neutral to alkaline side, and multiple proteases satisfying this condition can be used in combination. As the protease (B-1), it includes serine protease (B-1-1), aspartic acid protease (B-1-2), cysteine protease (B-1-3) and metalloprotease ( B-1-4).
絲胺酸蛋白酶(B-1-1)係擁有絲胺酸殘基作為觸媒殘基的蛋白酶,包含:胰凝乳蛋白酶、胰蛋白酶、凝血酶、胞漿素、彈性蛋白酶、枯草桿菌蛋白酶(枯草桿菌蛋白酶E、枯草桿菌蛋白酶BPN′)、克欣蛋白酶(Kexin),以及源自放線菌(鏈黴菌屬)的蛋白酶、源自枯草桿菌(桿菌屬)的蛋白酶或源自絲狀真菌(麴菌屬)的蛋白酶等。具體而言,可列舉:源自豬胰臟的胰蛋白酶、源自芽孢桿菌(Bacillus)的枯草桿菌蛋白酶Novo、枯草桿菌蛋白酶Carlsberg、枯草桿菌蛋白酶309、枯草桿菌蛋白酶147及枯草桿菌蛋白酶168。絲胺酸蛋白酶(B-1-1)已知係絲胺酸殘基涉及活性中心的蛋白酶,會因會特定與絲胺酸殘基鍵結的氟磷酸二異丙酯或苯甲基磺醯氟等藥劑而失去活性。絲胺酸蛋白酶(B-1-1)由於不需要還原劑,不會受金屬螯合劑的影響,在中性附近具有酵素活性的最合適pH,故在本揭露中適宜使用。Serine protease (B-1-1) is a protease with serine residues as catalyst residues, including: chymotrypsin, trypsin, thrombin, cytoplasmin, elastase, subtilisin ( Subtilisin E, subtilisin BPN'), Kexin protease (Kexin), and protease derived from actinomycetes (Streptomyces), protease derived from Bacillus subtilis (Bacillus) or filamentous fungus (Koji) Bacteria) protease, etc. Specifically, examples include trypsin derived from porcine pancreas, subtilisin Novo derived from Bacillus, subtilisin Carlsberg, subtilisin 309, subtilisin 147, and subtilisin 168. Serine protease (B-1-1) is known to be a protease whose serine residue is involved in the active center. It will be specific to the diisopropyl fluorophosphate or benzyl sulfonate that binds to the serine residue. Fluorine and other agents lose their activity. Serine protease (B-1-1) does not require a reducing agent, is not affected by metal chelating agents, and has the most suitable pH for enzyme activity near neutral, so it is suitable for use in this disclosure.
作為市售之絲胺酸蛋白酶(B-1-1),可列舉:諾維信公司製之Alcalase、Savinase、Everlase、Esperase、Kannase、Ovozyme、枯草桿菌蛋白酶A、PEM、PTN、Primase、Durazym、長瀨生化學工業股份有限公司製之BIOPRASE、天野製藥股份有限公司製之蛋白酶N「Amano」、蛋白酶P「Amano」、科研製藥股份有限公司製之Actinase AS、花王股份有限公司製之KAP、Genencor公司製之Purafect、Purafect OXP、Properase、Calbiochem公司製之Pronase、Invitrogen Corporation製之TrypLE Select及Chemicon International公司製之Accutase等。並且,亦可適宜使用日本專利公開第2007-61101號公報所記載之蛋白酶。Commercially available serine proteases (B-1-1) include: Alcalase, Savinase, Everlase, Esperase, Kannase, Ovozyme, Subtilisin A, PEM, PTN, Primase, Durazym, Long BIOPRASE manufactured by Seto Chemical Industry Co., Ltd., Protease N "Amano" and Protease P "Amano" manufactured by Amano Pharmaceutical Co., Ltd., Actinase AS manufactured by Scientific Research Pharmaceutical Co., Ltd., KAP manufactured by Kao Co., Ltd., Genencor Corporation Purafect, Purafect OXP, Properase, Pronase manufactured by Calbiochem, TrypLE Select manufactured by Invitrogen Corporation, Accutase manufactured by Chemicon International, etc. In addition, the protease described in Japanese Patent Publication No. 2007-61101 can also be suitably used.
天門冬胺酸蛋白酶(B-1-2)係在活性中心存在天門冬胺酸的蛋白酶,包含:胃蛋白酶、組織蛋白酶D、組織蛋白酶E、腎素及凝乳酶等。具體而言,可列舉源自人胃的胃蛋白酶等。天門冬胺酸蛋白酶(B-1-2)係一般亦稱為酸性蛋白酶的蛋白酶,於酸性區域中具有酵素活性。由於HFIP係酸性,故合適。Aspartic acid protease (B-1-2) is a protease with aspartic acid in the active center, including: pepsin, cathepsin D, cathepsin E, renin and chymosin, etc. Specifically, pepsin derived from the human stomach and the like can be cited. Aspartic acid protease (B-1-2) is a protease generally called acid protease, which has enzyme activity in the acidic region. Since HFIP is acidic, it is suitable.
半胱胺酸蛋白酶(B-1-3)係硫醇基存在於活性中心的蛋白酶,木瓜酶、鳳梨酶、無花果蛋白酶、獼猴桃鹼、組織蛋白酶B、組織蛋白酶H、組織蛋白酶L、半胱天門冬酶及薑蛋白酶等。半胱胺酸蛋白酶(B-1-3)由於活性中心係硫醇基,故以併用如半胱胺酸或硫脲的還原劑為佳。此種還原劑就防止由空氣中的氧所致之氧化之觀點而言,在即將清洗前或清洗時加入至清洗劑為佳。Cysteine protease (B-1-3) is a protease whose thiol group exists in the active center, papain, bromelase, ficin, kiwifruit, cathepsin B, cathepsin H, cathepsin L, cysteine Winter enzymes and ginger protease, etc. Since the active center of cysteine protease (B-1-3) is a thiol group, it is better to use a reducing agent such as cysteine or thiourea in combination. From the viewpoint of preventing oxidation caused by oxygen in the air, such a reducing agent is preferably added to the cleaning agent immediately before or during cleaning.
金屬蛋白酶(B-1-4)係在活性中心包含金屬離子的蛋白酶,可列舉例如:嗜熱菌蛋白酶、基質金屬蛋白酶、羧肽酶A、羧肽酶B、分散酶及膠原蛋白酶等。作為市售之金屬蛋白酶(B-1-4),可列舉Worthington Biochemical Corporation製之分散酶等。在一實施型態中,於併用金屬蛋白酶(B-1-4)與後述之螯合劑(C)的情況下,就保持金屬蛋白酶的活性之觀點而言,以使用不含金屬的螯合劑為佳。Metalloprotease (B-1-4) is a protease containing metal ions in the active center, and examples thereof include thermolysin, matrix metalloprotease, carboxypeptidase A, carboxypeptidase B, dispase, and collagenase. Examples of commercially available metalloprotease (B-1-4) include dispase manufactured by Worthington Biochemical Corporation. In one embodiment, when the metalloprotease (B-1-4) is used in combination with the chelating agent (C) described later, from the viewpoint of maintaining the activity of the metalloprotease, a metal-free chelating agent is used as good.
上述蛋白酶(B-1)之中,就效果的持續性及清洗性之觀點而言,以絲胺酸蛋白酶(B-1-1)、天門冬胺酸蛋白酶(B-1-2)為佳,以枯草桿菌蛋白酶、胞漿素為更佳。其中,以源自嗜鹽芽孢桿菌(Bacillus halodurans )、克勞氏芽孢桿菌(Bacillus clausii )的枯草桿菌蛋白酶為佳。Among the above-mentioned proteases (B-1), from the standpoint of durability and cleaning properties, serine protease (B-1-1) and aspartic acid protease (B-1-2) are preferred , Subtilisin and cytoplasmin are better. Among them, subtilisins derived from Bacillus halodurans and Bacillus clausii are preferred.
本揭露之清洗劑藉由含有蛋白酶(B-1),可更有效率清洗固著的蛋白質髒污。蛋白酶(B-1)可為清洗劑所含有,但亦可併用含有蛋白酶(B-1)的清洗劑與本揭露之清洗劑。就酵素穩定性之觀點而言,以另外製備含有蛋白酶(B-1)的清洗劑,在即將清洗前或清洗時組合使用為佳。The cleaning agent of the present disclosure contains protease (B-1), which can more efficiently clean fixed protein stains. The protease (B-1) may be contained in the cleaning agent, but the cleaning agent containing the protease (B-1) can also be used in combination with the cleaning agent of the present disclosure. From the standpoint of enzyme stability, it is better to separately prepare a cleaning agent containing protease (B-1) and use it in combination immediately before or during cleaning.
作為澱粉酶(B-2),包含起源於細菌或真菌者。亦包含經化學上或基因上修飾的變異體。作為澱粉酶(B-2),可列舉例如:英國專利第1,296,839號說明書所詳細記載之自地衣芽孢桿菌(B. licheniformis )之特殊株獲得的α-澱粉酶。作為市售之澱粉酶(B-2),可列舉:諾維信公司之Duramyl、Termamyl、Fungamyl及BAN,以及Gist-Brocades公司之Rapidase及Maxamyl P。As amylase (B-2), it includes those derived from bacteria or fungi. It also includes chemically or genetically modified variants. As an amylase (B-2), for example, the α-amylase obtained from a special strain of B. licheniformis described in detail in the specification of British Patent No. 1,296,839 can be cited. Commercially available amylases (B-2) include Duramyl, Termamyl, Fungamyl and BAN from Novozymes, and Rapidase and Maxamyl P from Gist-Brocades.
作為脂酶(B-3),包含起源於細菌或真菌者。亦包含經化學上或基因上修飾的變異體。作為脂酶之例,可列舉:柔毛腐質黴(Humicola lanuginosa )脂酶(歐洲專利第258068號說明書及歐洲專利第30216號說明書)、米式假根毛黴(Rhizomucor miehei )脂酶及念珠菌屬(Candida )脂酶(歐洲專利第238023號說明書)、南極念珠菌(C. antarctica )脂酶A及B、假單胞菌屬(Pseudomonas )脂酶(歐洲專利第214761號說明書)、類產鹼假單胞菌(P. pseudoalcaligenes )及產鹼假單胞菌(P. alcaligenes )脂酶(歐洲專利第218272號說明書)、洋蔥假單胞菌(P. cepacia )脂酶(歐洲專利第331376號說明書)、施氏假單胞菌(P. stutzeri )脂酶、螢光假單胞菌(P. fluorescens )脂酶及芽孢桿菌屬(Bacillus )脂酶(英國專利第1,372,034號說明書)、枯草桿菌(B. subtilis )脂酶(Dartois等人(1993), Biochemica et Biophysica Acta 1131, 253-260)、嗜熱脂肪桿菌(B. stearothermophilus )脂酶(日本專利公告第S64-744992號公報)以及短小芽孢桿菌(B. pumilus )脂酶(國際專利公開第91/16422號)。As lipase (B-3), those derived from bacteria or fungi are included. It also includes chemically or genetically modified variants. Examples of lipases include: Humicola lanuginosa lipase (European Patent No. 258068 and European Patent No. 30216), Rhizomucor miehei lipase, and Candida genus (Candida) lipase (European Patent specification No. 238 023), Candida antarctica (C. antarctica) A and B lipase, Pseudomonas (of Pseudomonas) lipase (European Patent specification No. 214 761), production class P. pseudoalcaligenes and P. alcaligenes lipase (European Patent No. 218272), P. cepacia lipase (European Patent No. 331376 Specification), P. stutzeri (P. stutzeri) lipase, P. fluorescens (P. fluorescens) lipase, and Bacillus ( Bacillus ) lipase (British Patent No. 1,372,034), subtilis B. subtilis lipase (Dartois et al. (1993), Biochemica et Biophysica Acta 1131, 253-260), B. stearothermophilus lipase (Japanese Patent Publication No. S64-744992), and Bacillus pumilus ( B. pumilus ) lipase (International Patent Publication No. 91/16422).
作為市售之脂酶(B-3),可列舉:Genencor公司之M1 Lipase、Luma fast及Lipomax、諾維信公司之Lipolase及Lipolase Ultra,以及天野酶公司之脂酶P「Amano」。Commercially available lipases (B-3) include: M1 Lipase, Luma fast and Lipomax from Genencor, Lipolase and Lipolase Ultra from Novozymes, and Lipase P "Amano" from Amano Enzyme.
作為纖維素酶(B-4),包含起源於細菌或真菌者。亦包含經化學上或基因上修飾的變異體。作為纖維素酶,包含美國專利第4,435,307號說明書所揭露作為由特異腐質黴(Humicola insolens )所生產之真菌纖維素酶者。As cellulase (B-4), those derived from bacteria or fungi are included. It also includes chemically or genetically modified variants. As the cellulase, the cellulase disclosed in the specification of US Patent No. 4,435,307 is a fungal cellulase produced by Humicola insolens (Humicola insolens).
作為市售之纖維素酶,可列舉利用特異腐質黴(Humicola insolens )之株所生產的諾維信公司之Celluzyme及花王股份有限公司之KAC-500(B)。Examples of commercially available cellulase enzymes include Novozymes' Celluzyme produced by Humicola insolens strains and KAC-500(B) from Kao Co., Ltd.
上述酵素(B)之中,在清洗性之觀點上,以蛋白酶(B-1)為佳。Among the above-mentioned enzymes (B), protease (B-1) is preferred from the viewpoint of cleaning properties.
在本揭露中,清洗劑所包含之酵素(B)可包含2種以上。作為包含2種以上之情形的組合,可列舉例如包含2種以上之蛋白酶、蛋白酶與澱粉酶、蛋白酶與脂酶或者蛋白酶與澱粉酶與脂酶的組合。In the present disclosure, the enzyme (B) contained in the cleaning agent may include two or more kinds. As a combination containing two or more types, for example, a combination containing two or more types of protease, protease and amylase, protease and lipase, or protease and amylase and lipase.
本揭露之清洗劑中所包含之酵素(B)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。The content (mass%) of the enzyme (B) contained in the cleaning agent of the present disclosure, from the viewpoint of cleaning properties, is preferably 0 mass% or more and 10 mass% or less with respect to the mass of the cleaning agent, and 0.05 Mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are particularly preferable.
作為螯合劑(C),可使用胺基酸系、有機酸系、膦酸系、磷酸系、聚羧酸系之任一者。可列舉例如:三乙酸基胺、亞胺二乙酸、乙二胺四乙酸(EDTA)、二伸乙三胺五乙酸、乙二醇雙胺乙基醚四乙酸、羥乙基亞胺二乙酸、三伸乙四胺六乙酸、金龜胺酸等胺基多乙酸或此等的鹽;縮二羥乙酸、氧基二琥珀酸、羧甲基氧基琥珀酸、檸檬酸、乳酸、酒石酸、草酸、蘋果酸、葡萄糖酸、羧甲基琥珀酸、羧甲基酒石酸、麩胺酸二乙酸等有機酸或此等的鹽;胺基三(亞甲基膦酸)、1-羥基亞乙基-1,1-二膦酸、乙二胺四(亞甲基膦酸)、二伸乙三胺五(亞甲基膦酸)等膦酸或其鹽;三聚磷酸等磷酸或其鹽;聚丙烯酸、聚甲基丙烯酸、聚順丁烯二酸等聚羧酸或其鹽等。螯合劑(C),就通用性之觀點而言,以選自胺基多乙酸及其鹽之1種或2種以上為佳,以選自乙二胺四乙酸(EDTA)及其鹽之1種或2種以上為較佳。作為此等之鹽的相對離子,可列舉鹼金屬、四級銨、醇胺等,但就對於醫療用器具之防蝕性這點而言,以醇胺鹽為佳。再者,以一乙醇胺鹽為佳。此等可單獨使用1種或組合2種以上使用。As the chelating agent (C), any of amino acid, organic acid, phosphonic acid, phosphoric acid, and polycarboxylic acid can be used. Examples include: triacetoxyamine, iminodiacetic acid, ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid, ethylene glycol diamine ethyl ether tetraacetic acid, hydroxyethyl imine diacetic acid, Amino polyacetic acids such as ethylenetetramine hexaacetic acid and berytolic acid or their salts; glycolic acid, oxydisuccinic acid, carboxymethyloxysuccinic acid, citric acid, lactic acid, tartaric acid, oxalic acid, Malic acid, gluconic acid, carboxymethyl succinic acid, carboxymethyl tartaric acid, glutamine diacetic acid and other organic acids or their salts; amino tris (methylene phosphonic acid), 1-hydroxyethylene-1 , 1-Diphosphonic acid, ethylene diamine tetra (methylene phosphonic acid), ethylene triamine penta (methylene phosphonic acid) and other phosphonic acids or their salts; tripolyphosphoric acid and other phosphoric acids or their salts; polyacrylic acid , Polymethacrylic acid, polymaleic acid and other polycarboxylic acids or their salts. From the viewpoint of versatility, the chelating agent (C) is preferably one or more selected from aminopolyacetic acid and its salts, and preferably one selected from ethylenediaminetetraacetic acid (EDTA) and its salts One type or two or more types are preferable. Examples of counter ions for these salts include alkali metals, quaternary ammonium, alcohol amines, etc. However, in terms of corrosion resistance for medical devices, alcohol amine salts are preferred. Furthermore, monoethanolamine salt is preferred. These can be used individually by 1 type or in combination of 2 or more types.
本揭露之清洗劑中所包含之螯合劑(C)的含量(質量%),就蛋白質髒污的去除效果及成本之觀點而言,相對於清洗劑的質量為0質量%以上且5質量%以下,以0.005質量%以上且2質量%以下為較佳,以0.01質量%以上且1質量%以下為更佳。螯合劑(C)的含量使用酸換算的量。The content (mass %) of the chelating agent (C) contained in the cleaning agent of the present disclosure is 0 mass% or more and 5 mass% from the viewpoint of the protein stain removal effect and cost Below, 0.005 mass% or more and 2 mass% or less are preferable, and 0.01 mass% or more and 1 mass% or less are more preferable. The content of the chelating agent (C) uses an acid-converted amount.
作為酵素穩定劑(D),可使用單醣、多醣或硼化合物。單醣、多醣可為取代或無取代,亦可為支鏈或直鏈。作為單醣、多醣,可列舉例如:糊精、葡萄糖、甘露糖等。硼化合物可為取代或無取代。作為硼化合物,可列舉例如:硼酸、三氧化二硼、酸或此等的鹽等。本揭露之清洗劑中所包含之酵素穩定劑(D)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。As the enzyme stabilizer (D), monosaccharides, polysaccharides, or boron compounds can be used. Monosaccharides and polysaccharides can be substituted or unsubstituted, and can also be branched or straight chain. Examples of monosaccharides and polysaccharides include dextrin, glucose, and mannose. The boron compound may be substituted or unsubstituted. Examples of boron compounds include boric acid, boron trioxide, Acid or these salts, etc. The content (mass%) of the enzyme stabilizer (D) contained in the cleaning agent of the present disclosure, from the viewpoint of cleaning properties, is preferably 0 mass% or more and 10 mass% or less relative to the mass of the cleaning agent, It is more preferably 0.05% by mass or more and 5% by mass or less, and particularly preferably 0.1% by mass or more and 3% by mass or less.
抗凝血劑(E)包含醣類(E-1)、非界面活性劑(E-2)、有機酸或其鹽(E-3)、無機含氧酸或其鹽(E-4)、丙三醇(E-5)。Anticoagulant (E) includes sugar (E-1), non-surfactant (E-2), organic acid or its salt (E-3), inorganic oxo acid or its salt (E-4), Glycerol (E-5).
作為醣類(E-1),可列舉:阿洛糖、阿卓糖、甘露糖、古洛糖、艾杜糖、半乳糖、太洛糖、碳數3~5的單醣類、碳數6的酮醣、雙醣以上的多醣類、碳數4~12的醣醇類等。作為碳數3~5的單醣類,可列舉:甘油醛、赤藻酮糖、赤藻糖、核糖、木糖、木酮糖等。作為碳數6的酮醣,可列舉:果糖、山梨糖等。作為雙醣以上的多醣類,可列舉:蔗糖、乳糖、繭糖、纖維雙醣、槐糖、棉子糖、麥芽三糖、羧甲基纖維素、澱粉、聚三葡萄糖、果膠、葡甘露聚糖等。作為碳數4~12的醣醇類,可列舉:山梨醇、木糖醇、新戊四醇、麥芽糖醇、乳糖醇、蔗糖素等。Examples of sugars (E-1) include allose, altose, mannose, gulose, idose, galactose, tarose, monosaccharides with 3 to 5 carbon atoms, and
作為非界面活性劑(E-2),可列舉:高級醇環氧烷加成物、烷基(或烯基)酚環氧烷加成物、苯乙烯化酚環氧烷加成物、苯乙烯化烷基酚環氧烷加成物、高級烷基(或高級烯基)胺環氧烷加成物、脂肪酸環氧烷加成物、脂肪醯胺環氧烷加成物、聚丙二醇環氧烷加成物、(一或多)脂肪酸甘油酯或其環氧烷加成物、脂肪酸蔗糖酯或其環氧烷加成物、脂肪酸山梨醇酐酯或其環氧烷加成物等。Examples of non-surfactant (E-2) include: higher alcohol alkylene oxide adduct, alkyl (or alkenyl) phenol alkylene oxide adduct, styrenated phenol alkylene oxide adduct, benzene Ethylene alkylphenol alkylene oxide adduct, higher alkyl (or higher alkenyl) amine alkylene oxide adduct, fatty acid alkylene oxide adduct, fatty amine alkylene oxide adduct, polypropylene glycol ring Oxyalkylene adducts, (one or more) fatty acid glycerides or their alkylene oxide adducts, fatty acid sucrose esters or their alkylene oxide adducts, fatty acid sorbitan esters or their alkylene oxide adducts, etc.
於此,高級醇通常係碳數8~24的直鏈或分支之不飽和或飽和的高級醇,烷基或烯基酚通常係具有碳數6~22的直鏈或分支之烷基或烯基的酚化合物,高級烷基或高級烯基胺通常係碳數8~24的直鏈或分支之高級烷基或高級烯基胺,脂肪酸通常係碳數8~24的不飽和或飽和之脂肪酸,聚丙二醇的重量平均分子量為900~5000。Here, the higher alcohol is usually a linear or branched unsaturated or saturated higher alcohol with 8 to 24 carbons, and the alkyl or alkenyl phenol is usually a linear or branched alkyl or alkene with 6 to 22 carbons. Alkyl phenolic compounds, higher alkyl or higher alkenyl amines are usually linear or branched higher alkyl or higher alkenyl amines with 8-24 carbons, and fatty acids are usually unsaturated or saturated fatty acids with 8-24 carbons. , The weight average molecular weight of polypropylene glycol is 900-5000.
環氧烷加成物的環氧烷基,可列舉例如:環氧乙基、環氧丙基、環氧丁基、苯基環氧乙基,此等可為單獨,亦可使用2種以上。在使用2種以上的情形中,對於環氧烷的加成型態並無限制,可列舉例如:雜亂加成、嵌段加成、將雜亂與嵌段混合的方法等。環氧烷加成物的加成莫耳數為1~1000。The alkylene oxide of the alkylene oxide adduct includes, for example, epoxy ethyl, epoxy propyl, epoxy butyl, and phenyl epoxy ethyl. These may be singly or in two or more types. . In the case of using two or more types, there is no restriction on the addition molding state of the alkylene oxide, and examples thereof include random addition, block addition, and a method of mixing a random and a block. The number of addition moles of the alkylene oxide adduct is 1 to 1,000.
作為有機酸或其鹽(E-3),可列舉:胺基酸、酮酸、氧基羧酸、聚羧酸,或者碳數1~24的飽和或不飽和脂肪酸及此等的鹽等。作為有機酸,可列舉例如:於分子內具有羧基、磺酸基、磷酸基、硫醇基、酚性羥基等酸性基的有機化合物,作為此等的鹽,可列舉例如:鹼金屬鹽、銨鹽、醇胺鹽等。Examples of organic acids or their salts (E-3) include amino acids, keto acids, oxycarboxylic acids, polycarboxylic acids, or saturated or unsaturated fatty acids having 1 to 24 carbon atoms, and salts thereof. Examples of organic acids include organic compounds having acidic groups such as carboxyl groups, sulfonic acid groups, phosphoric acid groups, thiol groups, and phenolic hydroxyl groups in the molecule. Examples of these salts include alkali metal salts and ammonium. Salt, alcohol amine salt, etc.
更具體而言,作為具有羧基的有機化合物,可列舉:胺基酸、酮酸、氧基羧酸、聚羧酸、碳數1~24的飽和或不飽和脂肪酸等。作為具有磺酸基的有機化合物,可列舉:苯磺酸、直鏈烷基苯磺酸、α-烯烴磺酸、硫酸一酯等。作為具有磷酸基的有機化合物,可列舉:腺苷酸、艾提壯酸、次磷酸一酯鹽、磷酸一酯、磷酸二酯等。作為具有硫醇基的有機化合物,可列舉:4-巰基苯乙酮、硫代水楊酸、硫代苄酸、硫代乙醇酸等。作為具有酚性羥基的有機化合物,可列舉:酚、2-萘酚、兒茶酚等。作為鹼金屬鹽,可列舉:鈉鹽、鉀鹽等。作為醇胺鹽,可列舉:一乙醇胺鹽、二乙醇胺鹽、三乙醇胺鹽等。More specifically, examples of the organic compound having a carboxyl group include amino acids, keto acids, oxycarboxylic acids, polycarboxylic acids, saturated or unsaturated fatty acids having 1 to 24 carbon atoms, and the like. Examples of the organic compound having a sulfonic acid group include benzene sulfonic acid, linear alkylbenzene sulfonic acid, α-olefin sulfonic acid, and sulfuric acid monoester. Examples of the organic compound having a phosphate group include adenylic acid, atitic acid, hypophosphorous acid monoester, phosphate monoester, and phosphodiester. Examples of the organic compound having a thiol group include 4-mercaptoacetophenone, thiosalicylic acid, thiobenzyl acid, thioglycolic acid, and the like. As an organic compound which has a phenolic hydroxyl group, phenol, 2-naphthol, catechol, etc. are mentioned. As alkali metal salt, sodium salt, potassium salt, etc. are mentioned. Examples of the alcoholamine salt include monoethanolamine salt, diethanolamine salt, triethanolamine salt, and the like.
作為無機含氧酸或其鹽(E-4),可列舉:磷酸鹽、次磷酸鹽、焦磷酸鹽、多磷酸鹽、硫酸鹽等。作為無機含氧酸,係例如:磷、硫、氮、硼、氯、溴、碘、矽等的含氧酸,作為此等的鹽,可列舉:鹼金屬鹽、銨鹽、醇胺鹽等。As an inorganic oxyacid or its salt (E-4), a phosphate, a hypophosphite, a pyrophosphate, a polyphosphate, a sulfate, etc. are mentioned. Examples of inorganic oxyacids include oxyacids such as phosphorus, sulfur, nitrogen, boron, chlorine, bromine, iodine, and silicon. Examples of these salts include alkali metal salts, ammonium salts, alcohol amine salts, etc. .
更具體而言,作為磷的含氧酸,可列舉:次磷酸、亞磷酸、磷酸、焦磷酸、聚合度為3~6的聚磷酸鹽等。作為硫的含氧酸,可列舉:次硫酸、亞硫酸、硫酸、過硫酸、焦硫酸、焦亞硫酸、硫代硫酸、胺磺酸、二亞硫磺酸等。作為氮的含氧酸,可列舉:亞硝酸、硝酸等。作為硼的含氧酸,可列舉:偏硼酸、硼酸、過硼酸等。作為氯的含氧酸,可列舉:次氯酸、亞氯酸、氯酸、過氯酸等。作為溴的含氧酸,可列舉:次溴酸、亞溴酸、溴酸、過溴酸等。作為碘的含氧酸,可列舉:次碘酸、碘酸、過碘酸等。作為矽的含氧酸,可列舉:正矽酸、偏矽酸、二矽酸等。作為鹼金屬鹽,可列舉:鈉鹽、鉀鹽等,作為醇胺鹽,可列舉:一乙醇胺鹽、二乙醇胺鹽、三乙醇胺鹽等。More specifically, examples of phosphorus-containing oxo acids include hypophosphorous acid, phosphorous acid, phosphoric acid, pyrophosphoric acid, and polyphosphates having a degree of polymerization of 3 to 6, and the like. Examples of sulfur oxyacids include hyposulfuric acid, sulfurous acid, sulfuric acid, persulfuric acid, pyrosulfuric acid, metabisulfuric acid, thiosulfuric acid, sulfamic acid, and disulfinic acid. As nitrogen oxyacid, nitrous acid, nitric acid, etc. are mentioned. Examples of the oxo acid of boron include metaboric acid, boric acid, perboric acid, and the like. Examples of chlorine-containing oxygen acids include hypochlorous acid, chlorous acid, chloric acid, perchloric acid, and the like. Examples of the oxygen-containing acid of bromine include hypobromous acid, bromous acid, bromic acid, perbromic acid, and the like. Examples of the oxo acid of iodine include hypoiodic acid, iodic acid, and periodic acid. Examples of the oxygen-containing acid of silicon include orthosilicic acid, metasilicic acid, and disilicic acid. Examples of alkali metal salts include sodium salts, potassium salts, and the like. Examples of alcoholamine salts include monoethanolamine salts, diethanolamine salts, and triethanolamine salts.
本揭露之清洗劑藉由含有抗凝血劑(E),可更有效率清洗血液的髒汙。舉例而言,本揭露之清洗劑中所包含之丙三醇(E-5)的含量(質量%),就抗凝血效果與凝固血液的溶解效果之觀點而言,相對於清洗劑的質量為0質量%以上且80質量%以下。By containing the anticoagulant (E), the cleansing agent of the present disclosure can clean blood dirt more efficiently. For example, the content (mass %) of glycerol (E-5) contained in the cleaning agent of the present disclosure is relative to the quality of the cleaning agent in terms of the anticoagulant effect and the dissolving effect of coagulated blood It is 0% by mass or more and 80% by mass or less.
作為抗金屬腐蝕劑(F),可使用矽酸鹽。舉例而言,做為矽酸鹽,可舉出矽酸鹼金屬鹽。作為矽酸鹼金屬鹽,可使用M2
O·nSiO2
的n為0.3〜5的化合物。並且,較為合適的n之值為1〜3。就輕金屬腐蝕抑制性能之觀點而言,n以0.3以上為佳,就防止源自矽酸的水鏽產生之觀點而言,n以5以下為佳。作為矽酸鹼金屬鹽,可列舉例如:正矽酸鉀、正矽酸鈉、倍半矽酸鈉、倍半矽酸鉀、偏矽酸鈉、偏矽酸鉀,或JIS K1408所規定之1號矽酸鈉、2號矽酸鈉、3號矽酸鈉,或日本化學工業公司製之商品名:1K矽酸鉀、2K矽酸鉀、A矽酸鉀(純度40%)(莫耳比K2
O:SiO2
=1:3)等。本揭露之清洗劑中所包含之抗金屬腐蝕劑(F)的含量(質量%),就腐蝕抑制性能之觀點而言,以相對於清洗劑的質量為0質量%以上且10質量%以下為佳。As the anti-metal corrosion agent (F), silicate can be used. For example, as the silicate, an alkali metal silicate can be cited. As the alkali metal silicate, a compound in which n of M 2 O· nSiO 2 is 0.3 to 5 can be used. In addition, a suitable value of n is 1~3. From the viewpoint of light metal corrosion inhibition performance, n is preferably 0.3 or more, and from the viewpoint of preventing the generation of scale derived from silicic acid, n is preferably 5 or less. As the alkali metal silicate, for example, potassium orthosilicate, sodium orthosilicate, sodium sesquisilicate, potassium sesquisilicate, sodium metasilicate, potassium metasilicate, or 1 specified in JIS K1408 No. 2 sodium silicate, No. 2 sodium silicate, No. 3 sodium silicate, or the product name manufactured by Japan Chemical Industry Corporation: 1K potassium silicate, 2K potassium silicate, A potassium silicate (
低分子多元醇(G)包含至少具有2個羥基之碳數2〜30的醇化合物。The low-molecular-weight polyol (G) includes an alcohol compound having at least two hydroxyl groups and a carbon number of 2-30.
作為低分子多元醇(G),可列舉例如:乙二醇、二乙二醇、三乙二醇、四乙二醇、丙二醇、二丙二醇、三丙二醇、丁二醇、甲基丙二醇、戊二醇、甲基丁二醇、乙基丙二醇、二甲基丙二醇、己二醇、甲基戊二醇、乙基甲基丙二醇、二甲基丁二醇、庚二醇、丙基甲基丙二醇、異丙基甲基丙二醇、辛二醇、乙基己二醇、二級丁基丁基丙二醇、二甲基己二醇、三甲基戊二醇、壬二醇、乙基(2-甲基)丙基丙二醇、三甲基己二醇、丁基乙基丙二醇、二乙基戊二醇、甲基辛二醇、癸二醇、二甲基辛二醇、十一烷二醇、乙基甲基辛二醇、十二烷二醇、二乙基辛二醇、三甲基壬二醇、十四烷二醇、十五烷二醇、十六烷二醇、十七烷二醇、十八烷二醇、二十烷二醇、二十二烷二醇、二十四烷二醇等飽和二醇或其縮合物等。Examples of low-molecular polyols (G) include ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, propylene glycol, dipropylene glycol, tripropylene glycol, butylene glycol, methyl propylene glycol, and pentane Alcohol, methyl butylene glycol, ethyl propylene glycol, dimethyl propylene glycol, hexylene glycol, methyl pentane glycol, ethyl methyl propylene glycol, dimethyl butylene glycol, heptanediol, propyl methyl propylene glycol, Isopropyl methyl propylene glycol, octanediol, ethyl hexanediol, secondary butyl propylene glycol, dimethyl hexanediol, trimethyl pentanediol, nonanediol, ethyl (2-methyl ) Propylene propylene glycol, trimethyl hexanediol, butyl ethyl propylene glycol, diethyl pentanediol, methyl octane diol, decane diol, dimethyl octane diol, undecane diol, ethyl Methyloctanediol, dodecanediol, diethyloctanediol, trimethylnonanediol, tetradecanediol, pentadecanediol, hexadecanediol, heptadecanediol, Saturated glycols such as octadecanediol, eicosanediol, behenyldiol, and tetracosanediol, or condensates thereof.
並且,可列舉:丁烯二醇、亞甲基丙二醇、丁炔二醇、己烯二醇、甲基戊烯二醇、己二烯二醇、辛烯二醇、二甲基己烯二醇、癸烯二醇、二甲基丁烯二醇、十四烯二醇、羥基十八烯醇、戊炔二醇、己炔二醇、甲基戊炔二醇、庚炔二醇、二甲基戊炔二醇、二甲基己炔二醇、癸炔二醇、二甲基辛炔二醇、四甲基辛炔二醇、四甲基癸炔二醇、四甲基十二炔二醇、四異丙基辛炔二醇、二乙基十四炔二醇等不飽和二醇等。In addition, butenediol, methylene propylene glycol, butynediol, hexenediol, methylpentenediol, hexadienediol, octenediol, dimethylhexenediol , Decenediol, dimethylbutenediol, tetradecenediol, hydroxyoctadecenol, pentynediol, hexynediol, methylpentynediol, heptynediol, dimethyl Dimethylpentynediol, dimethylhexynediol, decynediol, dimethyloctynediol, tetramethyloctynediol, tetramethyldecynediol, tetramethyldodecynediol Unsaturated diols such as alcohol, tetraisopropyloctynediol, diethyltetradecynediol, etc.
並且,可列舉:環戊二醇、環己二醇、環庚二醇、降𦯉二醇、環辛二醇、環癸二醇、環辛烯二醇、十氫萘二醇、薴烯-1,2-二醇、萜烯二醇、二環己二醇、環十二烷二醇等脂環狀二醇等。In addition, examples include: cyclopentanediol, cyclohexanediol, cycloheptanediol, norethanediol, cyclooctanediol, cyclodecanediol, cyclooctenediol, decahydronaphthalenediol, and phenylene- Alicyclic diols such as 1,2-diol, terpene diol, dicyclohexanediol, cyclododecanediol, etc.
並且,可列舉:丙三醇、丁三醇、甲基丙三醇、戊三醇、甲基丁三醇、三羥甲基乙烷、己三醇、乙基丁三醇、三羥甲基丙烷、丙基庚三醇、二甲基戊三醇、三乙醇胺、三異丙醇胺等3元醇等。In addition, examples include glycerol, butanetriol, methylglycerol, pentanetriol, methylbutanetriol, trimethylolethane, hexanetriol, ethylbutanetriol, and trimethylol Trivalent alcohols such as propane, propylheptatriol, dimethyl glutamate, triethanolamine, and triisopropanolamine, etc.
並且,可列舉:丁四醇、新戊四醇、戊四醇、己四醇、二丙三醇、山梨醇酐、N,N,N',N'-四(2-羥丙基)乙二胺、N,N,N',N'-四(羥乙基)乙二胺等4元醇等。In addition, examples include butane erythritol, neopentyl erythritol, pentaerythritol, hexaerythritol, diglycerol, sorbitol anhydride, N,N,N',N'-tetrakis (2-hydroxypropyl) ethyl Diamine, N,N,N',N'-tetra(hydroxyethyl)ethylenediamine and other tetravalent alcohols, etc.
並且,可列舉:側金盞醇、阿拉伯糖醇、木糖醇、三丙三醇等5元醇,以及二新戊四醇、山梨醇、甘露醇、艾杜糖醇、肌醇、半乳糖醇、太洛糖、阿洛糖等6元醇等。In addition, examples include: pentaerythritol, arabitol, xylitol, triglycerol, and other pentahydric alcohols, as well as dineopentaerythritol, sorbitol, mannitol, iditol, inositol, and galactose Alcohol, tyrolose, allose and other hexavalent alcohols, etc.
並且,可列舉:甲基丙三醇醚、乙基丙三醇醚、丙基丙三醇醚、異丙基丙三醇醚、丁基丙三醇醚、異丁基丙三醇醚、戊基丙三醇醚、己基丙三醇醚、庚基丙三醇醚、辛基丙三醇醚、(2-乙基己基)丙三醇醚、壬基丙三醇醚、癸基丙三醇醚、十一基丙三醇醚、十二基丙三醇醚、十三基丙三醇醚、十四基丙三醇醚、十六基丙三醇醚、十八基丙三醇醚、二十基丙三醇醚、烯丙基丙三醇醚、十一烯基丙三醇醚、十八烯基丙三醇醚、環己基丙三醇醚、苯基丙三醇醚等丙三醇一醚類等。In addition, examples include: methyl glycerol ether, ethyl glycerol ether, propyl glycerol ether, isopropyl glycerol ether, butyl glycerol ether, isobutyl glycerol ether, pentane Glycerol ether, hexyl glycerol ether, heptyl glycerol ether, octyl glycerol ether, (2-ethylhexyl) glycerol ether, nonyl glycerol ether, decyl glycerol ether Ether, undecyl glycerol ether, dodecyl glycerol ether, tridecyl glycerol ether, tetradecyl glycerol ether, hexadecyl glycerol ether, octadecyl glycerol ether, Eicosyl glycerol ether, allyl glycerol ether, undecenyl glycerol ether, octadecenyl glycerol ether, cyclohexyl glycerol ether, phenyl glycerol ether, etc. Alcohol-ethers and so on.
並且,可列舉:N-甲基二乙醇胺、N-乙基二乙醇胺、N-丙基二乙醇胺、N-異丙基二乙醇胺、N-丁基二乙醇胺、N-環己基二乙醇胺、N-(2-乙基己基)二乙醇胺等N-取代二乙醇胺類等。In addition, N-methyldiethanolamine, N-ethyldiethanolamine, N-propyldiethanolamine, N-isopropyldiethanolamine, N-butyldiethanolamine, N-cyclohexyldiethanolamine, N- (2-Ethylhexyl)diethanolamine and other N-substituted diethanolamines, etc.
並且,可列舉:N-甲基二異丙醇胺、N-乙基二異丙醇胺、N-丙基二異丙醇胺、N-異丙基二異丙醇胺、N-丁基二異丙醇胺、N-環己基二異丙醇胺、N-(2-乙基己基)二異丙醇胺等N-取代二異丙醇胺類等。In addition, N-methyldiisopropanolamine, N-ethyldiisopropanolamine, N-propyldiisopropanolamine, N-isopropyldiisopropanolamine, N-butyl N-substituted diisopropanolamines such as diisopropanolamine, N-cyclohexyldiisopropanolamine, N-(2-ethylhexyl)diisopropanolamine, etc.
並且,可列舉:二甲基胺基丙二醇、二乙基胺基丙二醇、二丙基胺基丙二醇、二異丙基胺基丙二醇、二丁基胺基丙二醇等N,N-二取代胺基丙二醇類。此等示例之低分子多元醇(G)亦得包含位置異構物化合物。In addition, N,N-disubstituted amino propylene glycol, such as dimethyl amino propylene glycol, diethyl amino propylene glycol, dipropyl amino propylene glycol, diisopropyl amino propylene glycol, and dibutyl amino propylene glycol, etc. kind. The low-molecular-weight polyols (G) in these examples must also contain positional isomer compounds.
本揭露之清洗劑中所包含之低分子多元醇(G)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且80質量%以下為佳。The content (mass%) of the low-molecular polyol (G) contained in the cleaning agent of the present disclosure is preferably 0 mass% or more and 80 mass% or less from the viewpoint of cleaning performance relative to the mass of the cleaning agent .
作為清洗助劑(增滌劑)(H),可列舉:聚羧酸鹽(丙烯酸鹽均聚物及順丁烯二酸鹽均聚物等)、多元羧酸鹽(檸檬酸及蘋果酸等)及鹼增滌劑(苛性鈉、鈉鹼灰、氨、三乙醇胺、三聚磷酸鈉及矽酸鈉等)等。本揭露之清洗劑中所包含之增滌劑(H)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且20質量%以下為佳。Examples of cleaning aids (detergents) (H) include: polycarboxylates (acrylate homopolymers and maleate homopolymers, etc.), polycarboxylates (citric acid, malic acid, etc.) ) And alkaline detergents (caustic soda, sodium soda ash, ammonia, triethanolamine, sodium tripolyphosphate and sodium silicate, etc.). The content (mass %) of the detergent (H) contained in the cleaning agent of the present disclosure is preferably 0% by mass or more and 20% by mass or less relative to the mass of the cleaning agent from the viewpoint of cleaning properties.
作為消泡劑(I),可列舉:聚矽氧系消泡劑、聚環氧烷系消泡劑及礦油系消泡劑等。本揭露之清洗劑中所包含之消泡劑(I)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且10質量%以下為佳。Examples of the defoaming agent (I) include polysiloxane defoamers, polyalkylene oxide defoamers, mineral oil defoamers, and the like. The content (mass%) of the defoaming agent (I) contained in the cleaning agent of the present disclosure is preferably 0 mass% or more and 10 mass% or less from the viewpoint of cleaning properties relative to the mass of the cleaning agent.
作為pH調整劑(J),可列舉:硫酸、鹽酸、檸檬酸、乳酸、丙酮酸、甲酸、氯化鈉、氯化鉀、一乙醇胺及二乙醇胺等。本揭露之清洗劑中所包含之pH調整劑(J)的含量(質量%),就清洗性之觀點而言,以相對於清洗劑的質量為0質量%以上且25質量%以下為佳,以0質量%以上且15質量%以下為更佳,以0質量%以上且10質量%以下為尤佳。在一實施型態中,於pH為鹼性側的情況下,於清洗乾燥後之被清洗物品的表面有時會殘留源自清洗劑的鹽,為了去除該鹽而變得需要擦拭等處理。因此,依清洗目標,本揭露之清洗劑有以做成酸性、中性或弱鹼性為佳的情形,有以酸性或中性為尤佳的情形。具體而言,本揭露之清洗劑的pH(25℃)有以未達9.0為佳的情形,有以7.0以下為尤佳的情形。此外,上述內容並不妨礙將本揭露之清洗劑的pH做成此範圍外的使用。於此,上述pH(25℃)係利用依循JIS Z 8802:2011「pH量測方法」之方法來量測之值。Examples of the pH adjuster (J) include sulfuric acid, hydrochloric acid, citric acid, lactic acid, pyruvic acid, formic acid, sodium chloride, potassium chloride, monoethanolamine, and diethanolamine. The content (mass%) of the pH adjuster (J) contained in the cleaning agent of the present disclosure is preferably 0 mass% or more and 25 mass% or less relative to the mass of the cleaning agent from the viewpoint of cleaning properties, It is more preferably 0% by mass or more and 15% by mass or less, and particularly preferably 0% by mass or more and 10% by mass or less. In one embodiment, when the pH is on the alkaline side, the surface of the article to be cleaned after washing and drying may leave salt originating from the cleaning agent, and treatment such as wiping may be necessary in order to remove the salt. Therefore, depending on the cleaning target, the cleaning agent disclosed in the present disclosure may be preferably acidic, neutral, or weakly alkaline, and may be acidic or neutral. Specifically, the pH (25°C) of the cleaning agent of the present disclosure may be less than 9.0, and may be less than 7.0. In addition, the above content does not prevent the pH of the cleaning agent of the present disclosure from being used outside this range. Here, the above-mentioned pH (25°C) is the value measured by the method according to JIS Z 8802:2011 "pH Measurement Method".
作用於病毒時之氟系醇的濃度亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為更佳。作用於病毒時之氟系醇的濃度以29質量%以上為較佳。此外,使氟系醇作用於病毒的時間並不特別受限。使氟系醇作用於病毒的時間即使係短時間亦有效。舉例而言,使氟系醇作用於病毒的時間亦可為30秒鐘以上,以1分鐘以上為佳,以20分鐘以上為較佳,以30分鐘以上為尤佳。The concentration of the fluorine-based alcohol when acting on the virus may be 0.1% by mass or more, preferably 1% by mass or more, and more preferably 8% by mass or more. The concentration of the fluorine-based alcohol when acting on the virus is preferably 29% by mass or more. In addition, the time for the fluorine-based alcohol to act on the virus is not particularly limited. The time for the fluorine-based alcohol to act on the virus is effective even for a short time. For example, the time for the fluorine-based alcohol to act on the virus may also be 30 seconds or more, preferably 1 minute or more, more preferably 20 minutes or more, and more preferably 30 minutes or more.
在一實施型態中,清洗劑亦可包含市售之消毒劑的有效成分作為添加劑。作為市售之消毒劑的有效成分,可列舉例如:高層次消毒劑的有效成分(例如:戊二醛、鄰苯二甲醛、過乙酸或過乙酸鹽)、中層次消毒劑的有效成分(次氯酸鈉、乙醇、優碘)、低層次消毒劑的有效成分(四級銨、葡萄糖酸洛赫西定)。本揭露之清洗劑中所包含之此等有效成分的含量(質量%),亦可為相對於清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上99質量%以下為佳,以0質量%以上92質量%以下為尤佳,以0質量%以上71質量%以下為更佳。In one embodiment, the cleaning agent may also contain the effective ingredients of a commercially available disinfectant as an additive. As the effective ingredients of commercially available disinfectants, for example, the effective ingredients of high-level disinfectants (such as glutaraldehyde, ortho-phthalaldehyde, peracetic acid or peracetate), the effective ingredients of middle-level disinfectants (sodium hypochlorite) , Ethanol, Betadine), the active ingredients of low-level disinfectants (quaternary ammonium, loxidine gluconate). The content (mass%) of these active ingredients contained in the cleaning agent of the present disclosure may also be 0 mass% or more and 99.9 mass% or less with respect to the mass of the cleaning agent, with 0 mass% or more and 99 mass% or less as Preferably, it is more preferably 0% by mass or more and 92% by mass or less, and more preferably 0% by mass or more and 71% by mass or less.
本揭露之清洗劑所包含之氟系醇,尤其HFIP對病毒的去活化有效。並且,HFIP能夠溶解蛋白質或細胞組織等有機物。是故,變得輕易去除附著於清洗之目標物的蛋白質或細胞組織等有機物,可提升清洗力。HFIP係分子量為168之穩定的低分子化合物,儲存性高。並且,由於具有良好的熱穩定性故清洗溫度並不受限,可進一步提升清洗力。HFIP對於金屬的腐蝕性低,對清洗之目標物的材質之影響少。再者,HFIP為難燃性,使用上的安全管理容易。The fluoroalcohol contained in the cleaning agent of the present disclosure, especially HFIP, is effective in deactivating viruses. In addition, HFIP can dissolve organic matter such as protein or cell tissue. Therefore, it becomes easier to remove organic matter such as protein or cell tissue attached to the cleaning target, and the cleaning power can be improved. HFIP is a stable low-molecular compound with a molecular weight of 168, with high storage properties. Moreover, the cleaning temperature is not limited due to its good thermal stability, which can further enhance the cleaning power. HFIP has low corrosiveness to metals and has little effect on the material of the cleaning target. Furthermore, HFIP is flame-retardant, and safety management in use is easy.
並且,TFIPL對於病毒的去活化有效。並且,TFIPL能夠溶解蛋白質或細胞組織等有機物。是故,去除附著於清洗之目標物的蛋白質或細胞組織等有機物一事會變容易,可提升清洗力。TFIPL係分子量為114.07之穩定的低分子化合物,儲存性高。並且,由於具有良好的熱穩定性故清洗溫度並不受限,可進一步提升清洗力。TFIPL對於金屬的腐蝕性低,對清洗之目標物的材質之影響少。再者,TFIPL為難燃性,使用上的安全管理容易。Moreover, TFIPL is effective for virus deactivation. In addition, TFIPL can dissolve organic matter such as protein or cell tissue. Therefore, it is easier to remove organic matter such as protein or cell tissue attached to the cleaning target, and the cleaning power can be improved. TFIPL is a stable low-molecular compound with a molecular weight of 114.07, with high storage properties. Moreover, the cleaning temperature is not limited due to its good thermal stability, which can further enhance the cleaning power. TFIPL has low corrosiveness to metals and has little effect on the material of the cleaning target. Furthermore, TFIPL is non-flammable, and safety management in use is easy.
[清洗方法][cleaning method]
包含本揭露之氟系醇的清洗劑尤其可使用於醫療用器具(包含例如內視鏡)的清洗,再來,可使用於包含動物用醫療器具、食用肉加工用具及調理用具之目標物的清洗。然而並不受限於此,可廣泛應用於病毒感染對策。舉例而言,可使用於在醫療領域中之手術室的清洗以及包含床、床單等亞麻織物、人手的消毒等之目標物的清洗。The cleaning agent containing the fluorine-based alcohol of the present disclosure can be particularly used for cleaning medical appliances (including endoscopes, for example), and furthermore, can be used for target objects including animal medical appliances, edible meat processing appliances, and conditioning appliances. Clean. However, it is not limited to this, and can be widely used in virus infection countermeasures. For example, it can be used for the cleaning of operating rooms in the medical field and the cleaning of objects including linen fabrics such as beds and sheets, and disinfection of human hands.
包含本揭露之氟系醇的清洗劑亦可使用於例如:手工清洗(包含浸漬清洗)、超音波清洗、噴射式清洗、沖淋清洗、蒸氣清洗、真空清洗、除氣清洗、清洗器―消毒器或此等2種以上之組合之任一清洗方法,但並非受限於此等者。舉例而言,使用清洗器―消毒器的清洗方法一般係由預備清洗、正式清洗、洗滌、消毒的工序所構成。包含本揭露之氟系醇的清洗劑可使用於預備清洗及正式清洗,亦可與其他清洗劑組合使用於預備清洗或正式清洗。於此,作為得容許之清洗劑所包含之氟系醇的濃度,與將病毒去活化的濃度相同,具體上亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為較佳,以29質量%以上為最佳。The cleaning agent containing the fluorine-based alcohol of the present disclosure can also be used in, for example, manual cleaning (including immersion cleaning), ultrasonic cleaning, jet cleaning, shower cleaning, steam cleaning, vacuum cleaning, degassing cleaning, washer-disinfection Cleaning method, but not limited to these cleaning methods. For example, the cleaning method using a washer-disinfector generally consists of pre-cleaning, formal cleaning, washing, and disinfection processes. The cleaning agent containing the fluorine-based alcohol disclosed in the present disclosure can be used for preliminary cleaning and formal cleaning, and can also be used in combination with other cleaning agents for preliminary cleaning or formal cleaning. Here, the concentration of the fluorine-based alcohol contained in the permissible cleaning agent is the same as the concentration to deactivate the virus. Specifically, it may be 0.1% by mass or more, preferably 1% by mass or more, and 8% by mass or more. More preferably, 29% by mass or more is most preferable.
包含本揭露之氟系醇的清洗劑透過使用於清洗方法的預備清洗工序及/或正式清洗工序,可以高效率自目標物去除源自生物體的血液或體液、脂肪、普里昂蛋白(Prion Protein,PrP)及感染性類澱粉蛋白等蛋白質或細胞組織等有機物、微生物、病毒、細菌等。The cleaning agent containing the fluorine-based alcohol of the present disclosure can efficiently remove blood, body fluid, fat, and Prion Protein (Prion Protein , PrP) and infectious amyloid-like proteins or organic matter such as cell tissues, microorganisms, viruses, bacteria, etc.
然而,包含本揭露之氟系醇的清洗劑並不受於上已述之用途所限定,可依清洗之目標物而比照眾所周知之抗病毒劑、抗菌劑、殺菌劑、消毒劑、抗真菌劑等使用。舉例而言,可就此使用對清洗之目標物噴灑之方法、塗布之方法、使目標物浸潤之方法、浸漬目標物之方法、將目標物暴露於高壓蒸氣之方法等通常採用的方法。However, the cleaning agent containing the fluorine-based alcohol of the present disclosure is not limited to the above-mentioned use, and can be compared with well-known antiviral agents, antibacterial agents, bactericides, disinfectants, and antifungal agents according to the cleaning target. And so on. For example, the method of spraying the cleaning target, the method of coating, the method of infiltrating the target, the method of immersing the target, the method of exposing the target to high-pressure steam, and other commonly used methods can be used for this.
本揭露之清洗劑所包含之氟系醇在將病毒去活化時的溫度並非特別受限者,以常溫以上(例如20℃以上)的溫度為佳。若使氟系醇與病毒接觸的溫度變高,病毒會變得更容易去活化。並且,亦可做成氟系醇之沸點以上的溫度,簡言之,亦可使之氣化成蒸氣而與病毒接觸。並且,亦可依清洗劑所包含之溶媒或添加劑,分別選擇最合適的溫度。The temperature at which the fluorine-based alcohol contained in the cleaning agent of the present disclosure deactivates the virus is not particularly limited, and a temperature above normal temperature (for example, above 20° C.) is preferred. If the temperature at which the fluorine-based alcohol comes into contact with the virus becomes higher, the virus becomes easier to deactivate. In addition, the temperature may be higher than the boiling point of the fluorine-based alcohol. In short, it may be vaporized into vapor and contact with the virus. In addition, the most suitable temperature can also be selected according to the solvent or additives contained in the cleaning agent.
[清洗裝置][Cleaning device]
在一實施型態中,可提供包含使於上已述之本揭露相關之氟系醇作用的清洗裝置。In one embodiment, a cleaning device including the fluorine-based alcohol function related to the present disclosure described above can be provided.
舉例而言,清洗裝置1亦可為用以清洗醫療用器具者。如圖1所示,清洗裝置1具備:具有收容目標物(醫療用器具)之收納部20的清洗槽10,以及將清洗劑供應至清洗槽10內的清洗劑供應裝置40。清洗槽10具備:於收納部20之下蓄積清洗水的貯水部12、用以將自供水源及供熱水源送出的水及熱水作為清洗水供應至貯水部12之作為清洗水供應手段的供水管14及供熱水管16、對收容於清洗槽10內之目標物噴射貯水部12之清洗水的清洗噴嘴22,以及將貯水部12之清洗水送出至清洗噴嘴22的清洗泵18。For example, the
使用清洗裝置1的清洗方法在藉由預備清洗工序、正式清洗工序及洗滌清洗工序清洗醫療用器具之後,藉由消毒工序沸水消毒。包含本揭露之氟系醇的清洗劑可使用於預備清洗及正式清洗,亦可與其他清洗劑組合使用於預備清洗或正式清洗。並且,在包含本揭露之氟系醇的清洗劑包含多種成分的情形中,亦可將成分之一部分或各成分自分別之生產線使用於預備清洗或正式清洗。In the cleaning method using the
一旦開始清洗工序,清洗裝置1首先會實行預備清洗工序。清洗裝置1打開供水閥,開始在預備清洗工序中的供水處理。藉此,供水源的水通過供水管14送出至清洗槽10的貯水部12。清洗裝置1藉由浮控開關的檢測判定貯水部12的水是否成為指定之水位。清洗裝置1若判定貯水部12的水成為指定之水位,則會關閉供水閥結束供水處理。在預備清洗工序中的水亦可為常溫(例如20℃)。Once the cleaning process is started, the
清洗裝置1利用清洗劑供應裝置40將清洗劑供應至清洗槽10內,使清洗泵18作動指定時間作為預備清洗處理。藉此,貯水部12內的清洗水中介循環管送出至清洗噴嘴22,清洗噴嘴22一邊旋轉,一邊將清洗水噴射至醫療用器具來清洗。清洗槽10內之包含清洗劑的清洗水落下而回流至貯水部12。預備清洗處理後,清洗裝置1使排水泵作動指定時間作為排水處理。藉此,貯水部12內的清洗水通過排水管34排出至機外。The
一旦預備清洗工序結束,清洗裝置1即會實行正式清洗工序。在正式清洗工序中,清洗裝置1打開供水閥及供熱水閥,開始在正式清洗工序中的供水處理。藉此,供水源的水及供熱水源的熱水通過供水管14及供熱水管16送出至清洗槽10的貯水部12。清洗裝置1藉由浮控開關的檢測判定貯水部12的水是否成為指定之水位。清洗裝置1若判定貯水部12的水成為指定之水位,則會關閉供水閥及供熱水閥結束供水處理。在正式清洗工序中的水以25℃以上為佳。Once the preliminary cleaning process is over, the
清洗裝置1利用清洗劑供應裝置40將清洗劑供應至清洗槽10內,使清洗泵18作動指定時間作為正式清洗處理。藉此,貯水部12內的清洗水中介循環管送出至清洗噴嘴22,清洗噴嘴22一邊旋轉,一邊將清洗水噴射至醫療用器具來清洗。清洗槽10內之包含清洗劑的清洗水落下而回流至貯水部12。正式清洗處理後,清洗裝置1使排水泵作動指定時間作為排水處理。藉此,貯水部12內的清洗水通過排水管34排出至機外。The
正式清洗工序亦可實行數次。在此情況下,舉例而言,亦可將清洗劑分開使用,進行數次正式清洗處理。於在第1次的正式清洗工序中使用包含本揭露之氟系醇的清洗劑之情況下,亦可以60℃以上的清洗水進行正式清洗處理。於在第2次的正式清洗工序中使用酵素系清洗劑之情形況下,亦可以30~40℃左右(例如37℃)的清洗水進行正式清洗處理。The formal cleaning process can also be carried out several times. In this case, for example, it is also possible to use the cleaning agent separately and perform several formal cleaning treatments. In the case of using the cleaning agent containing the fluorine-based alcohol of the present disclosure in the first main cleaning process, the main cleaning treatment can also be performed with cleaning water at 60° C. or higher. In the case of using an enzyme-based cleaning agent in the second main cleaning process, it is also possible to perform main cleaning with cleaning water at approximately 30-40°C (for example, 37°C).
一旦正式清洗工序結束,清洗裝置1即會實行洗滌工序。在洗滌清洗工序中,清洗裝置1打開供熱水閥,開始在洗滌工序中的供熱水處理。藉此,供熱水源的熱水通過供熱水管16送出至清洗槽10的貯水部12。清洗裝置1藉由浮控開關的檢測判定貯水部12的熱水是否成為指定之水位。清洗裝置1若判定貯水部12的熱水成為指定之水位,則會關閉供熱水閥結束供熱水處理。Once the formal cleaning process is over, the
清洗裝置1使清洗泵18作動指定時間作為洗滌處理。藉此,貯水部12內的熱水中介循環管送出至清洗噴嘴22,清洗噴嘴22一邊旋轉,一邊將熱水噴射至醫療用器具,沖洗包含清洗劑的清洗水。洗滌處理後,清洗裝置1使排水泵作動指定時間作為排水處理。藉此,貯水部12內的洗滌水通過排水管34排出至機外。The
一旦洗滌工序結束,清洗裝置1即會實行消毒工序。在消毒工序中,清洗裝置1打開供熱水閥,開始在消毒工序中的供熱水處理。藉此,供熱水源的沸水通過供熱水管16送出至清洗槽10的貯水部12。清洗裝置1藉由浮控開關的檢測判定貯水部12的沸水是否成為指定之水位。清洗裝置1若判定貯水部12的沸水成為指定之水位,則會關閉供熱水閥結束供熱水處理。在消毒工序中的沸水以60℃以上為佳。Once the washing process is over, the
清洗裝置1使清洗泵18作動指定時間作為消毒處理。藉此,貯水部12內的沸水中介循環管送出至清洗噴嘴22,清洗噴嘴22一邊旋轉,一邊將沸水噴射至醫療用器具。消毒處理後,清洗裝置1使排水泵作動指定時間作為排水處理。藉此,貯水部12內的沸水通過排水管34排出至機外。The
清洗裝置1藉由利用清洗劑供應裝置40將包含本揭露之氟系醇的清洗劑供應至清洗槽10內,可以高效率自目標物去除源自生物體的血液或體液、脂肪、普里昂蛋白(Prion Protein,PrP)及感染性類澱粉蛋白等蛋白質或細胞組織等有機物、微生物、病毒、細菌等。清洗裝置1亦可併用包含本揭露之氟系醇的清洗劑與眾所周知之清洗劑。The
[土壤清洗劑][Soil cleaning agent]
於上已述之本發明相關之清洗劑在一實施型態中可作為土壤清洗劑使用。藉由使用包含本揭露之氟系醇的土壤清洗劑,可期待土壤中所包含之病毒的去活化。在一實施型態中,土壤清洗劑亦可包含記載為眾所周知之技術的一般添加劑。此等亦包含使用於土壤的農藥、肥料、殺菌劑、消毒劑等。The cleaning agent related to the present invention described above can be used as a soil cleaning agent in one embodiment. By using the soil cleaning agent containing the fluorine-based alcohol of the present disclosure, the deactivation of the virus contained in the soil can be expected. In one embodiment, the soil cleaning agent may also contain general additives described as well-known technologies. These also include pesticides, fertilizers, fungicides, and disinfectants used in the soil.
在一實施型態中,土壤清洗劑亦可包含本揭露之氟系醇與溶媒。溶媒可選自能夠將氟系醇稀釋的物質,可列舉例如與已在前述清洗劑中列舉之溶媒相同者。此等可為一種或多種,但並非受限於此等者。In one embodiment, the soil cleaning agent may also include the fluorine-based alcohol and solvent disclosed in the present disclosure. The solvent may be selected from substances capable of diluting the fluorine-based alcohol, and examples thereof include the same solvents as those already listed in the aforementioned cleaning agent. These may be one or more, but are not limited to these.
在一實施型態中,土壤清洗劑中所包含之溶媒的含量(質量%),就清洗性之觀點而言,亦可為相對於土壤清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上71質量%以下為更佳。In one embodiment, the content (mass%) of the solvent contained in the soil cleaning agent may be 0 mass% or more and 99.9 mass% or less relative to the mass of the soil cleaning agent from the viewpoint of cleaning performance , Preferably 0 mass% or more and 99 mass% or less, more preferably 0 mass% or more and 92 mass% or less, and more preferably 0 mass% or more and 71 mass% or less.
在一實施型態中,土壤清洗劑亦可在除了本揭露之氟系醇與溶媒以外還包含添加劑。作為能夠添加至土壤清洗劑的添加劑,可列舉:界面活性劑、酵素、酵素穩定劑、抗金屬腐蝕劑、低分子多元醇、清洗助劑(增滌劑)、消泡劑、pH調整劑、香料、著色劑、抗氧化劑、防腐劑、漂白劑、漂白活化劑、腐蝕抑制劑、分散劑、增稠劑、黏度調整劑等,但並非受限於此等者。土壤清洗劑亦可包含一種或二種以上之添加劑。在一實施型態中,土壤清洗劑藉由包含氟系醇、溶媒與上述添加劑,可進一步提升清洗力。In one embodiment, the soil cleaning agent may also include additives in addition to the fluorine-based alcohol and the solvent disclosed in the present disclosure. Examples of additives that can be added to soil cleaning agents include: surfactants, enzymes, enzyme stabilizers, anti-metal corrosion agents, low-molecular polyols, cleaning aids (detergents), defoamers, pH adjusters, fragrances , Colorants, antioxidants, preservatives, bleaching agents, bleach activators, corrosion inhibitors, dispersants, thickeners, viscosity modifiers, etc., but not limited to these. The soil cleaning agent may also contain one or more than two additives. In one embodiment, the soil cleaning agent can further improve the cleaning power by including fluorine-based alcohol, solvent and the above additives.
界面活性劑(A)可列舉例如與已在前述清洗劑中列舉之界面活性劑(A)相同者。作為界面活性劑(A),可使用1種或2種以上。As the surfactant (A), for example, the same surfactants (A) listed in the aforementioned cleaning agent can be mentioned. As the surfactant (A), one type or two or more types can be used.
土壤清洗劑中所包含之界面活性劑(A)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.1質量%以上且5質量%以下為更佳。The content (mass%) of the surfactant (A) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is preferably 0 mass% or more and 10 mass% or less relative to the mass of the soil cleaning agent. It is more preferably 0.1% by mass or more and 5% by mass or less.
酵素(B)可列舉例如與已在前述清洗劑中列舉之酵素(B)相同者。作為酵素(B),可使用1種或2種以上。The enzyme (B) can be, for example, the same as the enzyme (B) listed in the aforementioned cleaning agent. As the enzyme (B), one kind or two or more kinds can be used.
在一實施型態中,土壤清洗劑中所包含之酵素(B)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。In one embodiment, the content (mass%) of the enzyme (B) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10 mass% relative to the mass of the soil cleaning agent The following is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are especially preferable.
作為酵素穩定劑(C),可列舉例如與已在前述清洗劑中列舉之酵素穩定劑(D)相同者。作為酵素穩定劑(C),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之酵素穩定劑(C)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上3質量%以下為尤佳。As the enzyme stabilizer (C), for example, the same enzyme stabilizer (D) listed in the aforementioned cleaning agent can be cited. As the enzyme stabilizer (C), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the enzyme stabilizer (C) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10% relative to the mass of the soil cleaning agent. Mass% or less is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are particularly preferable.
作為抗金屬腐蝕劑(D),可列舉例如與已在前述清洗劑中列舉之抗金屬腐蝕劑(F)相同者。作為抗金屬腐蝕劑(D),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之抗金屬腐蝕劑(D)的含量(質量%),就腐蝕抑制性能之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳。As the anti-metal corrosion agent (D), for example, the same ones as the anti-metal corrosion agent (F) listed in the aforementioned cleaning agent can be cited. As the anti-metal corrosion agent (D), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the anti-metal corrosion agent (D) contained in the soil cleaning agent is 0 mass% or more from the viewpoint of corrosion inhibition performance relative to the mass of the soil cleaning agent. 10% by mass or less is preferable.
低分子多元醇(E)可列舉例如與已在前述清洗劑中列舉之低分子多元醇(G)相同者。作為低分子多元醇(E),可使用1種或2種以上。Examples of the low-molecular-weight polyol (E) are the same as the low-molecular-weight polyol (G) listed in the aforementioned cleaning agent. As the low-molecular-weight polyol (E), one type or two or more types can be used.
在一實施型態中,土壤清洗劑中所包含之低分子多元醇(E)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且80質量%以下為佳。In one embodiment, the content (mass %) of the low-molecular polyol (E) contained in the soil cleaning agent is 0 mass% or more from the viewpoint of cleaning performance relative to the mass of the soil cleaning agent. 80% by mass or less is preferable.
作為清洗助劑(增滌劑)(F),可列舉例如與已在前述清洗劑中列舉之清洗助劑(增滌劑)(H)相同者。作為增滌劑(F),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之增滌劑(F)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且20質量%以下為佳。As the cleaning aid (washing agent) (F), for example, the same washing aids (washing agent) (H) listed in the above-mentioned washing agent can be mentioned. As the detergent (F), one type or two or more types can be used. In one embodiment, the content (mass %) of the detergent (F) contained in the soil cleaning agent is 0 mass% or more and 20% from the viewpoint of cleaning performance relative to the mass of the soil cleaning agent. The mass% or less is better.
作為消泡劑(G),可列舉例如與已在前述清洗劑中列舉之消泡劑(I)相同者。作為消泡劑(G),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之消泡劑(G)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳。As the defoaming agent (G), for example, the same as the defoaming agent (I) listed in the aforementioned cleaning agent can be cited. As the defoaming agent (G), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the defoaming agent (G) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10% relative to the mass of the soil cleaning agent. The mass% or less is better.
作為pH調整劑(H),可列舉例如與已在前述清洗劑中列舉之pH調整劑(J)相同者。作為pH調整劑(H),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之pH調整劑(H)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且25質量%以下為佳,以0質量%以上且15質量%以下為更佳,以0質量%以上且10質量%以下為尤佳。As the pH adjuster (H), for example, the same as the pH adjuster (J) listed in the aforementioned cleaning agent can be mentioned. As the pH adjuster (H), one type or two or more types can be used. In one embodiment, the content (mass %) of the pH adjuster (H) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 25% relative to the mass of the soil cleaning agent. Mass% or less is preferable, 0 mass% or more and 15 mass% or less are more preferable, and 0 mass% or more and 10 mass% or less are particularly preferable.
作用於病毒時之氟系醇的濃度亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為更佳。作用於病毒時之氟系醇的濃度以29質量%以上為較佳。此外,使氟系醇作用於病毒的時間並不特別受限。使氟系醇作用於病毒的時間即使係短時間亦有效。舉例而言,使氟系醇作用於病毒的時間亦可為30秒鐘以上,以1分鐘以上為佳,以20分鐘以上為較佳,以30分鐘以上為尤佳。為了提升作用效果,亦以在每日單位或週單位甚至每一季使用的間隔拉開之下分段性使用多次的方法為佳。The concentration of the fluorine-based alcohol when acting on the virus may be 0.1% by mass or more, preferably 1% by mass or more, and more preferably 8% by mass or more. The concentration of the fluorine-based alcohol when acting on the virus is preferably 29% by mass or more. In addition, the time for the fluorine-based alcohol to act on the virus is not particularly limited. The time for the fluorine-based alcohol to act on the virus is effective even for a short time. For example, the time for the fluorine-based alcohol to act on the virus may also be 30 seconds or more, preferably 1 minute or more, more preferably 20 minutes or more, and more preferably 30 minutes or more. In order to improve the effect, it is also better to use the method several times in segments with the interval of daily unit or weekly unit or even each season opened.
在一實施型態中,土壤清洗劑亦可包含市售之消毒劑的有效成分作為添加劑。作為市售之消毒劑的有效成分,可列舉例如與已在前述清洗劑中列舉之市售之消毒劑的有效成分相同者。在一實施型態中,土壤清洗劑中所包含之此等有效成分的含量(質量%),亦可為相對於土壤清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上且71質量%以下為更佳。In one embodiment, the soil cleaning agent may also contain the effective ingredients of a commercially available disinfectant as an additive. As the effective ingredient of the commercially available disinfectant, for example, the same effective ingredients as those of the commercially available disinfectant listed in the aforementioned cleaning agent can be cited. In one embodiment, the content (mass%) of these active ingredients contained in the soil cleaning agent may also be 0 mass% or more and 99.9 mass% or less relative to the mass of the soil cleaning agent, with 0 mass% The above is preferably 99% by mass or less, more preferably 0% by mass or more and 92% by mass or less, and more preferably 0% by mass or more and 71% by mass or less.
在一實施型態中,土壤清洗劑所包含之氟系醇,尤其HFIP及TFIPL在受到病毒汙染之土壤的清洗上有效。HFIP及TFIPL係穩定的低分子化合物,儲存性高。並且,由於具有良好的熱穩定性故清洗溫度並不受限,可進一步提升清洗力。再者,HFIP及TFIPL為難燃性,使用上的安全管理容易。In one embodiment, the fluorine-based alcohols contained in the soil cleaning agent, especially HFIP and TFIPL, are effective in cleaning soil contaminated by viruses. HFIP and TFIPL are stable low-molecular compounds with high storage properties. Moreover, the cleaning temperature is not limited due to its good thermal stability, which can further enhance the cleaning power. Furthermore, HFIP and TFIPL are non-flammable, and safety management in use is easy.
[清洗方法][cleaning method]
使用本實施型態相關之土壤清洗劑,可清洗受到病毒汙染之土壤或者有汙染可能之土壤。或者,亦可預防性使用本實施型態相關之土壤清洗劑來清洗土壤。在一實施型態中,亦可將土壤清洗劑以上述溶媒稀釋使用於清洗。在一實施型態中,藉由將本實施型態相關之土壤清洗劑或者溶媒與土壤清洗劑添加混合至清洗目標之土壤將清洗土分離並使之乾燥的方法,可將病毒去活化來清洗土壤。Use the soil cleaning agent related to this implementation type to clean soil contaminated by viruses or soil that may be contaminated. Alternatively, the soil cleaning agent related to this implementation type can also be used preventively to clean the soil. In one embodiment, the soil cleaning agent can also be diluted with the above solvent for cleaning. In one embodiment, by adding and mixing the soil cleaning agent or solvent and soil cleaning agent related to this embodiment to the soil of the cleaning target to separate and dry the cleaning soil, the virus can be deactivated for cleaning soil.
在一實施型態中,清洗時氟系醇或由通式(1)所示之化合物的濃度亦可為0.01質量%以上,以0.1重量%以上為佳,以1質量%以上為尤佳。可考慮使用時之土壤汙染的程度、受到汙染的時期、土壤之周邊環境等任意調整。In one embodiment, the concentration of the fluorine-based alcohol or the compound represented by the general formula (1) during cleaning may also be 0.01% by mass or more, preferably 0.1% by weight or more, and particularly preferably 1% by mass or more. The degree of soil pollution at the time of use, the period of pollution, and the surrounding environment of the soil can be adjusted arbitrarily.
在一實施型態中,氟系醇或由通式(1)所示之化合物亦可作為土壤燻蒸劑使用。舉例而言,藉由對懷疑有汙染之土壤使用包含氟系醇或由通式(1)所示之化合物的土壤燻蒸劑來燻蒸,可清洗土壤。In one embodiment, the fluorine-based alcohol or the compound represented by the general formula (1) can also be used as a soil fumigant. For example, by fumigating the suspected polluted soil with a soil fumigant containing a fluorine-based alcohol or a compound represented by the general formula (1), the soil can be cleaned.
[殺菌清洗劑][Bactericidal cleaning agent]
於上已述之本發明相關之清洗劑,在一實施型態中,可作為殺菌清洗劑使用。本揭露之氟系醇合適作為進行殺菌的化合物。尤其,HFIP及TFE合適作為進行殺菌的化合物。藉由使用包含本揭露之氟系醇的殺菌清洗劑,可期待細菌的殺滅效果。The cleaning agent related to the present invention described above can be used as a sterilizing cleaning agent in one embodiment. The fluorine-based alcohol disclosed in the present disclosure is suitable as a compound for sterilization. In particular, HFIP and TFE are suitable as compounds for sterilization. By using the bactericidal cleaning agent containing the fluorine-based alcohol of the present disclosure, the effect of killing bacteria can be expected.
在本說明書中,所謂細菌,可示例:金黃色葡萄球菌、大腸桿菌、腸道出血性大腸桿菌、結核菌、MRSA、抗萬古黴素腸球菌、多重抗藥性綠膿桿菌、多重抗藥性不動桿菌等,但並非受限於此等者。In this specification, examples of bacteria include: Staphylococcus aureus, Escherichia coli, Enterohemorrhagic Escherichia coli, Tuberculosis, MRSA, Vancomycin-resistant Enterococcus, Multidrug-resistant Pseudomonas aeruginosa, Multidrug-resistant Acinetobacter Etc., but not limited to those.
在一實施型態中,殺菌清洗劑亦可包含本揭露之氟系醇與溶媒。溶媒可選自能夠將氟系醇稀釋的物質,可列舉例如與已在前述清洗劑中列舉之溶媒相同者。此等可為一種或多種,但並非受限於此等者。In one embodiment, the bactericidal cleaning agent may also include the fluorine-based alcohol and solvent disclosed in the present disclosure. The solvent may be selected from substances capable of diluting the fluorine-based alcohol, and examples thereof include the same solvents as those already listed in the aforementioned cleaning agent. These may be one or more, but are not limited to these.
在一實施型態中,殺菌清洗劑中所包含之溶媒的含量(質量%),就清洗性之觀點而言,亦可為相對於清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上且71質量%以下為更佳。In one embodiment, the content (mass%) of the solvent contained in the disinfectant cleaning agent may be 0 mass% or more and 99.9 mass% or less relative to the mass of the cleaning agent from the viewpoint of cleaning properties. It is preferably 0% by mass or more and 99% by mass or less, particularly preferably 0% by mass or more and 92% by mass or less, and more preferably 0% by mass or more and 71% by mass or less.
在一實施型態中,殺菌清洗劑除了本揭露之氟系醇與溶媒以外還可包含添加劑。作為能夠添加至殺菌清洗劑的添加劑,可列舉:界面活性劑、酵素、螯合劑、酵素穩定劑、抗凝血劑、抗金屬腐蝕劑、低分子多元醇、清洗助劑(增滌劑)、消泡劑、pH調整劑、香料、著色劑、抗氧化劑、防腐劑、漂白劑、漂白活化劑、腐蝕抑制劑、分散劑、增稠劑、黏度調整劑等,但並非受限於此等者。殺菌清洗劑亦可包含一種或二種以上之添加劑。在一實施型態中,殺菌清洗劑藉由包含氟系醇、溶媒與上述添加劑,可進一步提升清洗力。In one embodiment, the bactericidal cleaning agent may also include additives in addition to the fluorine-based alcohol and solvent disclosed in the present disclosure. Examples of additives that can be added to the sterilization cleaning agent include: surfactants, enzymes, chelating agents, enzyme stabilizers, anticoagulants, anti-metal corrosion agents, low-molecular polyols, cleaning aids (detergents), and detergents. Foaming agents, pH adjusters, fragrances, colorants, antioxidants, preservatives, bleaching agents, bleach activators, corrosion inhibitors, dispersants, thickeners, viscosity adjusters, etc., but are not limited to these. The bactericidal cleaning agent may also contain one or more than two additives. In one embodiment, the bactericidal cleaning agent contains fluorine-based alcohols, solvents and the above additives to further enhance the cleaning power.
界面活性劑(A),可列舉例如與已在前述清洗劑中列舉之界面活性劑(A)相同者。作為界面活性劑(A),可使用1種或2種以上。The surfactant (A) can be, for example, the same as the surfactant (A) listed in the aforementioned cleaning agent. As the surfactant (A), one type or two or more types can be used.
殺菌清洗劑中所包含之界面活性劑(A)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且10質量%以下為佳,0.1質量%以上且5質量%以下為更佳。The content (mass%) of the surfactant (A) contained in the disinfectant cleaning agent, from the viewpoint of cleaning properties, is preferably 0 mass% or more and 10 mass% or less relative to the mass of the disinfection cleaning agent, 0.1 More preferably, it is greater than or equal to 5% by mass and less than or equal to 5% by mass.
酵素(B),可列舉例如與已在前述清洗劑中列舉之酵素(B)相同者。作為酵素(B),可使用1種或2種以上。The enzyme (B) can be, for example, the same as the enzyme (B) listed in the aforementioned cleaning agent. As the enzyme (B), one kind or two or more kinds can be used.
在一實施型態中,殺菌清洗劑中所包含之酵素(B)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。In one embodiment, the content (mass%) of the enzyme (B) contained in the disinfectant cleaning agent is 0 mass% or more and 10 mass% from the viewpoint of cleaning performance relative to the mass of the disinfectant cleaning agent The following is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are especially preferable.
作為螯合劑(C),可列舉例如與已在前述清洗劑中列舉之螯合劑(C)相同者。作為螯合劑(C),可單獨使用1種或使用2種以上。在一實施型態中,殺菌清洗劑中所包含之螯合劑(C)的含量(質量%),就蛋白質髒污的去除效果及成本之觀點而言,相對於殺菌清洗劑的質量為0質量%以上且5質量%以下,以0.005質量%以上且2質量%以下為較佳,以0.01質量%以上且1質量%以下為更佳。螯合劑(C)的含量使用酸換算的量。As the chelating agent (C), for example, the same chelating agent (C) as mentioned in the aforementioned cleaning agent can be mentioned. As the chelating agent (C), one type can be used alone or two or more types can be used. In one embodiment, the content (mass %) of the chelating agent (C) contained in the antiseptic cleaning agent is 0 mass relative to the quality of the antiseptic cleaning agent in terms of the removal effect and cost of protein stains % Or more and 5 mass% or less, preferably 0.005 mass% or more and 2 mass% or less, and more preferably 0.01 mass% or more and 1 mass% or less. The content of the chelating agent (C) uses an acid-converted amount.
作為酵素穩定劑(D),可列舉例如與已在前述清洗劑中列舉之酵素穩定劑(D)相同者。作為酵素穩定劑(D),可單獨使用1種或使用2種以上。在一實施型態中,殺菌清洗劑中所包含之酵素穩定劑(D)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。As the enzyme stabilizer (D), for example, the same enzyme stabilizer (D) listed in the aforementioned cleaning agent can be cited. As the enzyme stabilizer (D), one type can be used alone or two or more types can be used. In one embodiment, the content (mass %) of the enzyme stabilizer (D) contained in the disinfectant cleaning agent, from the viewpoint of cleaning performance, is 0 mass% or more and 10% relative to the mass of the disinfectant cleaning agent. Mass% or less is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are particularly preferable.
作為抗凝血劑(E),可列舉例如與已在前述清洗劑中列舉之抗凝血劑(E)相同者。作為抗凝血劑(E),可單獨使用1種或使用2種以上。舉例而言,在一實施型態中,殺菌清洗劑中所包含之丙三醇(E-5)的含量(質量%),就抗凝血效果與凝固血液的溶解效果之觀點而言,相對於殺菌清洗劑的質量為0質量%以上且80質量%以下。As the anticoagulant (E), for example, the same anticoagulant (E) as the anticoagulant (E) listed in the aforementioned cleaning agent can be cited. As the anticoagulant (E), one type may be used alone or two or more types may be used. For example, in one embodiment, the content (mass %) of glycerol (E-5) contained in the antiseptic cleaning agent is relatively The mass of the disinfectant cleaning agent is 0% by mass or more and 80% by mass or less.
作為抗金屬腐蝕劑(F),可列舉例如與已在前述清洗劑中列舉之抗金屬腐蝕劑(F)相同者。作為抗金屬腐蝕劑(F),可使用1種或2種以上。在一實施型態中,抗金屬腐蝕劑(F)的含量(質量%),就腐蝕抑制性能之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且10質量%以下為佳。As the anti-metal corrosion agent (F), for example, the same ones as the anti-metal corrosion agent (F) listed in the aforementioned cleaning agent can be cited. As the anti-metal corrosion agent (F), one kind or two or more kinds can be used. In one embodiment, the content (% by mass) of the anti-corrosive agent (F) is preferably 0% by mass or more and 10% by mass or less relative to the mass of the sterilizing cleaning agent from the viewpoint of corrosion inhibition performance.
低分子多元醇(G),可列舉例如與已在前述清洗劑中列舉之低分子多元醇(G)相同者。作為低分子多元醇(G),可使用1種或2種以上。The low-molecular-weight polyol (G) includes, for example, the same low-molecular-weight polyol (G) as the aforementioned cleaning agent. As the low-molecular-weight polyol (G), one type or two or more types can be used.
在一實施型態中,殺菌清洗劑中所包含之低分子多元醇(G)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且80質量%以下為佳。In one embodiment, the content (mass %) of the low-molecular polyol (G) contained in the sterilizing cleaning agent is 0% by mass or more from the viewpoint of cleaning performance relative to the mass of the sterilizing cleaning agent. 80% by mass or less is preferable.
作為清洗助劑(增滌劑)(H),可列舉例如與已在前述清洗劑中列舉之清洗助劑(增滌劑)(H)相同者。作為增滌劑(H),可使用1種或2種以上。在一實施型態中,殺菌清洗劑中所包含之增滌劑(H)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且20質量%以下為佳。As the cleaning aid (washing agent) (H), for example, the same washing aids (washing agent) (H) listed in the aforementioned washing agent can be mentioned. As the detergent (H), one type or two or more types can be used. In one embodiment, the content (mass%) of the detergent (H) contained in the disinfectant cleaning agent is 0 mass% or more and 20% from the viewpoint of cleaning performance relative to the mass of the disinfectant cleaning agent. The mass% or less is better.
作為消泡劑(I),可列舉例如與已在前述清洗劑中列舉之消泡劑(I)相同者。作為消泡劑(I),可使用1種或2種以上。在一實施型態中,殺菌清洗劑中所包含之消泡劑(I)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且10質量%以下為佳。As the defoaming agent (I), for example, the same as the defoaming agent (I) listed in the aforementioned cleaning agent can be cited. As the defoamer (I), one kind or two or more kinds can be used. In one embodiment, the content (mass%) of the defoaming agent (I) contained in the sterilizing cleaning agent is set to be 0% by mass or more and 10% from the viewpoint of cleaning performance relative to the mass of the sterilizing cleaning agent. The mass% or less is better.
作為pH調整劑(J),可列舉例如與已在前述清洗劑中列舉之pH調整劑(J)相同者。作為pH調整劑(J),可使用1種或2種以上。在一實施型態中,殺菌清洗劑中所包含之pH調整劑(J)的含量(質量%),就清洗性之觀點而言,以相對於殺菌清洗劑的質量為0質量%以上且25質量%以下為佳,以0質量%以上且15質量%以下為更佳,以0質量%以上且10質量%以下為尤佳。在一實施型態中,於pH為鹼性側的情況下,於清洗乾燥後之被清洗物品的表面有時會殘留源自清洗劑的鹽,為了去除該鹽而變得需要擦拭等處理。因此,依清洗目標,本揭露之殺菌清洗劑有以做成酸性、中性或弱鹼性為佳的情形,有以酸性或中性為尤佳的情形。具體而言,本揭露之殺菌清洗劑的pH(25℃)有以未達9.0為佳的情形,有以7.0以下為尤佳的情形。此外,上述內容並不妨礙將本揭露之殺菌清洗劑的pH做成此範圍外的使用。於此,上述pH(25℃)係利用依循JIS Z 8802:2011「pH量測方法」之方法來量測之值。As a pH adjuster (J), the same thing as the pH adjuster (J) mentioned in the said cleaning agent is mentioned, for example. As the pH adjuster (J), one type or two or more types can be used. In one embodiment, the content (mass%) of the pH adjuster (J) contained in the sterilizing cleaning agent is set to be 0% by mass or more and 25% from the viewpoint of cleaning performance relative to the mass of the sterilizing cleaning agent. Mass% or less is preferable, 0 mass% or more and 15 mass% or less are more preferable, and 0 mass% or more and 10 mass% or less are particularly preferable. In one embodiment, when the pH is on the alkaline side, the surface of the article to be cleaned after washing and drying may leave salt originating from the cleaning agent, and treatment such as wiping may be necessary in order to remove the salt. Therefore, depending on the cleaning target, the disinfectant cleaning agent disclosed in the present disclosure may be preferably acidic, neutral, or weakly alkaline, and may be acidic or neutral. Specifically, the pH (25°C) of the disinfectant cleaning agent disclosed in the present disclosure may be less than 9.0, and may be less than 7.0. In addition, the above content does not prevent the pH of the disinfectant cleaning agent of the present disclosure from being used outside this range. Here, the above-mentioned pH (25°C) is the value measured by the method according to JIS Z 8802:2011 "pH Measurement Method".
作用於細菌時之氟系醇的濃度亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為更佳,以29質量%以上為尤佳。此外,使氟系醇作用於細菌的時間並不特別受限。使氟系醇作用於細菌的時間即使係短時間亦有效。舉例而言,使氟系醇作用於細菌的時間亦可為30秒鐘以上,以1分鐘以上為佳,以20分鐘以上為較佳,以30分鐘以上為尤佳。The concentration of the fluorine-based alcohol when acting on bacteria may be 0.1% by mass or more, preferably 1% by mass or more, more preferably 8% by mass or more, and particularly preferably 29% by mass or more. In addition, the time for the fluorine-based alcohol to act on the bacteria is not particularly limited. It is effective even for a short period of time for the fluorine-based alcohol to act on the bacteria. For example, the time for the fluorine-based alcohol to act on the bacteria may also be 30 seconds or more, preferably 1 minute or more, more preferably 20 minutes or more, and more preferably 30 minutes or more.
在一實施型態中,殺菌清洗劑亦可包含市售之消毒劑的有效成分作為添加劑。作為市售之消毒劑的有效成分,可列舉例如與已在前述清洗劑中列舉之市售之消毒劑的有效成分相同者。在一實施型態中,殺菌清洗劑中所包含之此等有效成分的含量(質量%),亦可為相對於殺菌清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上且71質量%以下為更佳。In one embodiment, the antiseptic cleaning agent may also contain the effective ingredients of a commercially available disinfectant as an additive. As the effective ingredient of the commercially available disinfectant, for example, the same effective ingredients as those of the commercially available disinfectant listed in the aforementioned cleaning agent can be cited. In one embodiment, the content (mass%) of these active ingredients contained in the disinfectant cleaning agent may also be 0 mass% or more and 99.9 mass% or less relative to the mass of the disinfection cleaning agent, with 0 mass% The above is preferably 99% by mass or less, more preferably 0% by mass or more and 92% by mass or less, and more preferably 0% by mass or more and 71% by mass or less.
在一實施型態中,殺菌清洗劑所包含之氟系醇亦可作為殺菌劑使用。氟系醇之中,HFIP及TFE尤為合適。此等氟系醇會表現出有效性的細菌,可列舉例如:金黃色葡萄球菌、大腸桿菌、腸道出血性大腸桿菌、結核菌、MRSA、抗萬古黴素腸球菌、多重抗藥性綠膿桿菌、多重抗藥性不動桿菌等,但不受限於此等。In one embodiment, the fluorine-based alcohol contained in the disinfectant cleaning agent can also be used as a disinfectant. Among fluorine alcohols, HFIP and TFE are particularly suitable. These fluorine-based alcohols can show effective bacteria, for example: Staphylococcus aureus, Escherichia coli, Enterohemorrhagic Escherichia coli, Tuberculosis, MRSA, Vancomycin-resistant Enterococcus, Multidrug-resistant Pseudomonas aeruginosa , Multi-drug resistant Acinetobacter, etc., but not limited to these.
[清洗方法][cleaning method]
包含本揭露之氟系醇的殺菌清洗劑尤其可使用於醫療用器具(包含例如內視鏡)的清洗,再來,可使用於包含動物用醫療器具、食用肉加工用具及調理用具之目標物的清洗。然而並不受限於此,可廣泛應用於細菌感染對策。舉例而言,可使用於在醫療領域中之手術室的清洗以及包含床、床單等亞麻織物、人手的消毒等之目標物的清洗。The bactericidal cleaning agent containing the fluorine-based alcohol disclosed in the present disclosure can be particularly used for cleaning medical appliances (including endoscopes, for example), and furthermore, can be used for target objects including animal medical appliances, edible meat processing appliances, and conditioning appliances Of cleaning. However, it is not limited to this, and can be widely applied to countermeasures against bacterial infections. For example, it can be used for the cleaning of operating rooms in the medical field and the cleaning of objects including linen fabrics such as beds and sheets, and disinfection of human hands.
包含本揭露之氟系醇的殺菌清洗劑亦可使用於例如與已在前述醫療用器具之清洗方法中列舉之清洗方法相同者。作為清洗方法,可使用1種或2種以上之組合之任一清洗方法。於此,作為得容許之殺菌清洗劑所包含之氟系醇的濃度,與將細菌殺滅的濃度相同,具體上亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為較佳,以29質量%以上為最佳。The bactericidal cleaning agent containing the fluorine-based alcohol of the present disclosure can also be used, for example, in the same cleaning methods as those listed in the cleaning methods of the aforementioned medical appliances. As the cleaning method, any cleaning method of one type or a combination of two or more types can be used. Here, the concentration of the fluorine-based alcohol contained in the permissible bactericidal cleaning agent is the same as the concentration that kills bacteria. Specifically, it may be 0.1% by mass or more, preferably 1% by mass or more, and 8% by mass The above is preferable, and 29% by mass or more is most preferable.
包含本揭露之氟系醇的殺菌清洗劑透過使用於清洗方法的預備清洗工序及/或正式清洗工序,可以高效率自目標物去除源自生物體的血液或體液、脂肪、普里昂蛋白(Prion Protein,PrP)及感染性類澱粉蛋白等蛋白質或細胞組織等有機物、微生物、病毒、細菌等。The bactericidal cleaning agent containing the fluoroalcohol of the present disclosure can efficiently remove blood, body fluids, fat, and Prion protein from the target substance by being used in the preliminary cleaning process and/or the formal cleaning process of the cleaning method. Protein, PrP) and infectious amyloid-like proteins or organic matter such as cell tissues, microorganisms, viruses, bacteria, etc.
然而,包含本揭露之氟系醇的殺菌清洗劑並不受於上已述之用途所限定,可依清洗之目標物而比照眾所周知之抗病毒劑、抗菌劑、殺菌劑、消毒劑、抗真菌劑等使用。舉例而言,可就此使用對清洗之目標物噴灑之方法、塗布之方法、使目標物浸潤之方法、浸漬目標物之方法、將目標物暴露於高壓蒸氣之方法等通常採用的方法。However, the bactericidal cleaning agent containing the fluorine-based alcohol of the present disclosure is not limited by the above-mentioned use, and can be compared with well-known antiviral agents, antibacterial agents, bactericides, disinfectants, and antifungals according to the cleaning target. Agents and other use. For example, the method of spraying the cleaning target, the method of coating, the method of infiltrating the target, the method of immersing the target, the method of exposing the target to high-pressure steam, and other commonly used methods can be used for this.
本揭露之殺菌清洗劑所包含之氟系醇在將細菌殺滅時的溫度並非特別受限者,以常溫以上(例如20℃以上)的溫度為佳。若使氟系醇與細菌接觸的溫度變高,細菌會變得更容易殺滅。並且,亦可做成氟系醇之沸點以上的溫度,簡言之,亦可使之氣化成蒸氣而與細菌接觸。並且,亦可依清洗劑所包含之溶媒或添加劑,分別選擇最合適的溫度。The temperature of the fluoroalcohol contained in the disinfectant cleaning agent of the present disclosure when killing bacteria is not particularly limited, and a temperature above normal temperature (for example, above 20°C) is preferred. If the temperature at which the fluorine-based alcohol comes into contact with the bacteria becomes higher, the bacteria will become easier to kill. In addition, the temperature may be higher than the boiling point of the fluorine-based alcohol. In short, it may be vaporized into vapor and brought into contact with bacteria. In addition, the most suitable temperature can also be selected according to the solvent or additives contained in the cleaning agent.
[清洗裝置][Cleaning device]
於上已述之本發明相關之清洗裝置在一實施型態中可使用殺菌清洗劑。清洗裝置透過供應包含本揭露之氟系醇的殺菌清洗劑,可以高效率自目標物去除源自生物體的血液或體液、脂肪、普里昂蛋白(Prion Protein,PrP)及感染性類澱粉蛋白等蛋白質或細胞組織等有機物、微生物、病毒、細菌等。清洗裝置亦可併用包含本揭露之氟系醇的殺菌清洗劑與眾所周知之清洗劑。In one embodiment of the cleaning device related to the present invention described above, a sterilizing cleaning agent can be used. The cleaning device can efficiently remove blood or body fluids, fat, Prion Protein (PrP), infectious amyloid, etc. from the target by supplying a sterilizing cleaning agent containing the fluoroalcohol of the present disclosure. Organic matter such as protein or cell tissue, microorganisms, viruses, bacteria, etc. The cleaning device may also use a disinfectant cleaning agent containing the fluorine-based alcohol of the present disclosure and a well-known cleaning agent in combination.
[土壤清洗劑][Soil cleaning agent]
於上已述之本發明相關之清洗劑在一實施型態中可作為土壤清洗劑使用。藉由使用包含本揭露之氟系醇的土壤清洗劑,可期待土壤中所包含之細菌的殺滅效果。在一實施型態中,土壤清洗劑亦可包含記載為眾所周知之技術的一般添加劑。此等亦包含使用於土壤的農藥、肥料、殺菌劑、消毒劑等。The cleaning agent related to the present invention described above can be used as a soil cleaning agent in one embodiment. By using the soil cleaning agent containing the fluorine-based alcohol of the present disclosure, the killing effect of the bacteria contained in the soil can be expected. In one embodiment, the soil cleaning agent may also contain general additives described as well-known technologies. These also include pesticides, fertilizers, fungicides, and disinfectants used in the soil.
在一實施型態中,土壤清洗劑亦可包含本揭露之氟系醇與溶媒。溶媒可選自能夠將氟系醇稀釋的物質,可列舉例如與已在前述清洗劑中列舉之溶媒相同者。此等可為一種或多種,但並非受限於此等者。In one embodiment, the soil cleaning agent may also include the fluorine-based alcohol and solvent disclosed in the present disclosure. The solvent may be selected from substances capable of diluting the fluorine-based alcohol, and examples thereof include the same solvents as those already listed in the aforementioned cleaning agent. These may be one or more, but are not limited to these.
在一實施型態中,土壤清洗劑中所包含之溶媒的含量(質量%),就清洗性之觀點而言,亦可為相對於土壤清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上71質量%以下為更佳。In one embodiment, the content (mass%) of the solvent contained in the soil cleaning agent may be 0 mass% or more and 99.9 mass% or less relative to the mass of the soil cleaning agent from the viewpoint of cleaning performance , Preferably 0 mass% or more and 99 mass% or less, more preferably 0 mass% or more and 92 mass% or less, and more preferably 0 mass% or more and 71 mass% or less.
在一實施型態中,土壤清洗劑除了本揭露之氟系醇與溶媒以外還可包含添加劑。作為能夠添加至土壤清洗劑的添加劑,可列舉:界面活性劑、酵素、酵素穩定劑、抗金屬腐蝕劑、低分子多元醇、清洗助劑(增滌劑)、消泡劑、pH調整劑、香料、著色劑、抗氧化劑、防腐劑、漂白劑、漂白活化劑、腐蝕抑制劑、分散劑、增稠劑、黏度調整劑等,但並非受限於此等者。土壤清洗劑亦可包含一種或二種以上之添加劑。在一實施型態中,土壤清洗劑藉由包含氟系醇、溶媒與上述添加劑,可進一步提升清洗力。In one embodiment, the soil cleaning agent may contain additives in addition to the fluorine-based alcohol and solvent disclosed in the present disclosure. Examples of additives that can be added to soil cleaning agents include: surfactants, enzymes, enzyme stabilizers, anti-metal corrosion agents, low-molecular polyols, cleaning aids (detergents), defoamers, pH adjusters, fragrances , Colorants, antioxidants, preservatives, bleaching agents, bleach activators, corrosion inhibitors, dispersants, thickeners, viscosity modifiers, etc., but not limited to these. The soil cleaning agent may also contain one or more than two additives. In one embodiment, the soil cleaning agent can further improve the cleaning power by including fluorine-based alcohol, solvent and the above additives.
界面活性劑(A)可列舉例如與已在前述清洗劑中列舉之界面活性劑(A)相同者。作為界面活性劑(A),可使用1種或2種以上。As the surfactant (A), for example, the same surfactants (A) listed in the aforementioned cleaning agent can be mentioned. As the surfactant (A), one type or two or more types can be used.
土壤清洗劑中所包含之界面活性劑(A)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.1質量%以上且5質量%以下為更佳。The content (mass%) of the surfactant (A) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is preferably 0 mass% or more and 10 mass% or less relative to the mass of the soil cleaning agent. It is more preferably 0.1% by mass or more and 5% by mass or less.
酵素(B)可列舉例如與已在前述清洗劑中列舉之酵素(B)相同者。作為酵素(B),可使用1種或2種以上。The enzyme (B) can be, for example, the same as the enzyme (B) listed in the aforementioned cleaning agent. As the enzyme (B), one kind or two or more kinds can be used.
在一實施型態中,土壤清洗劑中所包含之酵素(B)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。In one embodiment, the content (mass%) of the enzyme (B) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10 mass% relative to the mass of the soil cleaning agent The following is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are especially preferable.
作為酵素穩定劑(C),可列舉例如與已在前述清洗劑中列舉之酵素穩定劑(D)相同者。作為酵素穩定劑(C),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之酵素穩定劑(C)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳,以0.05質量%以上且5質量%以下為更佳,以0.1質量%以上且3質量%以下為尤佳。As the enzyme stabilizer (C), for example, the same enzyme stabilizer (D) listed in the aforementioned cleaning agent can be cited. As the enzyme stabilizer (C), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the enzyme stabilizer (C) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10% relative to the mass of the soil cleaning agent. Mass% or less is preferable, 0.05 mass% or more and 5 mass% or less are more preferable, and 0.1 mass% or more and 3 mass% or less are particularly preferable.
作為抗金屬腐蝕劑(D),可列舉例如與已在前述清洗劑中列舉之抗金屬腐蝕劑(F)相同者。作為抗金屬腐蝕劑(D),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之抗金屬腐蝕劑(D)的含量(質量%),就腐蝕抑制性能之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳。As the anti-metal corrosion agent (D), for example, the same ones as the anti-metal corrosion agent (F) listed in the aforementioned cleaning agent can be cited. As the anti-metal corrosion agent (D), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the anti-metal corrosion agent (D) contained in the soil cleaning agent is 0 mass% or more from the viewpoint of corrosion inhibition performance relative to the mass of the soil cleaning agent. 10% by mass or less is preferable.
低分子多元醇(E)可列舉例如與已在前述清洗劑中列舉之低分子多元醇(G)相同者。作為低分子多元醇(E),可使用1種或2種以上。Examples of the low-molecular-weight polyol (E) are the same as the low-molecular-weight polyol (G) listed in the aforementioned cleaning agent. As the low-molecular-weight polyol (E), one type or two or more types can be used.
在一實施型態中,土壤清洗劑中所包含之低分子多元醇(E)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且80質量%以下為佳。In one embodiment, the content (mass %) of the low-molecular polyol (E) contained in the soil cleaning agent is 0 mass% or more from the viewpoint of cleaning performance relative to the mass of the soil cleaning agent. 80% by mass or less is preferable.
作為清洗助劑(增滌劑)(F),可列舉例如與已在前述清洗劑中列舉之清洗助劑(增滌劑)(H)相同者。作為增滌劑(F),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之增滌劑(F)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且20質量%以下為佳。As the cleaning aid (washing agent) (F), for example, the same washing aids (washing agent) (H) listed in the above-mentioned washing agent can be mentioned. As the detergent (F), one type or two or more types can be used. In one embodiment, the content (mass %) of the detergent (F) contained in the soil cleaning agent is 0 mass% or more and 20% from the viewpoint of cleaning performance relative to the mass of the soil cleaning agent. The mass% or less is better.
作為消泡劑(G),可列舉例如與已在前述清洗劑中列舉之消泡劑(I)相同者。作為消泡劑(G),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之消泡劑(G)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且10質量%以下為佳。As the defoaming agent (G), for example, the same as the defoaming agent (I) listed in the aforementioned cleaning agent can be cited. As the defoaming agent (G), one kind or two or more kinds can be used. In one embodiment, the content (mass %) of the defoaming agent (G) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 10% relative to the mass of the soil cleaning agent. The mass% or less is better.
作為pH調整劑(H),可列舉例如與已在前述清洗劑中列舉之pH調整劑(J)相同者。作為pH調整劑(H),可使用1種或2種以上。在一實施型態中,土壤清洗劑中所包含之pH調整劑(H)的含量(質量%),就清洗性之觀點而言,以相對於土壤清洗劑的質量為0質量%以上且25質量%以下為佳,以0質量%以上且15質量%以下為更佳,以0質量%以上且10質量%以下為尤佳。As the pH adjuster (H), for example, the same as the pH adjuster (J) listed in the aforementioned cleaning agent can be mentioned. As the pH adjuster (H), one type or two or more types can be used. In one embodiment, the content (mass %) of the pH adjuster (H) contained in the soil cleaning agent, from the viewpoint of cleaning properties, is 0 mass% or more and 25% relative to the mass of the soil cleaning agent. Mass% or less is preferable, 0 mass% or more and 15 mass% or less are more preferable, and 0 mass% or more and 10 mass% or less are particularly preferable.
作用於細菌時之氟系醇的濃度亦可為0.1質量%以上,以1質量%以上為佳,以8質量%以上為更佳,以29質量%以上為尤佳。此外,使氟系醇作用於細菌的時間並不特別受限。使氟系醇作用於細菌的時間即使係短時間亦有效。舉例而言,使氟系醇作用於細菌的時間亦可為30秒鐘以上,以1分鐘以上為佳,以20分鐘以上為較佳,以30分鐘以上為尤佳。為了提升作用效果,亦以在每日單位或週單位甚至每一季使用的間隔拉開之下分段性使用多次的方法為佳。The concentration of the fluorine-based alcohol when acting on bacteria may be 0.1% by mass or more, preferably 1% by mass or more, more preferably 8% by mass or more, and particularly preferably 29% by mass or more. In addition, the time for the fluorine-based alcohol to act on the bacteria is not particularly limited. It is effective even for a short period of time for the fluorine-based alcohol to act on the bacteria. For example, the time for the fluorine-based alcohol to act on the bacteria may also be 30 seconds or more, preferably 1 minute or more, more preferably 20 minutes or more, and more preferably 30 minutes or more. In order to improve the effect, it is also better to use the method several times in segments with the interval of daily unit or weekly unit or even each season opened.
在一實施型態中,土壤清洗劑亦可包含市售之消毒劑的有效成分作為添加劑。作為市售之消毒劑的有效成分,可列舉例如與已在前述清洗劑中列舉之市售之消毒劑的有效成分相同者。在一實施型態中,土壤清洗劑中所包含之此等有效成分的含量(質量%),亦可為相對於土壤清洗劑的質量為0質量%以上且99.9質量%以下,以0質量%以上且99質量%以下為佳,以0質量%以上且92質量%以下為尤佳,以0質量%以上且71質量%以下為更佳。In one embodiment, the soil cleaning agent may also contain the effective ingredients of a commercially available disinfectant as an additive. As the effective ingredient of the commercially available disinfectant, for example, the same effective ingredients as those of the commercially available disinfectant listed in the aforementioned cleaning agent can be cited. In one embodiment, the content (mass%) of these active ingredients contained in the soil cleaning agent may also be 0 mass% or more and 99.9 mass% or less relative to the mass of the soil cleaning agent, with 0 mass% The above is preferably 99% by mass or less, more preferably 0% by mass or more and 92% by mass or less, and more preferably 0% by mass or more and 71% by mass or less.
在一實施型態中,土壤清洗劑所包含之氟系醇,尤其HFIP及TFE在受到細菌汙染之土壤的清洗上有效。HFIP及TFE係穩定的低分子化合物,儲存性高。並且,由於具有良好的熱穩定性故清洗溫度並不受限,可進一步提升清洗力。再者,HFIP及TFE為難燃性,使用上的安全管理容易。In one embodiment, the fluoroalcohol contained in the soil cleaning agent, especially HFIP and TFE, are effective in cleaning soil contaminated by bacteria. HFIP and TFE are stable low-molecular compounds with high storage properties. Moreover, the cleaning temperature is not limited due to its good thermal stability, which can further enhance the cleaning power. Furthermore, HFIP and TFE are flame-retardant, and safety management in use is easy.
[清洗方法][cleaning method]
使用本實施型態相關之土壤清洗劑,可清洗受到細菌汙染之土壤或者有汙染可能之土壤。或者,亦可預防性使用本實施型態相關之土壤清洗劑來清洗土壤。在一實施型態中,亦可將土壤清洗劑以上述溶媒稀釋使用於清洗。在一實施型態中,藉由將本實施型態相關之土壤清洗劑或者溶媒與土壤清洗劑添加混合至清洗目標之土壤將清洗土分離並使之乾燥的方法,可將細菌殺滅清洗土壤。Using the soil cleaning agent related to this implementation type can clean soil contaminated by bacteria or soil that may be contaminated. Alternatively, the soil cleaning agent related to this implementation type can also be used preventively to clean the soil. In one embodiment, the soil cleaning agent can also be diluted with the above solvent for cleaning. In one embodiment, by adding and mixing the soil cleaning agent or solvent and soil cleaning agent related to this embodiment to the soil of the cleaning target, separating and drying the cleaning soil, the bacteria can be killed and the soil can be cleaned. .
在一實施型態中,清洗時氟系醇或由通式(1)所示之化合物的濃度亦可為0.01質量%以上,以0.1重量%以上為佳,以1質量%以上為尤佳。可考慮使用時之土壤汙染的程度、受到汙染的時期、土壤之周邊環境等任意調整。In one embodiment, the concentration of the fluorine-based alcohol or the compound represented by the general formula (1) during cleaning may also be 0.01% by mass or more, preferably 0.1% by weight or more, and particularly preferably 1% by mass or more. The degree of soil pollution at the time of use, the period of pollution, and the surrounding environment of the soil can be adjusted arbitrarily.
在一實施型態中,氟系醇或由通式(1)所示之化合物亦可作為土壤燻蒸劑使用。舉例而言,藉由對懷疑有汙染之土壤使用包含氟系醇或由通式(1)所示之化合物的土壤燻蒸劑來蒸蒸,可清洗土壤。In one embodiment, the fluorine-based alcohol or the compound represented by the general formula (1) can also be used as a soil fumigant. For example, by steaming the soil suspected of being contaminated with a soil fumigant containing a fluorine-based alcohol or a compound represented by the general formula (1), the soil can be cleaned.
『實施例』"Example"
以下藉由實施例進一步具體說明本發明,但只要不超出其要旨,本發明即非受限於以下實施例者。The following examples further illustrate the present invention in detail, but as long as it does not exceed the gist, the present invention is not limited to the following examples.
〈清洗劑〉<detergent>
準備HFIP(1,1,1,3,3,3-六氟-2-丙醇,中央硝子股份有限公司,純度99%以上)作為將病毒去活化的化合物,與EtOH(日本藥典消毒用乙醇,80容量%)比較。並且,準備TFIPL(外消旋體)(1,1,1-三氟-2-丙醇,中央硝子股份有限公司,純度99%以上)、S-TFIPL(1,1,1-三氟-2-丙醇,中央硝子股份有限公司,純度99%以上)、R-TFIPL(1,1,1-三氟-2-丙醇,中央硝子股份有限公司,純度99%以上)作為將病毒去活化的化合物。Prepare HFIP (1,1,1,3,3,3-hexafluoro-2-propanol, Central Glass Co., Ltd., purity 99% or more) as a compound to deactivate the virus, and EtOH (Japanese Pharmacopoeia ethanol for disinfection) , 80% of capacity) comparison. In addition, prepare TFIPL (racemate) (1,1,1-trifluoro-2-propanol, Central Glass Co., Ltd., with a purity of 99% or more), S-TFIPL (1,1,1-trifluoro- 2-Propanol, Central Glass Co., Ltd., purity over 99%), R-TFIPL (1,1,1-trifluoro-2-propanol, Central Glass Co., Ltd., purity over 99%) is used to remove the virus Activated compound.
〈病毒感染用細胞〉<Cells for virus infection>
準備作為於後所述之BVDV感染用細胞的MDBK細胞株(源自牛腎臟的細胞株,Madin-Darby bovine kidney cell line,ATCC(註冊商標) CCL-22)、作為於後所述之FCV感染用細胞的CRFK細胞株(源自貓腎臟的細胞株,Crandell Rees feline kidney cell line,ATCC(註冊商標) CCL-94)、作為於後所述之腺病毒感染用細胞的A549細胞株(源自人類肺泡基底上皮腺癌的細胞株,Human Lung Epithelial cell line,ATCC(註冊商標) CCL-185),以及作為於後所述之腸病毒感染用細胞的Vero細胞株(源自猿猴腎臟的細胞株,Cercopithecus aethiops kidney cell line,ATCC(註冊商標) CCL-81)這4種細胞株。Prepare the MDBK cell line (a bovine kidney-derived cell line, Madin-Darby bovine kidney cell line, ATCC (registered trademark) CCL-22) as the cell for BVDV infection described later, as the FCV infection described later CRFK cell line (cat kidney-derived cell line, Crandell Rees feline kidney cell line, ATCC (registered trademark) CCL-94) using cells, and A549 cell line (derived from A cell line of human alveolar basal epithelial adenocarcinoma, Human Lung Epithelial cell line, ATCC (registered trademark) CCL-185), and a Vero cell line (a cell line derived from ape kidney as the cell line for enterovirus infection described later) , Cercopithecus aethiops kidney cell line, ATCC (registered trademark) CCL-81) these 4 cell lines.
MDBK細胞株係以包含1%FBS(胎牛血清,Fetal Bovine Serum,Sigma-Aldrich Japan有限責任公司)的DMEM(杜爾貝寇改良伊格爾培養基,Dulbecco’s Modified Eagle’s Medium,Sigma-Aldrich Japan有限責任公司)作為培養基,在加濕、37℃、5%CO2 條件下培養。The MDBK cell line is made of DMEM (Dulbecco's Modified Eagle's Medium, Dulbecco's Modified Eagle's Medium, Sigma-Aldrich Japan Co., Ltd.) containing 1% FBS (Fetal Bovine Serum, Sigma-Aldrich Japan Co., Ltd.) Company) as a culture medium, cultured under humidified, 37°C, 5% CO 2 conditions.
CRFK細胞株係以包含2%FBS的EMEM(伊格爾最低必需培養基,Eagle’s minimal essential medium,日水製藥股份有限公司)作為培養基,在加濕、37℃、5%CO2 條件下培養。The CRFK cell line was cultured with EMEM (Eagle's minimal essential medium, Nissui Pharmaceutical Co., Ltd.) containing 2% FBS as a medium, and was cultured under humidified, 37°C, and 5% CO 2 conditions.
A549細胞株係以包含2%FBS的DMEM作為培養基,在加濕、37℃、5%CO2 條件下培養。The A549 cell line uses DMEM containing 2% FBS as a medium and is cultured under humidified, 37°C, and 5% CO 2 conditions.
Vero細胞株係以包含5%FBS的EMEM作為培養基,在加濕、37℃、5%CO2 條件下培養。The Vero cell line uses EMEM containing 5% FBS as a medium, and is cultured under humidified, 37°C, and 5% CO 2 conditions.
細胞培養容器使用細胞培養用皿(AGC TECHNO GLASS CO., LTD.)及細胞培養用微量盤(48孔或96孔,AGC TECHNO GLASS CO., LTD.)。The cell culture container uses a cell culture dish (AGC TECHNO GLASS CO., LTD.) and a cell culture microplate (48-well or 96-well, AGC TECHNO GLASS CO., LTD.).
於細胞培養用48孔盤接種MDBK細胞或CRFK細胞,在37℃、5%CO2 條件下培養,作為BVDV感染用細胞或FCV感染用細胞使用。Inoculate MDBK cells or CRFK cells in a 48-well plate for cell culture, culture them at 37°C and 5% CO 2 and use them as BVDV infection cells or FCV infection cells.
〈病毒〉<Virus>
準備係為C型肝炎病毒之替代病毒的牛病毒性腹瀉病毒(Bovine viral diarrhea virus 1,Strain:NADL,ATCC(註冊商標) VR-534,以下記載為BVDV)作為擁有套膜的RNA病毒以及係為諾羅病毒之替代病毒的貓杯狀病毒(Feline calicivirus,Strain:F-9,ATCC(註冊商標) VR-782,以下記載為FCV)作為不擁有套膜的RNA病毒。再者,準備係為泳池熱之病原病毒的腺病毒(Human adenovirus 3,Strain:GB,ATCC(註冊商標) VR-3)作為不擁有套膜的DNA病毒,以及據稱對藥劑之去活化耐受性高的係為手足口症之病原病毒的腸病毒(Human Enterovirus 71,strain:H,ATCC(註冊商標) VR-1432)作為不擁有套膜的RNA病毒。Bovine viral diarrhea virus (Bovine
使BVDV感染MDBK細胞株,在培養細胞之約90%以上表現出細胞病變效應(cytopathic effect,以下記載為CPE)的時候將培養細胞連同細胞培養容器在-30℃下冷凍儲存。之後,進行凍融操作1次,採取以2380×g離心10分鐘的上清液,以利用超過濾透膜濃縮的病毒作為儲存病毒。儲存病毒液就此作為BVDV試驗病毒液使用。BVDV is infected with the MDBK cell line, and when more than 90% of the cultured cells show cytopathic effect (hereinafter referred to as CPE), the cultured cells together with the cell culture container are frozen and stored at -30°C. After that, the freeze-thaw operation was performed once, and the supernatant liquid centrifuged at 2380×g for 10 minutes was collected, and the virus concentrated by the ultrafiltration membrane was used as the stored virus. The stored virus solution was then used as the BVDV test virus solution.
使FCV感染CRFK細胞,在培養細胞之約90%以上表現出CPE的時候將培養細胞連同細胞培養容器在-30℃下冷凍儲存。之後,進行凍融操作1次,採取以2380×g離心10分鐘的上清液,利用超過濾透膜濃縮。以藉由使用蔗糖墊之超離心分離濃縮的病毒作為儲存病毒。儲存病毒液以DPBS(Dulbecco’s Phosphate buffered saline,日水製藥)稀釋10倍作為FCV試驗病毒液。Infect CRFK cells with FCV, and store the cultured cells together with the cell culture container at -30℃ when more than 90% of the cultured cells exhibit CPE. After that, the freeze-thaw operation was performed once, and the supernatant was collected by centrifugation at 2380×g for 10 minutes, and concentrated by ultrafiltration membrane. The concentrated virus was separated by ultracentrifugation using a sucrose cushion as the stored virus. The stored virus solution was diluted 10 times with DPBS (Dulbecco’s Phosphate buffered saline, Nissui Pharmaceutical) as the FCV test virus solution.
使腺病毒感染A549細胞,培養細胞之約90%以上表現出CPE的時候將培養細胞連同細胞培養容器在-30℃下冷凍儲存。之後,進行凍融操作1次,採取以2380×g離心10分鐘的上清液,利用超過濾透膜濃縮後,以利用蔗糖濃度差離心分離法製備的病毒作為儲存病毒。儲存病毒液以DPBS稀釋10倍作為腺病毒試驗病毒液。Infect A549 cells with adenovirus. When more than 90% of the cultured cells exhibit CPE, store the cultured cells together with the cell culture container at -30℃. After that, the freezing and thawing operation was performed once, and the supernatant was collected by centrifugation at 2380×g for 10 minutes, and concentrated by ultrafiltration membrane, and then the virus prepared by the centrifugal separation method using the sucrose concentration difference was used as the stored virus. The stored virus solution was diluted 10 times with DPBS as the adenovirus test virus solution.
使腸病毒感染Vero細胞,在培養細胞之約90%以上表現出CPE的時候將培養細胞連同細胞培養容器在-30℃下冷凍儲存。之後,進行凍融操作1次,採取以2380×g離心10分鐘的上清液,以利用超過濾透膜濃縮的病毒作為儲存病毒。儲存病毒液就此作為腸病毒試驗病毒液使用。Infect Vero cells with enterovirus. When more than 90% of the cultured cells exhibit CPE, the cultured cells together with the cell culture container are frozen and stored at -30°C. After that, the freeze-thaw operation was performed once, and the supernatant liquid centrifuged at 2380×g for 10 minutes was collected, and the virus concentrated by the ultrafiltration membrane was used as the stored virus. The stored virus solution is thus used as the enterovirus test virus solution.
[實施例1][Example 1]
將HFIP以蒸餾水稀釋,以100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP作為實施例1-1至實施例1-5之樣品(此外,針對各樣品,若將容量%換算成質量%,分別為100質量%(原液)、86質量%、52質量%、29質量%、8質量%。下同。)。將實施例1-1至實施例1-5之樣品分別分離取出0.9 mL至各個5 mL容量的試管之後,加入BVDV試驗病毒液0.1 mL並混合,使之在室溫(20℃)下作用30分鐘。自作用液採取0.1 mL,添加至作為作用終止液之SCDLP肉汁培養基(榮研化學股份有限公司)9.9 mL,透過將樣品稀釋來終止樣品之作用。Dilute HFIP with distilled water, and use 100% by volume (stock solution), 80% by volume, 40% by volume, 20% by volume, and 5% by volume of HFIP as the samples of Examples 1-1 to 1-5 (in addition, for each For the sample, if the volume% is converted into mass%, they are 100% by mass (stock solution), 86% by mass, 52% by mass, 29% by mass, and 8% by mass respectively. The same below.). After the samples of Example 1-1 to Example 1-5 were separated and taken out 0.9 mL to each 5 mL volume test tube, 0.1 mL of BVDV test virus liquid was added and mixed, and allowed to act at room temperature (20°C). minute. Take 0.1 mL of the action liquid and add it to 9.9 mL of SCDLP gravy medium (Eiken Chemical Co., Ltd.) as the action termination solution. The action of the sample is terminated by diluting the sample.
經實施例1-1至實施例1-5之HFIP作用的BVDV試驗病毒液在以DPBS分別自1至105 倍以10倍為一階稀釋之後,於已接種MDBK細胞之48孔盤的2孔各接種0.1 mL(n=2)。在37℃、5%CO2 條件下靜置1小時使病毒感染細胞之後,去除病毒液,將0.5 mL之培養基添加於各孔,在37℃、5%CO2 條件下培養4日。The BVDV test virus solution that has been subjected to the HFIP effect of Example 1-1 to Example 1-5 was diluted with DPBS from 1 to 10 5 times and 10 times as a first step, and then applied to a 48-well plate inoculated with MDBK cells. Each well was inoculated with 0.1 mL (n=2). After standing for 1 hour at 37°C and 5% CO 2 to infect the cells with the virus, the virus solution was removed, 0.5 mL of medium was added to each well, and cultured at 37°C and 5% CO 2 for 4 days.
[參考例1][Reference example 1]
除了以乙醇代替HFIP作為參考例1之樣品以外,比照實施例1進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例1-1之樣品,以40容量%之乙醇作為參考例1-2之樣品。Except that ethanol was used instead of HFIP as the sample of Reference Example 1, it was carried out in accordance with Example 1. Dilute ethanol with distilled water, use 80% by volume (original solution) of ethanol as the sample of Reference Example 1-1, and use 40% by volume of ethanol as the sample of Reference Example 1-2.
[比較例1][Comparative Example 1]
除了以DPBS代替HFIP作為比較例1之樣品以外,比照實施例1進行。Except that DPBS was used instead of HFIP as the sample of Comparative Example 1, the same procedure was followed in Example 1.
[實施例2][Example 2]
除了以FCV與CRFK細胞代替BVDV與MDBK細胞作為實施例2之試驗病毒液及病毒感染用細胞以外,比照實施例1進行。將HFIP以蒸餾水稀釋,以100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP作為實施例2-1至實施例2-5之樣品。Except that FCV and CRFK cells were used instead of BVDV and MDBK cells as the test virus solution and virus infection cells of Example 2, the same procedure was followed in Example 1. Dilute HFIP with distilled water, and use 100% by volume (stock solution), 80% by volume, 40% by volume, 20% by volume, and 5% by volume of HFIP as samples of Examples 2-1 to 2-5.
[參考例2][Reference example 2]
除了以乙醇代替HFIP作為參考例2之樣品以外,比照實施例2進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例2-1之樣品,以40容量%之乙醇作為參考例2-2之樣品。Except that ethanol was used as the sample of Reference Example 2 instead of HFIP, the same procedure was followed in Example 2. Dilute ethanol with distilled water, use 80% by volume (stock solution) of ethanol as the sample of Reference Example 2-1, and use 40% by volume of ethanol as the sample of Reference Example 2-2.
[比較例2][Comparative Example 2]
除了以DPBS代替HFIP作為比較例2之樣品以外,比照實施例2進行。Except that DPBS was used instead of HFIP as the sample of Comparative Example 2, the procedure was carried out in accordance with Example 2.
[實施例3][Example 3]
除了將使實施例2之HFIP樣品與FCV試驗病毒混合的作用時間自30分鐘縮短為1分鐘以外,比照實施例2進行。簡言之,實施例2與實施例3之差異僅為HFIP與FCV病毒的接觸時間。將HFIP以蒸餾水稀釋,以100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP作為實施例3-1至實施例3-5之樣品。Except that the action time of mixing the HFIP sample of Example 2 with the FCV test virus was shortened from 30 minutes to 1 minute, the procedure was carried out in accordance with Example 2. In short, the difference between Example 2 and Example 3 is only the contact time between HFIP and FCV virus. Dilute HFIP with distilled water, and use 100% by volume (stock solution), 80% by volume, 40% by volume, 20% by volume, and 5% by volume of HFIP as samples of Examples 3-1 to 3-5.
[參考例3][Reference example 3]
除了以乙醇代替HFIP作為參考例3之樣品以外,比照實施例3進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例3-1之樣品,將40容量%之乙醇作為參考例3-2之樣品。Except that ethanol was used instead of HFIP as the sample of Reference Example 3, the procedure was carried out in accordance with Example 3. Dilute ethanol with distilled water, use 80% by volume (stock solution) of ethanol as the sample of Reference Example 3-1, and use 40% by volume of ethanol as the sample of Reference Example 3-2.
[比較例3][Comparative Example 3]
除了以DPBS代替HFIP作為比較例3之樣品以外,比照實施例3進行。Except that DPBS was used instead of HFIP as the sample of Comparative Example 3, the procedure was carried out in accordance with Example 3.
[實施例4][Example 4]
除了以腺病毒與A549細胞代替BVDV與MDBK細胞作為實施例4之試驗病毒液及病毒感染用細胞並將作用時間定為1分鐘以外,比照實施例1進行。將HFIP以蒸餾水稀釋,以100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP作為實施例4-1至實施例4-5之樣品。Except that adenovirus and A549 cells were used instead of BVDV and MDBK cells as the test virus solution and virus infection cells of Example 4, and the action time was set at 1 minute, the procedure was carried out in accordance with Example 1. Dilute HFIP with distilled water, and use 100% by volume (stock solution), 80% by volume, 40% by volume, 20% by volume, and 5% by volume of HFIP as samples of Examples 4-1 to 4-5.
[參考例4][Reference example 4]
除了以乙醇代替HFIP作為參考例4之樣品以外,比照實施例4進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例4-1之樣品,以40容量%之乙醇作為參考例4-2之樣品。Except that ethanol was used instead of HFIP as the sample of Reference Example 4, the same procedure was followed in Example 4. Dilute ethanol with distilled water, use 80% by volume (stock solution) of ethanol as the sample of Reference Example 4-1, and use 40% by volume of ethanol as the sample of Reference Example 4-2.
[比較例4][Comparative Example 4]
除了以DPBS代替HFIP作為比較例4之樣品以外,比照實施例4進行。Except that DPBS was used instead of HFIP as the sample of Comparative Example 4, the procedure was carried out in accordance with Example 4.
[實施例5][Example 5]
除了以腸病毒與Vero細胞代替BVDV與MDBK細胞作為實施例5之試驗病毒液及病毒感染用細胞並將作用時間定為1分鐘以外,比照實施例1進行。將HFIP以蒸餾水稀釋,以100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP作為實施例5-1至實施例5-5之樣品。Except that enterovirus and Vero cells were used instead of BVDV and MDBK cells as the test virus solution and virus infection cells of Example 5, and the action time was set to 1 minute, the procedure was carried out in accordance with Example 1. Dilute HFIP with distilled water, and use 100% by volume (stock solution), 80% by volume, 40% by volume, 20% by volume, and 5% by volume of HFIP as samples of Examples 5-1 to 5-5.
[參考例5][Reference example 5]
除了以乙醇代替HFIP作為參考例5之樣品以外,比照實施例5進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例5-1之樣品。此外,腸病毒由於係不易去活化的病毒,故未準備作為參考例之40容量%之乙醇。Except that ethanol was used instead of HFIP as the sample of Reference Example 5, the procedure was carried out in accordance with Example 5. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 5-1. In addition, because enterovirus is a virus that is not easily deactivated, 40% ethanol as a reference example has not been prepared.
[比較例5][Comparative Example 5]
除了將DPBS代替HFIP作為比較例5之樣品以外,比照實施例5進行。Except that DPBS was used as the sample of Comparative Example 5 instead of HFIP, the same procedure was followed in Example 5.
〈由HFIP所致之病毒去活化的評價〉<Evaluation of virus deactivation caused by HFIP>
由HFIP所致之病毒去活化的評價,透過感染了經HFIP作用之病毒的細胞之使用顯微鏡的型態觀察來進行。圖2至圖6中,以黑圓點(●)表示可確認到由病毒之增殖所致之CPE者(已病毒感染的細胞),以白圓點(○)表示未確認到CPE者(未病毒感染的細胞)。此外,以白三角(△)表示可看到細胞毒性但未確認到由病毒之增殖所致之CPE者(未病毒感染的細胞),並以黑三角(▲)表示可看到細胞毒性且可確認到由病毒之增殖所致之CPE者(已病毒感染的細胞)。並且,圖2至圖6中的「%」表示「容量%」。The evaluation of virus inactivation caused by HFIP is carried out by observing the type of cells infected with HFIP virus using a microscope. In Figures 2 to 6, black dots (●) indicate those who can confirm CPE caused by virus proliferation (virus-infected cells), and white dots (○) indicate those who have not confirmed CPE (no virus) Infected cells). In addition, a white triangle (△) indicates that the cytotoxicity can be seen but CPE caused by the proliferation of the virus has not been confirmed (cells not infected by the virus), and a black triangle (▲) indicates that the cytotoxicity can be seen and confirmed To CPE caused by the proliferation of the virus (cells that have been infected with the virus). In addition, "%" in Figs. 2 to 6 means "capacity%".
如圖2至圖6所示,相比於比較例,在所有實施例及參考例中觀察到病毒去活化的效果。As shown in Fig. 2 to Fig. 6, compared with the comparative example, the virus deactivation effect was observed in all the examples and the reference example.
如圖2所示,對於BVDV,相比於參考例1-2,在實施例1-1至實施例1-5及參考例1-1中觀察到較強的病毒去活化的效果。亦即,表示在5容量%以上之HFIP中,有較40容量%EtOH還強的BVDV去活化的效果。As shown in Fig. 2, for BVDV, compared with Reference Example 1-2, a stronger virus inactivation effect was observed in Examples 1-1 to 1-5 and Reference Example 1-1. In other words, it means that in HFIP above 5 volume %, there is a stronger BVDV deactivation effect than 40 volume% EtOH.
如圖3所示,對於FCV,相比於參考例2-2,在實施例2-1至實施例2-5、參考例2-1中觀察到強的病毒去活化的效果。再來,實施例2-1至實施例2-4觀察到較實施例2-5及參考例2-1強的病毒去活化效果。亦即,表示在20容量%以上之HFIP中,有較5容量%HFIP及80容量%EtOH還強的FCV去活化的效果。As shown in Fig. 3, for FCV, compared with Reference Example 2-2, a strong virus deactivation effect was observed in Examples 2-1 to 2-5 and Reference Example 2-1. Furthermore, in Example 2-1 to Example 2-4, a stronger virus deactivation effect was observed than in Example 2-5 and Reference Example 2-1. In other words, it means that in HFIP with a volume of 20% or more, the FCV deactivation effect is stronger than that of 5% by volume of HFIP and 80% by volume of EtOH.
如圖4所示,縮短了HFIP對FCV之作用時間的實施例3-1至實施例3-5表現出較比較例3或參考例3-1、參考例3-2還強的病毒去活化效果。亦即,表示在5容量%以上之HFIP中,有較40容量%EtOH及80容量%EtOH還強的FCV去活化的效果。As shown in Figure 4, Examples 3-1 to 3-5, which shortened the action time of HFIP on FCV, showed stronger virus deactivation than Comparative Example 3, Reference Example 3-1, and Reference Example 3-2. Effect. In other words, it means that in HFIP with a volume of more than 5% by volume, the FCV deactivation effect is stronger than that of 40% by volume EtOH and 80% by volume EtOH.
如圖5所示,對於腺病毒,相比於參考例4-2,在實施例4-1至實施例4-5、參考例4-1中觀察到強的病毒去活化的效果。亦即,表示在5容量%以上之HFIP中,有較40容量%EtOH還強的腺病毒去活化的效果。As shown in FIG. 5, for adenovirus, compared with Reference Example 4-2, a strong virus inactivation effect was observed in Examples 4-1 to 4-5 and Reference Example 4-1. In other words, it means that in HFIP above 5% by volume, there is a stronger effect of deactivating adenovirus than 40% by volume EtOH.
如圖6所示,對於腸病毒,相比於參考例5-1,在實施例5-1至實施例5-5中觀察到強的病毒去活化的效果。尤其在實施例5-1至實施例5-3中觀察到較強的病毒去活化的效果。亦即,在5容量%以上之HFIP中,有較80容量%EtOH還強的腺病毒去活化的效果,尤其在40容量%以上之HFIP中,其去活化的效果顯著。As shown in Fig. 6, for enteroviruses, compared with Reference Example 5-1, a strong virus inactivation effect was observed in Examples 5-1 to 5-5. Especially in Example 5-1 to Example 5-3, a strong virus deactivation effect was observed. That is, in HFIP above 5% by volume, the adenovirus deactivation effect is stronger than that with 80% by volume EtOH. Especially in HFIP above 40% by volume, its deactivation effect is significant.
關於在實施例中觀察到細胞毒性者,若考量使用於醫療用器具之清洗的目的,則細胞毒性之有無並非對其清洗效果有影響者。Regarding those who have observed cytotoxicity in the examples, if the purpose of cleaning for medical appliances is considered, the presence or absence of cytotoxicity is not the one that has an influence on the cleaning effect.
[實施例6][Example 6]
除了以S-TFIPL代替實施例3之HFIP作為實施例6之樣品以外,比照實施例3進行。將S-TFIPL以蒸餾水稀釋,以100容量%(原液)、40容量%、20容量%之S-TFIPL作為實施例6-1至實施例6-3之樣品(此外,針對各樣品,若將容量%換算成質量%,分別為100質量%(原液)、46質量%、24質量%。下同。)。Except that S-TFIPL was used instead of the HFIP of Example 3 as the sample of Example 6, the same procedure was followed in Example 3. Dilute S-TFIPL with distilled water, and use 100% by volume (stock solution), 40% by volume, and 20% by volume of S-TFIPL as the samples of Examples 6-1 to 6-3 (In addition, for each sample, if The volume% is converted into mass%, and they are 100% by mass (stock solution), 46% by mass, and 24% by mass. The same below.).
[參考例6][Reference example 6]
除了以乙醇代替S-TFIPL作為參考例6之樣品以外,比照實施例6進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例6之樣品。Except that ethanol was used instead of S-TFIPL as the sample of Reference Example 6, the same procedure was followed in Example 6. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 6.
[比較例6][Comparative Example 6]
除了以DPBS代替S-TFIPL作為比較例6之樣品以外,比照實施例6進行。Except that DPBS was used instead of S-TFIPL as the sample of Comparative Example 6, the same procedure was followed in Example 6.
[實施例7][Example 7]
除了以TFIPL(外消旋體)代替S-TFIPL作為實施例7之樣品以外,比照實施例6進行。將TFIPL(外消旋體)以蒸餾水稀釋,以100容量%(原液)、40容量%、20容量%之TFIPL(外消旋體)作為實施例7-1至實施例7-3之樣品(此外,針對各樣品,若將容量%換算成質量%,分別為100質量%(原液)、46質量%、24質量%。下同。)。Except that TFIPL (racemate) was used instead of S-TFIPL as the sample of Example 7, the same procedure was followed in Example 6. Dilute TFIPL (racemate) with distilled water, and use 100% by volume (stock solution), 40% by volume, and 20% by volume of TFIPL (racemate) as the samples of Examples 7-1 to 7-3 ( In addition, for each sample, if the volume% is converted into mass %, they are 100 mass% (stock solution), 46 mass %, and 24 mass %. The same applies hereinafter.).
[參考例7][Reference example 7]
除了以乙醇代替TFIPL(外消旋體)作為參考例7之樣品以外,比照實施例7進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例7之樣品。Except that ethanol was used instead of TFIPL (racemate) as the sample of Reference Example 7, the same procedure was followed in Example 7. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 7.
[比較例7][Comparative Example 7]
除了以DPBS代替TFIPL(外消旋體)作為比較例7之樣品以外,比照實施例7進行。Except that DPBS was used instead of TFIPL (racemate) as the sample of Comparative Example 7, the same procedure was followed in Example 7.
[實施例8][Example 8]
除了以S-TFIPL代替HFIP作為實施例8之樣品並將作用時間自30分鐘縮短為1分鐘以外,比照實施例1進行。將S-TFIPL以蒸餾水稀釋,以100容量%(原液)、40容量%、20容量%之S-TFIPL作為實施例8-1至實施例8-3之樣品(此外,針對各樣品,若將容量%換算成質量%,分別為100質量%(原液)、46質量%、24質量%。下同。)。Except that S-TFIPL was used instead of HFIP as the sample of Example 8 and the action time was shortened from 30 minutes to 1 minute, the procedure was carried out in accordance with Example 1. Dilute S-TFIPL with distilled water, and use 100% by volume (stock solution), 40% by volume, and 20% by volume of S-TFIPL as the samples of Examples 8-1 to 8-3 (in addition, for each sample, if the The volume% is converted into mass%, and they are 100% by mass (stock solution), 46% by mass, and 24% by mass. The same below.).
[參考例8][Reference Example 8]
除了以乙醇代替S-TFIPL作為參考例8之樣品以外,比照實施例8進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例8之樣品。Except that ethanol was used instead of S-TFIPL as the sample of Reference Example 8, the same procedure was followed in Example 8. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 8.
[比較例8][Comparative Example 8]
除了以DPBS代替S-TFIPL作為比較例8之樣品以外,比照實施例8進行。Except that DPBS was used instead of S-TFIPL as the sample of Comparative Example 8, the same procedure was followed in Example 8.
[實施例9][Example 9]
除了以R-TFIPL代替實施例8之S-TFIPL作為實施例9之樣品以外,比照實施例8。將R-TFIPL以蒸餾水稀釋,以100容量%(原液)、40容量%、20容量%之R-TFIPL作為實施例9-1至實施例9-3之樣品。Except that R-TFIPL was used instead of S-TFIPL of Example 8 as the sample of Example 9, the same as Example 8. The R-TFIPL was diluted with distilled water, and 100% by volume (stock solution), 40% by volume, and 20% by volume of R-TFIPL were used as samples of Examples 9-1 to 9-3.
[參考例9][Reference Example 9]
除了以乙醇代替R-TFIPL作為參考例9之樣品以外,比照實施例9進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例9之樣品。Except that ethanol was used instead of R-TFIPL as the sample of Reference Example 9, the same procedure was followed in Example 9. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 9.
[比較例9][Comparative Example 9]
除了以DPBS代替R-TFIPL作為比較例9之樣品以外,比照實施例9進行。Except that DPBS was used instead of R-TFIPL as the sample of Comparative Example 9, the same procedure was followed in Example 9.
[實施例10][Example 10]
除了以TFIPL(外消旋體)代替實施例9之R-TFIPL作為實施例10之樣品以外,比照實施例9進行。將TFIPL(外消旋體)以蒸餾水稀釋,以100容量%(原液)、40容量%、20容量%之TFIPL(外消旋體)作為實施例10-1至10-3之樣品。Except that TFIPL (racemate) was used instead of R-TFIPL of Example 9 as the sample of Example 10, the same procedure was followed in Example 9. The TFIPL (racemate) was diluted with distilled water, and 100% by volume (stock solution), 40% by volume, and 20% by volume of TFIPL (racemate) were used as samples of Examples 10-1 to 10-3.
[參考例10][Reference Example 10]
除了以乙醇代替TFIPL(外消旋體)作為參考例10之樣品以外,比照實施例10進行。將乙醇以蒸餾水稀釋,以80容量%(原液)之乙醇作為參考例10之樣品。Except that ethanol was used instead of TFIPL (racemate) as the sample of Reference Example 10, the same procedure was followed in Example 10. The ethanol was diluted with distilled water, and 80% by volume (stock solution) of ethanol was used as the sample of Reference Example 10.
[比較例10][Comparative Example 10]
除了以DPBS代替TFIPL(外消旋體)作為比較例10之樣品以外,比照實施例10進行。Except that DPBS was used instead of TFIPL (racemate) as the sample of Comparative Example 10, the same procedure was followed in Example 10.
〈由TFIPL所致之病毒去活化的評價〉<Evaluation of virus deactivation caused by TFIPL>
由TFIPL所致之病毒去活化的評價,透過感染了經TFIPL作用之病毒的細胞之使用顯微鏡的型態觀察來進行。圖7至圖11中,以黑圓點(●)表示可確認到由病毒之增殖所致之CPE者(已病毒感染的細胞),以白圓點(○)表示未確認到CPE者(未病毒感染的細胞)。此外,以白三角(△)表示可看到細胞毒性但未確認到由病毒之增殖所致之CPE者(未病毒感染的細胞),並以黑三角(▲)表示可看到細胞毒性且可確認到由病毒之增殖所致之CPE者(已病毒感染的細胞)。並且,圖7至圖11中的「%」表示「容量%」。The evaluation of virus inactivation caused by TFIPL is carried out by observing the type of cells infected with the virus that has been acted on by TFIPL using a microscope. In Figures 7 to 11, black dots (●) indicate those who can confirm CPE caused by virus proliferation (virus-infected cells), and white dots (○) indicate those who have not confirmed CPE (no virus) Infected cells). In addition, a white triangle (△) indicates that the cytotoxicity can be seen but CPE caused by the proliferation of the virus has not been confirmed (cells not infected by the virus), and a black triangle (▲) indicates that the cytotoxicity can be seen and confirmed To CPE caused by the proliferation of the virus (cells that have been infected with the virus). In addition, "%" in FIGS. 7 to 11 represents "capacity%".
如圖7至圖11所示,相比於比較例,在所有實施例及參考例中觀察到病毒去活化的效果。As shown in FIGS. 7 to 11, compared with the comparative example, the effect of virus inactivation was observed in all the examples and the reference example.
如圖7所示,對於FCV之經S-TFIPL作用的實施例6-1至實施例6-3,與參考例6比較,確認到強的病毒去活化的效果。亦即,表示在20容量%以上之S-TFIPL中,有較80容量%EtOH還強的FCV去活化的效果。As shown in FIG. 7, for Examples 6-1 to 6-3 in which FCV was acted on by S-TFIPL, compared with Reference Example 6, a strong virus inactivation effect was confirmed. That is, it means that in S-TFIPL of 20% by volume or more, there is a stronger FCV deactivation effect than 80% by volume of EtOH.
如圖8所示,對於FCV之經TFIPL(外消旋體)作用的實施例7-1至實施例7-3,與參考例7比較,確認到強的病毒去活化的效果。尤其在實施例7-1及實施例7-2中,觀察到較強的病毒去活化的效果。亦即,表示在20容量%以上之TFIPL(外消旋體)中,有較80容量%EtOH還強的FCV去活化的效果。As shown in FIG. 8, for Examples 7-1 to 7-3 in which FCV was acted on by TFIPL (racemate), compared with Reference Example 7, a strong virus inactivation effect was confirmed. Especially in Example 7-1 and Example 7-2, a strong virus inactivation effect was observed. In other words, it means that in TFIPL (racemate) of 20% by volume or more, there is a stronger FCV deactivation effect than 80% by volume of EtOH.
如圖9所示,對於BVDV之經S-TFIPL作用的實施例8-1至實施例8-3,與比較例8比較,確認到強的病毒去活化的效果。亦即,表示在20容量%以上之S-TFIPL中有BVDV去活化的效果。As shown in FIG. 9, compared with Comparative Example 8 in Examples 8-1 to 8-3 in which BVDV was acted on by S-TFIPL, a strong virus inactivation effect was confirmed. That is, it means that there is a BVDV deactivation effect in S-TFIPL above 20% by volume.
如圖10所示,對於BVDV之經R-TFIPL作用的實施例9-1至實施例9-3,與比較例9比較,確認到強的病毒去活化的效果。亦即,表示在20容量%以上之R-TFIPL中有BVDV去活化的效果。As shown in FIG. 10, for Examples 9-1 to 9-3 in which BVDV was acted on by R-TFIPL, compared with Comparative Example 9, a strong virus inactivation effect was confirmed. That is, it means that there is a BVDV deactivation effect in R-TFIPL of more than 20% by volume.
如圖11所示,對於BVDV之經TFIPL(外消旋體)作用的實施例10-1至實施例10-3,與比較例10比較,確認到強的病毒去活化的效果。亦即,表示在20容量%以上之TFIPL(外消旋體)中有BVDV去活化的效果。As shown in FIG. 11, compared with Comparative Example 10, in Examples 10-1 to 10-3 in which TFIPL (racemate) of BVDV acts, a strong virus inactivation effect was confirmed. That is, it means that there is a BVDV deactivation effect in TFIPL (racemate) of more than 20% by volume.
[蛋白質溶解性試驗][Protein solubility test]
將HFIP以蒸餾水稀釋,使用100容量%(原液)、80容量%、40容量%、20容量%、5容量%之HFIP水溶液,實施使用了醫療機器之清洗評價指示器(TOSI,松吉醫科器械股份有限公司製)的疑似人類血漿蛋白質之汙染物的清洗評價。使TOSI浸漬於各濃度之HFIP水溶液,在20℃下實施10分鐘超音波清洗之後,利用殘留蛋白檢測液(Saraya Co., Ltd.製,Power Quick)確認TOSI上之殘留蛋白質的有無,結果無論在使用何種濃度之HFIP水溶液的情形中皆未檢測到殘留蛋白質。亦即,可知在5容量%以上之HFIP中,可去除TOSI上的疑似汙染物。Dilute HFIP with distilled water, use 100% (original solution), 80%, 40%, 20%, and 5% of HFIP water solution to implement the cleaning evaluation indicator for medical equipment (TOSI, Songji Medical Instruments Co., Ltd.) Co., Ltd.) cleaning evaluation of suspected human plasma protein contaminants. After immersing TOSI in the HFIP aqueous solution of each concentration and performing ultrasonic cleaning at 20°C for 10 minutes, the residual protein detection solution (manufactured by Saraya Co., Ltd., Power Quick) was used to confirm the presence or absence of residual protein on TOSI. In the case of using any concentration of HFIP aqueous solution, no residual protein was detected. In other words, it can be seen that in HFIP of more than 5% by volume, suspected contaminants on TOSI can be removed.
[殺菌性評價試驗][Bactericidal evaluation test]
〈接種菌株〉<Inoculation strain>
菌株使用Escherichia coli NBRC3972株(大腸桿菌)。Escherichia coli NBRC3972 strain (E. coli) was used as the strain.
〈量測用培養基〉<Measuring Medium>
量測用培養基使用胰蛋白腖大豆瓊脂培養基(美商必帝,Becton, Dickinson)。The measurement medium used tryptic soy agar medium (Becton, Dickinson).
〈評價溶液的製備〉<Preparation of Evaluation Solution>
使用滅菌水,稀釋評價樣本,調整成任意濃度。Use sterilized water to dilute the evaluation sample and adjust to any concentration.
〈接種菌液的製備〉<Preparation of inoculum solution>
將菌體以前培養基培養一夜之後,刮取此菌體,以成為108 cfu/mL之方式,使用含0.1重量體積%胰蛋白腖之0.85重量體積%之生理食鹽水製備接種菌液。After culturing the bacteria in the previous medium overnight, scrape the bacteria to become 10 8 cfu/mL, and prepare the inoculation bacterial solution with 0.85% by weight of saline containing 0.1% by weight of tryptic protein.
[實施例11-1][Example 11-1]
取10 μL之接種菌液分別注入微量試管,將190 μL之評價樣本液:80%HFIP加入微量試管使之作用30秒鐘之後,取10 μL之反應液,使用含0.1重量體積%胰蛋白腖之0.85重量體積%之生理食鹽水稀釋成100倍,使樣本之作用終止(將該溶液稱為反應終止液)。使用含0.1重量體積%胰蛋白腖之0.85重量體積%之生理食鹽水,將反應終止液以10倍為單位分段稀釋至10,000倍。自各稀釋溶液分離取出100 μL,分別塗布至前培養基。將此等以35℃之培養箱培養一夜,以肉眼量測培育出之菌落數。Take 10 μL of the inoculum solution into the micro test tube, add 190 μL of the evaluation sample solution: 80% HFIP into the micro test tube and let it act for 30 seconds, then take 10 μL of the reaction solution and use 0.1% by weight of tryptic protein. 0.85 wt% of normal saline is diluted to 100 times to stop the action of the sample (this solution is called the reaction stop solution). Use 0.85 wt% physiological saline containing 0.1 wt% tryptic protein to dilute the reaction stop solution to 10,000 times in 10-fold units. Separate 100 μL from each diluted solution, and apply to the pre-medium separately. Incubate them in an incubator at 35°C overnight, and measure the number of colonies grown by naked eyes.
〈殺菌性評價方法〉<Evaluation Method of Sterilization>
求出接種菌液所包含之生菌數(CFU/mL)的常用對數值與其平均值。由此平均值與評價樣本液作用後之生菌數(CFU/mL)之對數值的平均值,以下式求出對數減少值(Log Reduction Value:LR值)。 Log Reduction=A-B A:接種菌液所包含之生菌數(常用對數值)的平均值 B:評價樣本液作用後之生菌數(常用對數值)的平均值Calculate the common logarithmic value of the number of bacteria (CFU/mL) contained in the inoculum solution and its average value. From this average value and the average value of the logarithmic value of the number of bacteria (CFU/mL) after the evaluation of the sample solution, the log reduction value (Log Reduction Value: LR value) is calculated by the following formula. Log Reduction=A-B A: The average value of the number of bacteria (commonly used logarithmic value) contained in the inoculum solution B: The average value of the number of bacteria (commonly used logarithmic value) after the evaluation of the sample solution
[實施例11-2][Example 11-2]
除了將評價樣本液定為40%HFIP以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 40% HFIP, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[實施例11-3][Example 11-3]
除了將評價樣本液定為20%HFIP以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 20% HFIP, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[實施例11-4][Example 11-4]
除了將評價樣本液定為10%HFIP並將反應終止液以10倍為單位稀釋至1,000倍以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 10% HFIP and the reaction termination liquid was diluted to 1,000 times in units of 10 times, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[實施例11-5][Example 11-5]
除了將評價樣本液定為5%HFIP並將反應終止液以10倍為單位稀釋至1,000倍以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 5% HFIP and the reaction termination liquid was diluted to 1,000 times in 10-fold units, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[實施例11-6][Example 11-6]
除了將評價樣本液定為2.5%HFIP並將反應終止液以10倍為單位稀釋至1,000倍以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 2.5% HFIP and the reaction termination liquid was diluted to 1,000 times in 10-fold units, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[實施例12-1][Example 12-1]
除了將評價樣本液定為80%TFE(此外,若將容量%換算成質量%為85質量%TFE。下同。)以外,以與實施例11-1相同的程序實施殺菌性評價試驗。The bactericidal evaluation test was carried out in the same procedure as in Example 11-1, except that the evaluation sample liquid was set to 80% TFE (in addition, if the volume% is converted to mass %, it is 85% by mass TFE. The same hereinafter.).
[實施例12-2][Example 12-2]
除了將評價樣本液定為40%TFE(此外,若將容量%換算成質量%為48質量%TFE。下同。)以外,以與實施例12-1相同的程序實施殺菌性評價試驗。The bactericidal evaluation test was carried out in the same procedure as in Example 12-1 except that the evaluation sample liquid was set to 40% TFE (in addition, if the volume% is converted to mass %, it is 48% by mass TFE. The same hereinafter.).
[實施例12-3][Example 12-3]
除了將評價樣本液定為20%TFE(此外,若將容量%換算成質量%為26質量%TFE。下同。)以外,以與實施例12-1相同的程序實施殺菌性評價試驗。The bactericidal evaluation test was performed in the same procedure as in Example 12-1, except that the evaluation sample liquid was set to 20% TFE (in addition, if the volume% is converted to mass %, it is 26% by mass TFE. The same hereinafter.).
[實施例12-4][Example 12-4]
除了將評價樣本液定為10%TFE(此外,若將容量%換算成質量%為13質量%TFE。下同。)並將反應終止液以10倍為單位稀釋至1,000倍以外,以與實施例12-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample solution is set to 10% TFE (in addition, if the volume% is converted to mass%, it is 13 mass% TFE. The same below.) and the reaction termination solution is diluted to 1,000 times by 10 times. The bactericidal evaluation test was carried out in the same procedure as in Example 12-1.
[比較例11][Comparative Example 11]
除了將評價樣本液定為生理食鹽水以外,以與實施例11-1相同的程序實施殺菌性評價試驗。The bactericidal evaluation test was carried out in the same procedure as in Example 11-1 except that the evaluation sample liquid was set to physiological saline.
[參考例11-1][Reference Example 11-1]
除了將評價樣本液定為80%EtOH以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 80% EtOH, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[參考例11-2][Reference example 11-2]
除了將評價樣本液定為40%EtOH以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 40% EtOH, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
[參考例11-3][Reference example 11-3]
除了將評價樣本液定為20%EtOH以外,以與實施例11-1相同的程序實施殺菌性評價試驗。Except that the evaluation sample liquid was set to 20% EtOH, the sterilization evaluation test was carried out in the same procedure as in Example 11-1.
對於實施例11-1至實施例11-6、實施例12-1至實施例12-4、比較例11及參考例11-1至參考例11-3,彙整好接種菌濃度、評價樣本液、接觸時間、以各稀釋倍率培養後之菌落數者揭示於圖12。圖12中,「―」表示未實施。並且,於圖13,對於各評價樣本液,以LR值(Log Reduction Value)表示殺菌效力。對於各評價樣本液,LR值為3.0以上(生菌數減少99.9%以上)者判定為「◎」,LR值未達1.0者判定為「╳」。For Example 11-1 to Example 11-6, Example 12-1 to Example 12-4, Comparative Example 11 and Reference Example 11-1 to Reference Example 11-3, the concentration of inoculation bacteria was collected and the sample solution was evaluated , The contact time, and the number of colonies after culturing at each dilution rate are shown in Figure 12. In Figure 12, "-" indicates that it has not been implemented. In addition, in FIG. 13, for each evaluation sample liquid, the bactericidal efficacy is represented by an LR value (Log Reduction Value). For each evaluation sample solution, those with an LR value of 3.0 or more (the number of bacteria reduced by 99.9% or more) is judged as "◎", and those with an LR value of less than 1.0 are judged as "╳".
如圖13所示,HFIP及TFE對於大腸桿菌表現殺菌效果顯而易見。尤其,由參考例11-3與實施例11-3的比較以及參考例11-3與實施例12-3的比較可知,HFIP及TFE表現出較EtOH強的殺菌性。在本實施例中揭露對於大腸桿菌的殺菌效果,但可想見HFIP、TFE等氟系醇對於其他菌,例如:金黃色葡萄球菌、大腸桿菌、腸道出血性大腸桿菌、結核菌、MRSA、抗萬古黴素腸球菌、多重抗藥性綠膿桿菌、多重抗藥性不動桿菌等亦表現同樣的殺菌效果。As shown in Figure 13, HFIP and TFE have obvious bactericidal effects on Escherichia coli. In particular, the comparison between Reference Example 11-3 and Example 11-3 and the comparison between Reference Example 11-3 and Example 12-3 show that HFIP and TFE exhibit stronger bactericidal properties than EtOH. In this embodiment, the bactericidal effect on Escherichia coli is disclosed, but it is conceivable that fluoroalcohols such as HFIP and TFE have effects on other bacteria, such as: Staphylococcus aureus, Escherichia coli, enterohemorrhagic Escherichia coli, tuberculosis, MRSA, Vancomycin-resistant enterococci, multi-drug resistant Pseudomonas aeruginosa, multi-drug resistant Acinetobacter, etc. also show the same bactericidal effect.
在本揭露中之將病毒去活化的清洗劑可有利使用於醫療用器具等的清洗。The cleaning agent for deactivating viruses in the present disclosure can be advantageously used for cleaning medical appliances and the like.
1:清洗裝置 10:清洗槽 12:貯水部 14:供水管 16:供熱水管 18:清洗泵 20:收納部 22:清洗噴嘴 34:排水管 40:清洗劑供應裝置1: Cleaning device 10: Cleaning tank 12: Water storage department 14: Water supply pipe 16: Hot water supply pipe 18: Cleaning the pump 20: Storage department 22: Cleaning the nozzle 34: Drain pipe 40: Cleaning agent supply device
〈圖1〉係說明本揭露之一實施例相關之清洗裝置之構造的剖面圖。<Figure 1> is a cross-sectional view illustrating the structure of a cleaning device related to an embodiment of the present disclosure.
〈圖2〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 2> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖3〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 3> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖4〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 4> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖5〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 5> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖6〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 6> is a diagram showing the evaluation of virus deactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖7〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 7> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖8〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 8> is a diagram showing the evaluation of virus deactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖9〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 9> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖10〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 10> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖11〉係揭示本揭露之一實施例相關之清洗劑之病毒去活化之評價的圖。<Figure 11> is a diagram showing the evaluation of virus inactivation of the cleaning agent related to an embodiment of the present disclosure.
〈圖12〉係揭示本揭露之一實施例相關之清洗劑之殺菌性之評價的圖。<Figure 12> is a diagram showing the evaluation of the sterilization of the cleaning agent related to an embodiment of the present disclosure.
〈圖13〉係揭示本揭露之一實施例相關之清洗劑之殺菌性之評價的圖。<Figure 13> is a diagram showing the evaluation of the sterilization of the cleaning agent related to an embodiment of the present disclosure.
1:清洗裝置 1: Cleaning device
10:清洗槽 10: Cleaning tank
12:貯水部 12: Water storage department
14:供水管 14: Water supply pipe
16:供熱水管 16: Hot water supply pipe
18:清洗泵 18: Cleaning the pump
20:收納部 20: Storage department
22:清洗噴嘴 22: Cleaning the nozzle
34:排水管 34: Drain pipe
40:清洗劑供應裝置 40: Cleaning agent supply device
Claims (46)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019221416 | 2019-12-06 | ||
| JP2019-221416 | 2019-12-06 | ||
| JP2020066224 | 2020-04-01 | ||
| JP2020-066224 | 2020-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202128973A true TW202128973A (en) | 2021-08-01 |
Family
ID=76222390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109142718A TW202128973A (en) | 2019-12-06 | 2020-12-04 | Cleaning agent, and cleaning method and cleaning device using cleaning agent |
Country Status (2)
| Country | Link |
|---|---|
| TW (1) | TW202128973A (en) |
| WO (1) | WO2021112172A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023088527A (en) * | 2021-12-15 | 2023-06-27 | 株式会社クレオ | Cleaning equipment, cleaning liquid and cleaning method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4017492A1 (en) * | 1989-11-06 | 1991-12-05 | Kali Chemie Ag | CLEANING COMPOSITIONS OF HYDROGEN-BASED FLUOROCHLORINE HYDROCARBONS AND PARTIALLY FLUORED ALKANOLS |
| US6030934A (en) * | 1997-02-19 | 2000-02-29 | 3M Innovative Properties Company | Azeotropic compositions of methoxy-perfluoropropane and their use |
| EP1160313A1 (en) * | 2000-06-02 | 2001-12-05 | The Procter & Gamble Company | Cleaning composition and device for electronic equipment |
| US7629307B2 (en) * | 2008-01-17 | 2009-12-08 | 3M Innovative Properties Company | Ternary azeotropic-like compositions with 1,1,1,2,3,3-hexafluoro-3-methoxy-propane and trans-1,2-dichloroethylene |
| CN103122285A (en) * | 2011-11-21 | 2013-05-29 | 天津市浩宇助剂有限公司 | Bactericidal cleaner |
-
2020
- 2020-12-03 WO PCT/JP2020/045015 patent/WO2021112172A1/en not_active Ceased
- 2020-12-04 TW TW109142718A patent/TW202128973A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021112172A1 (en) | 2021-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6644887B2 (en) | Cleaning and disinfecting compositions | |
| US7501027B2 (en) | Non-chlorinated concentrated all-in-one acid detergent and method for using the same | |
| CN101146905B (en) | Anti-corrosion detergent compositions and use of same in cleaning dental and medical instruments | |
| CN101878290B (en) | biofilm remover | |
| PL196210B1 (en) | A way to clean and sanitize sensitive medical equipment | |
| US20100190676A1 (en) | Composition for enhanced removal of blood soils | |
| WO2012090306A1 (en) | Method for cleaning medical appliance | |
| JP5584613B2 (en) | Cleaning method for medical equipment | |
| ES2257576T3 (en) | CLEANING COMPOSITION AND METHOD FOR USE. | |
| JP6732454B2 (en) | Cleaning disinfectant composition | |
| TWI848958B (en) | Compositions for treatment and methods for making and using the same | |
| JP4244190B2 (en) | Cleaning and disinfection of surgical and medical equipment and instruments | |
| TW202128973A (en) | Cleaning agent, and cleaning method and cleaning device using cleaning agent | |
| RU2370283C2 (en) | Machine disinfection of objects | |
| US9045718B2 (en) | Residue cleaning composition and method | |
| WO2021090910A1 (en) | Molecular structure altering agent for detecting protein aggregates, detection method thereof, medical equipment cleaning agent, soil cleaning agent and soil cleaning method | |
| JP2022056396A (en) | How to clean cleaning agents, cleaning agent products, and articles | |
| US20250331516A1 (en) | Citric acid and lactic acid disinfecting solution for soft porous surfaces | |
| HK1118572B (en) | Anti-corrosion detergent compositions and use of same in cleaning dental and medical instruments | |
| US20150225670A1 (en) | Residue cleaning composition and method |